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ABSTRACT 
 
Caspases are important players in programmed cell death. Normal activities of caspases are criti-
cal for the cell life cycle and dysfunction of caspases may lead to the development of cancer and neuro-
degenerative diseases. They have become a popular target for drug design against abnormal cell death. In 
this study, the recognition of P5 position in substrates by caspase-3, -6 and -7 has been investigated by 
kinetics, modeling and crystallography. Crystal structures of caspase-3 and -7 in complexes with substrate 
analog inhibitor Ac-LDESD-CHO have been determined at resolutions of 1.61 and 2.45 Å, respectively, 
while a model of caspase-6/LDESD is constructed. Enzymatic study and structural analysis have revealed 
that Caspase-3 and -6 recognize P5 in pentapeptides, while caspase-7 lacks P5-binding residues.  
D-arginine dehydrogenase catalyzes the flavin-dependent oxidative deamination of D-amino ac-
ids to the corresponding imino acids and ammonia. The X-ray crystal structures of DADH and its com-
plexes with several imino acids were determined at 1.03-1.30 Å resolution. The DADH crystal structure 
comprises a product-free conformation and a product-bound conformation. A flexible loop near the active 
site forms an “active site lid” and may play an essential role in substrate recognition. The DADH Glu87 
forms an ionic interaction with the side chain of iminoarginine, suggesting its importance for DADH 
preference of positively charged D-amino acids. Comparison of the kinetic data of DADH activity on dif-
ferent D-amino acids and the crystal structures demonstrated that this enzyme is characterized by relative-
ly broad substrate specificity, being able to oxidize positively charged and large hydrophobic D-amino 
acids bound within a flask-like cavity. 
Understanding biology at the system level has gained much more attention recently due to the 
rapid development in genome sequencing and high-throughput measurements. Current simulation meth-
ods include deterministic method and stochastic method. Both have their own advantages and disad-
vantages. Our group has developed a deterministic-stochastic crossover algorithm for simulating bio-
chemical networks. Simulation studies have been performed on biological systems like auto-regulatory 
gene network and glycolysis system. The new system retains the high efficiency of deterministic method 
while still reflects the random fluctuations at lower concentration. 
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1 
1 INTRODUCTION 
1.1  Substrate Specificity of Executioner Caspases 
1.1.1  Apoptosis 
 The programmed cell death, also known as apoptosis, is a critical event in the life cycle of all liv-
ing organisms [1]. It is a highly regulated process important in normal physiological activities as well as 
in many diseases [2]. Apoptosis will lead to the cell morphological and biochemical changes and eventu-
ally cell death. Changes including blebbing, membrane detachment, nuclear fragmentation, and chromatin 
condensation are normally seen during the development of apoptosis. The cell fragments produced by 
apoptosis are quickly degraded and removed before further damages occur [3]. Regular apoptosis is a 
non-harmful activity and is required in a healthy organism. For example, during the development of a 
human embryo, apoptosis occurs to the tissue cells between the fingers and triggers the differentiation of 
fingers and toes. Other factors such as virus infection, toxic materials, and radiation can also induce apop-
tosis. 
 The occurrence of apoptosis can be triggered by a diverse range of signals, which could be intra-
cellular (intrinsic pathway) or extracellular (extrinsic pathway). The execution of apoptosis is shown to be 
carried out by the caspase family, which will be further discussed in the following sections. The intrinsic 
pathway is activated in response to cell stresses, such as DNA damage and loss of cell survival factors. 
The Bcl-2 protein family plays important roles in the regulation of the mitochondria-initiated intrinsic 
apoptosis [4]. More than twenty members of the Bcl-2 family have been identified. The Bcl-2 family 
members are grouped into three subfamilies according to their sequence and function similarity [5]. The 
anti-apoptosis subfamily includes Bcl-2 and Bcl-xL in mammals and CED-9 in nematodes. Bcl-2 and 
Bcl-xL prevent the mitochondrial proteins from being released. CED-9 inhibits apoptosis through pre-
venting CED-4 from activating CED-3 [4]. The pro-apoptotic Bcl-2 members are grouped into multi-
domain pro-apoptotic subfamily including Bax and Bak, and BH3-only pro-apoptotic subfamily [6]. Bax 
2 
and Bak exist as cytosolic monomers in healthy cells and will oligomerize upon receiving the death sig-
nal. It is suggested that these oligomers will form pores on the outer mitochondrial membrane, thus allow-
ing the release of mitochondrial proteins like cytochrome c and SMAC/DIABLO into the cytosol [7]. Cy-
tochrome c binds the adaptor apoptotic protease activating factor-1 (Apaf-1) to facilitate the formation of 
apoptosome, which recruits and activates caspase-9. Caspase-9 then activates the downstream executioner 
caspases to carry out the apoptosis. 
 The extrinsic apoptosis pathway is initiated by extracellular signals, such as hormones,  toxins, 
nitric oxide, growth factors and cytokines [4]. Extracellular molecules such as Apo2L/TRAIL and 
CD95L/FasL are also known as pro-apoptotic ligands [8]. These pro-apoptotic ligands bind to the death 
receptors on the cell surface. The death receptors are characterized by extracellular cysteine-rich domains 
(CRDs) and belong to the tumor necrosis factor (TNF) family of proteins [9]. Members of the well-
studied death receptors include TNFR1 (p55 or CD120a), Fas (Apo1 or CD95), and TRAIL (R1/R2) [4]. 
A death domain (DD) is found in the intracellular domain of all death receptors. The death domain is sug-
gested to be responsible for the binding of adapter proteins such as Fas-associated death domain (FADD) 
during the activation of initiator caspases. The activation of caspase-8 is a result of a cascading 
oligomerization. The activated death ligands exist as homotrimers, thus leading to the oligomerization of 
death receptors upon binding. Adaptor proteins and other effector proteins are then recruited by the death 
receptors. The adaptor proteins like FADD contain death effecter domains (DED) that interact with the 
DED of procaspase-8 and trigger the oligomerization of procaspase-8 [10]. Therefore, the multi-
component death-inducing signaling complex (DISC) is formed at the plasma membrane. Procaspase-8 
molecules are activated by cleaving each other when they are brought together, while only weak 
proteolytic activity is detected for single monomers of procaspase-8 [10]. The active caspase-8 then starts 
to process downstream executioner procaspases, including procaspase-3, -6 and -7.  
 Abnormal inhibition of apoptosis results in uncontrolled cell proliferation, which leads to cancer 
and autoimmune disease [11]. In contrast, excessive cell death has been identified in a number of neuro-
degenerative disorders such as Alzheimer’s disease [12]. Current treatments for cancer include surgery, 
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radiation, chemotherapy, hormone therapy, biological therapy, and targeted therapy [13]. Most of these 
approaches kill cancer cells by inducing apoptosis. However, cancer cells often develop resistance to the-
se therapies. Many cancer therapies introduce chemical or physical damages to DNA, thus increasing the 
chances of developing mutated cancer cells with resistance [6]. Therefore, knowledge of how apoptotic 
pathways are regulated in cancer is critical for understanding the development of the disease and design-
ing effective and reliable anti-cancer treatments. Novel therapies that are both safer and more effective 
could be developed through directly activating or suppressing apoptosis by regulating the caspase activity. 
1.1.2 Caspase Family 
 Caspases are cysteinyl aspartate proteinases that play important roles in the regulation of cell life 
cycle [14]. The first member of caspase family was initially identified as interleukin-1β-converting en-
zyme (ICE, now named caspase-1), which is involved in the maturation of IL1β [15]. Caspase-2 was 
found as the product of the Caenorhabditis elegans cell death gene ced-3 in 1993 [16]. Many caspase 
members have been identified in different organisms, including eleven from human, ten from mouse, four 
from chicken and four from zebrafish [17]. Caspases are classified into three groups according to their 
functions and structures. Some of the caspase members like caspase-1 do not have a role in apoptosis exe-
cution, whereas some caspases are functional in both apoptotic and non-apoptotic signaling. Caspase-1, -
4, -5, -11 and -12 are involved in inflammation. Caspase-2, -8, -9 and -10 are initiators while caspase-3, -
6 and -7 are executioners of apoptosis (Figure 1.1) [6, 18].  
 In healthy cells, caspases normally exist as inactive precursors called procaspases or caspase zy-
mogens. Procaspases are shown to have limited catalytic activity and they are under critical regulation by 
various regulatory molecules [19]. They are composed of three domains: a large subunit (~20kDa, p20), a 
small subunit (~10kDa, p10) and an N-terminal prodomain with various lengths (Figure 1.2a). The long 
prodomain contains different protein-protein interaction domains that play important roles in caspase ac-
tivation, such as the caspase recruitment domain (CARD) in caspase-2 and -9, and death effector domains 
(DEDs) as in caspase-8 and -10. These are known as initiators and their prodomains recruit the 
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procaspases to the death-inducing signaling complex (DISC), while oligomerization leads to their auto-
catalytic activation, known as "proximity-induced" activation [18, 20]. The executioner caspases, 
caspase-3, -6, and -7, do not have a long prodomain and could not perform self-activation. Therefore, the 
downstream caspases are activated through cleavage by active initiator caspases. Procaspases are activat-
ed through removal of the prodomain and cleavage of the linker region between the p20 and p10. One 
molecule of p20 and one molecule of p10 will form an active heterodimer. Two heterodimers will form a 
heterotetramer as the mature caspase under physiological conditions (Figure 1.2a). The 3D structure of 
caspase-3 heterotetramer is shown in Figure 1.2b. It consists of two large subunits and two small subunits 
which are indicated by different colors in the figure.  
 In mammals, the apoptotic caspases have been classified as initiator caspases (caspases-2, -8, -9, 
and -10) and effector caspases (caspases-3, -6, and -7) based on their structures and functions. The activa-
tion of initiator caspases results from cell death signaling through either the extrinsic (death receptor) 
pathway or the intrinsic (mitochondrial) pathway (Figure 1.3). Caspase-8 is an essential component of the 
extrinsic cell death pathways initiated by the TNF family members [19]. The extrinsic pathway initiates 
when the death ligand binds to the cell surface receptor, such as Fas/CD95/Apo-1, which is a member of 
the TNF family of apoptosis-inducing receptors. Binding of Fas and procaspase-8 to the adaptor molecule 
FADD leads to the formation of the death-inducing signaling complex. The aggregated procaspase-8 mol-
ecules then undergo auto-activation and activate the downstream effector caspases [21-22]. It is suggested 
that caspase-8 plays non-redundant roles in normal embryonic development and apoptosis mediated by 
the TNFR family members, while it is not critically required in other apoptotic pathways [19]. Further-
more, caspase-8 is also shown to be involved in macrophage differentiation and in the formation of yolk 
sac vasculature of endothelial cells [23]. Caspase-9 is regarded as the canonical caspase in the intrinsic 
mitochondrial pathway [18]. When the intrinsic pathway is initiated, cytochome c from the inner-
mitochondrial membrane space is released into the cytosol. Binding of cytochrome c and dATP to the 
adaptor molecule, Apaf-1, forms a large multimeric complex called apoptosome. Procaspase-9 is then 
recruited to the apoptosome through the interaction of the caspase CARD domains. Procaspase-9 is acti-
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vated by autocatalysis and then activates the downstream effector caspases [24]. Caspase-10 contains two 
DEDs like caspase-8. Caspase-2 contains one CARD domain similar to caspase-9. However, their func-
tions in apoptosis still remain unclear [19]. It is suggested that human caspase-10 may have a function 
overlapping with caspase-8 in Fas ligand-mediated cell death pathway [25]. Caspase-2 was demonstrated 
to be required for mitochondrial outer membrane permeabilization and the release of apoptogenic factors 
in response to DNA damaging agents [26]. 
 Caspase-3, -6 and -7 are the downstream effector caspases. Caspase-3 is the major executioner 
that cleaves the majority of the cellular substrates in apoptotic cells while caspase-6 and -7 are involved to 
a lesser extent [27]. Activation of caspase-3 is carried out by caspase-8 and -9 but not by caspase-2 [18]. 
Capase-7 is quite similar to caspase-3 and they share similar substrate specificity [18-19]. Reduced cell 
death and increased cell number in the central nervous system (CNS) have been observed in caspase-3 
mutant mice [28]. DNA fragmentation defects are also detected in the cells derived from these animals. 
Caspase-3 knockout animals in C57BL/6 background showed certain viability with reduced fertility, indi-
cating that caspase-3 is redundant for most developmental cell death [29]. If only caspase-7 was knocked 
out, the animals showed normal development and their cells were still sensitive to a variety of apoptotic 
agents [29]. However, when both caspase-3 and caspase-7 are knocked out, the animals will die rapidly 
after birth, suggesting that these two caspases are critical for the apoptosis execution. Caspases-3 and -7 
share high sequence identity of 56% and they preferentially recognize DEVD in their substrate sequence. 
Caspase-6 shares 37% and 41% sequence identity with caspase-7 and -3, respectively, and it shows struc-
tural homology to caspase-3 and -7. However, it has a different substrate specificity showing preference 
for peptide sequence VEHD rather than DEVD preferred by caspase-3 and -7 [30]. The function of 
caspase-6 remains unclear. The caspase-6 knock-out mice developed normally and the cells were still 
sensitive to various apoptotic agents, suggesting caspase-6 is not essential for apoptosis [19]. These stud-
ies suggest that any of the effector caspases may be important for certain apoptosis pathways while others 
may act as redundant or compensatory executioners. 
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1.1.3 Caspase Substrate Specificity 
 Caspases are major executioners of apoptosis. Substrates of caspases have been identified in 
many biological pathways, such as proteins involved in framework of the cytoplasm and nucleus, tran-
scription regulatory, and DNA replication and repair [31]. The analysis of binding preferences in caspase 
active site or the cleavage site sequences on their natural substrates are two different ways for investigat-
ing caspase substrates [32]. More than 280 protein substrates of caspase have been identified in cells and 
the discovery has been considerably accelerated by the systematic proteome analysis of apoptotic cells 
[31].  
 Most of the caspases recognize certain tetrapeptide sequences in their substrates (Figure 1.4a) 
[32].  This was initially investigated by Thornberry et al. [30] using positional scanning synthetic peptide-
based libraries and Talanian et al. [33] using sets of individual peptide substrates and later refined by oth-
ers. The positions on the N-terminal side of the scissile bond are called P1, P2, P3 and P4 with the corre-
sponding binding sites called S1-S4, while the positions on the C-terminal side are called P1’ and P2’. 
The active site groove of caspase-3 with DEVD binding in the active site is shown in Figure 1.4b (PDB: 
2H5I) [34]. The substrate P1-P4 residues bind into the corresponding S1-S4 pockets in the active site. A 
requirement for aspartic acid is highly restricted at the P1 position while the residues at other positions 
may vary with different preferences. The substrate specificities of caspases are summarized in Figure 
1.4c. Previous studies have showed that the substrate preference is W/YExD (x refers to any amino acid) 
for caspase-1, 4, 5, 14, I/LExD for caspase-8, 9, 10, DExD for caspase-3, 7, VExD for caspase-6, and 
DExD for caspase-2 [32]. Furthermore, the residue at the P1’ position was also shown to be important for 
the caspase substrate specificity. Small and uncharged residues like Gly, Ala, Thr, Ser and Asn at P1’ 
form good substrates, while bulky or charged residues like Glu, Asp, Lys, Arg, Trp are poorly tolerated 
[35]. The substrate recognition was extended to P5 for caspase-2 [36]. Similarly, it is reported that 
caspase-3 prefers pentapeptides with hydrophobic amino acids at P5 over tetrapeptides [34, 37]. 
 Knowledge of caspase substrate specificity has been verified and refined by many investigators 
and has led to various novel methods to study the activity of caspases. Peptide-based small substrate re-
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porters have been developed to measure the activity of caspases [38]. These reporters normally contain a 
caspase preferred tetrapeptide sequence with a C-terminal fluorogenic reporter, which is released to pro-
duce a fluorescent signal upon cleavage. This method has greatly facilitated the characterization of 
caspase substrate specificity. However, the over-simplified traditional understanding of caspase substrate 
specificity does not work well for prediction of caspase protein substrates [32]. Due to the simplicity of 
caspase preferred tetrapeptide sequence, many proteins may possess one or more similar sequences. 
However, this is far from sufficient requirement for the protein to be a natural caspase substrate. First of 
all, the cleavage site needs to be properly exposed to the caspase active site, while most of the time these 
potential cleavage sites are deeply embedded inside the protein 3-dimensional structures. This brings out 
another concept called exosite, the enzyme regions that are distant from the active site but involved in 
substrate binding. Some studies have showed additional interactions between caspases and their sub-
strates. However, the mechanism still remains unclear. The crystal structure of viral caspase inhibitor p35 
with caspase-8 revealed a p35 loop region interacts with a surface area of caspase-8 distant from the ac-
tive site, suggesting a possible exosite interaction [39]. Moreover, the cleavage site sequences on caspase 
natural substrates are also different from canonical sequences. It is suggested that about 45% of reported 
caspase-3 natural substrates contain cleavage site sequences different from classical substrate sequences 
[31]. Therefore, the presence of a preferred cleavage site sequence on a protein does not always guarantee 
it is a real caspase cleavage site in vivo.  
 As caspases play essential roles in the regulation of apoptosis, their substrate specificities have 
been intensively studied by many research groups over a decade. The previous research results helped the 
discovery of various natural caspase substrates. Determination of these canonical substrate sequences 
helped us to better understand the caspase substrate specificity. However, many aspects of the caspase 
substrate specificities still remain elusive. We are studying the substrate binding of caspases by applying 
crystallography, kinetic study and computational modeling in order to provide valuable information for 
future studies of caspase substrate specificity. The recognition of P5 position in substrates by caspase-3, -
6 and -7 has been investigated in this study [37]. In caspase-3, the enzyme residues Ser209, Phe250 and 
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Phe252 interact with the P5 residue in substrate. It showed 50% increased hydrolysis of LDEVD relative 
to DEVD in enzymatic experiment. A model of caspase-6 indicated its preference for polar P5 in QDEVD 
likely due to interactions with polar Lys265 and hydrophobic Phe263 in loop-4. Unlike the other two exe-
cutioner caspases, Caspase-7 exhibited no preference for P5 residue in agreement with the absence of P5 
interactions in the caspase-7/LDESD crystal structure. These findings will provide valuable information 
for better understanding the different roles of the executioner caspases. The differences identified in P5 
recognition are particularly important for caspase-3 and -7, which showed very similar preferences for 
tetrapeptide sequence in substrate. Such knowledge can be applied in the design of selective inhibitors for 
caspases, which can be potentially used in the treatment of diseases caused by increased activities of 
caspases. 
1.2 Structural Analysis of D-Arginine Dehydrogenase 
1.2.1 Flavoenzymes 
Flavoenzymes play important roles in a large variety of biological processes. They typically con-
tain a molecule of flavin mononucleotide (FMN) or flavin adenine dinucleotide (FAD) as a cofactor. In 
most flavoenzymes, the cofactor is non-covalently bound to the apoprotein, with a few exceptions that the 
cofactor forms covalent bond with a Histidine, Cysteine or Tyrosine of the protein [40-41]. The cofactor 
FAD is composed of one molecule of adenosine monophosphate (AMP) and one flavin mononucleotide 
(FMN), which are linked together by a pyrophosphate bond (Figure 1.5a). The FMN moiety contains an 
isoalloxazine ring, which is the catalytic center of FAD, while the other groups mainly contribute to the 
binding of the cofactors to the protein. The isoalloxazine ring contains a xylene group, which is hydro-
phobic and forms better interaction with hydrophobic protein residues, and a pyrimidine ring, which is 
hydrophilic and is easier to form hydrogen bonds [42]. The flavin can transfer one or two elections from 
the substrate to another substrate or an electron acceptor. Therefore, three different redox states for flavin 
have been identified: oxidized, semiquinoid, and fully reduced (Figure 1.5b). Furthermore, the catalytic 
activities of the flavin are also affected by the surrounding protein residues. For example, protein positive 
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charges have been identified in flavoprotein oxidases such as glucose oxidase and choline oxidase. The 
positive charges are involved in the electrostatically stabilization of the oxygen activation in flavoprotein 
oxidases [43]. Other protein structures affecting the flavin’s oxidation-reduction potential are also report-
ed, such as the Ala113 in L-galactono-γ-lactone dehydrogenase, which is suggested to block the oxygen 
access to FAD. Mutation of this Ala to a Gly has increased the reactivity of the reduced flavin with oxy-
gen by about 400-fold [44]. A similar structure has been observed for D-arginine dehydrogenase Ala46, 
which will be discussed in details in the following chapters [45]. 
Flavoenzymes are involved in a wide range of biological processes. Their functions are not only 
limited to electron-transfer reactions, but extended to energy production, light sensing and emission, neu-
ral development and protein folding (Figure 1.6) [41, 46]. The cofactor is reduced by the enzyme sub-
strate and then oxidized by an electron acceptor. The flavoenzymes are characterized into different groups 
based on the type of their electron acceptors. Those convert oxygen to hydrogen peroxide are named 
flavoprotein oxidases, such as L-amino acid oxidase and D-amino acid oxidase [47-48]. Those employ 
other electron acceptors are called flavoprotein dehydrogenases, such as Cytokinin dehydrogenase and L-
proline dehydrogenase [49-50]. Another group of flavoenzymes are known as monooxygenases, which 
introduce a single oxygen atom into the substrate and reduce the other oxygen atom to water [41]. A tran-
sient C4a-hydroperoxide intermediate is formed during the activation of molecular oxygen in the 
monooxygenases. Several members of this family have been identified in the past few years, including 
Baeyer-Villiger monooxygenases, flavin-containing monooxygenases and N-hydroxylating enzymes [51]. 
A great variety of substrate specificity has been observed for flavoenzymes. Some have very narrow sub-
strate specificity, while others have a broader selection of susbtrates. For example, glycine oxidase is able 
to react with various amines and D-amino acids in thiamine biosynthesis [52]. On the contrary, L-
tryptophan oxidase, which is involved in the biosynthesis of the antitumor compound rebeccamycin, 
strictly prefers 7-chloro-L-tryptophan [53]. 
Flavoenzymes have been the subject of many studies for more than 50 years [54]. Hundreds of 
members have been identified in prokaryotic and eukaryotic organisms, for which about 1-3% of their 
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genes are suggested to encode flavin-containing proteins [46, 54]. The enzymological and structural prop-
erties of many flavoenzymes have been intensively studied and characterized, while certain aspects of the 
reaction mechanism still remain unclear. Although they are identified in different organisms and involved 
in various biological processes, similarities have been found in sequences and structures of flavoenzymes. 
So far, four different FAD-binding folds have been defined for flavoenzymes [55]. They are represented 
by glutathione reductase (GR), ferredoxin reductase (FR), p-cresol methylhydroxylase (PCMH), and py-
ruvate oxidase (PO), respectively (Figure 1.7). Unique FAD-binding patterns have been identified to dis-
tinguish different flavoenzyme families. However, sequence and structure studies of flavoenzymes have 
revealed some conserved sequence motifs and similar 3-D structures that are essential for cofactor bind-
ing. One of the most well-known folds was first identified in NADH-binding dehydrogenases by 
Rossmann, and is named Rossmann fold [56]. This structure is later found to be conserved in the GR 
flavoenzyme family. The Rossmann fold is composed of a central five-stranded parallel β-sheet with α-
helices on one side and a three-stranded antiparallel β-sheet on the other side (Figure 1.7a). A conserved 
sequence motif has been identified in the GR family members, xhxhGxGxxGxxxhxxh(x)8hxhE(D), in 
which x stands for any residue and h represents a hydrophobic residue [57-58]. A sequence-structure 
analysis of 32 nonredundant FAD-containing enzymes has revealed many structural and sequence proper-
ties that are conserved among the flavoenzymes [55]. For example, all the members of the FR family con-
tain a cylindrical β-domain in their FAD-binding fold, while the FAD-binding domain of PCMH mem-
bers all consists of two α+β subdomains (Figure 1.7b, c) [55, 59]. The PO family contains a double 
Rossmann fold similar to the FAD fold in GR family; despite the fact the two families share very little 
similarity in their sequences (Figure 1.7d) [56]. Further, the various FAD-binding domains allows FAD 
bind to the enzyme in different conformations, such as the elongated or bent butterfly conformation. In 
the elongated conformation, the adenine ring is located far from the isoalloxazine ring as seen in the struc-
tures of D-Amino acid oxidase [60] and glutathione reductase (FAD in Figure 1.7a) [61]. In the bent con-
formation, the adenine and isoalloxazine ring are very close to each other as observed in flavodoxin 
reductase and other members of the FR family (FAD in Figure 1.7b) [62]. In conclusion, the sequence and 
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structure analysis on the conserved motifs, cofactor binding, and cofactor conformation of flavoenzymes 
will improve our understanding of the reaction mechanisms and provide useful information for recogniz-
ing new flavin-containing proteins from the sequence. 
1.2.2 D-Amino Acids 
The standard amino acids except glycine can exist as either L- or D- optical isomers. An example 
of L- and D- forms of alanine is shown in Figure 1.8. The L-amino acids are utilized as building blocks 
for proteins synthesized by all living organisms. D-amino acids are important for bacteria as fundamental 
elements of the bacterial cell wall peptidoglycan layer, but their catabolism mechanism is not well under-
stood [63]. Several D-amino acids are reported to be involved in disassembly of bacterial biofilms [64] 
and growth phase-dependent cell wall remodeling [65]. Moreover, specific D-amino acids have been dis-
covered in many physiological processes in vertebrates, including humans [66]. Dunlop et al. identified 
D-aspartate in the brain and other tissues of mammals and suggested that it may play a role in regulating 
the development of these organs [67]. D-serine was identified at significant levels in rat brain, at about a 
third of the level of L-serine [68]. Further, D-serine in the rat brain is distributed in close association with 
N-methyl-D-aspartate (NMDA) and it may act as an endogenous agonist of the NMDA receptor in mam-
malian brains [68]. 
The catabolism of D-amino acids has not been intensively studied when compared to those of L-
amino acids. D-amino acids could be metabolized either directly or after conversion into the L-
enantiomers. Conversion of L- and D-amino acids in living organisms is commonly catalyzed by 
racemases. Various amino-acid racemases have been identified in bacteria, archaea, and eucaryotes in-
cluding mammals. These racemases are classified into two groups: pyridoxal 5’-phosphate (PLP) -
dependent and -independent enzymes [66]. D-serine racemases and D-aspartate racemases are intensively 
studied in mammals due to their involvement in cell aging and neural signaling [69-70]. In bacteria, D-
amino acids are deaminated by flavin-dependent oxidases or dehydrogenase, allowing the bacteria to 
grow using D-amino acids as the nutrient and energy source [71-73]. 
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Many flavoenzymes have been identified in the catabolism pathway of D-amino acids. D-amino 
acid oxidase has been the most extensively studied member since its first discovery in 1930s [48]. This 
enzyme catalyzes the dehydrogenation of D-amino acids into their corresponding imino acids. The imino 
acids are converted to keto acids and ammonium through a non-enzymatical reaction, while the reduced 
enzyme cofactor FAD is oxidized by molecule oxygen. The structure of DAAO is composed of two do-
mains, a FAD-binding domain and a substrate-binding domain (or interface domain) (Figure 1.9a) [74]. 
The cofactor FAD adopts the elongated conformation with the flavin ring located at the interface between 
the two domains. The enzyme active site is identified near the re face of the cofactor as shown in the 
structures of DAAO with ligands [74-75]. 
DAAO is widely distributed in nature, from microorganisms to mammalian tissues, such as brain, 
kidney, and liver. The studies on DAAO used to be difficult due to the low content in tissues and low sta-
bility of this enzyme. However, investigation in DAAO has increased dramatically since mid 1990s be-
cause of the importance of its physiological roles and development of genetic engineering which allows 
producing the enzyme in large quantity [76-77]. DAAO is able to catalyze the deamination of many D-
amino acids. Therefore, it is involved in many physiological processes. In microorganisms, DAAO can 
provide D-amino acids as a source of carbon, nitrogen, and energy [78]. In mammalian cells, DAAO 
plays important roles in many processes such as neutral signaling and hormone secretion by regulating 
level of D-amino acids. One of the most important functions of DAAO is its regulation of D-serine, which 
is known to be an endogenous agonist of NMDA-receptors in mammalian brains [68]. Increased DAAO 
activity will lead to decreased level of D-serine, hence lowering the activity of NMDA-receptors. It is 
suggested that this regulation is related to the development of schizophrenia [76]. Moreover, DAAO is 
involved in the process of hormone secretion due to its regulation of D-Aspartate [77]. DAAO also regu-
lates the levels of D-proline and D-alanine. The level of D-oxyproline has been suggested to be related to 
aging [79]. D-alanine is found to be important for intracellular osmotic pressure and increased level of D-
alanine has been reported in the gray matter of Alzheimer’s patient [80-81].  
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One of the major characteristics of DAAO is its high specificity to D-amino acids, while it is al-
most inactive to the corresponding L-amino acids. The deamination of L-amino acids is catalyzed by an-
other flavin-dependent oxidoreductase, L-Amino acid oxidase (LAAO), which accepts most of the 20 L-
amino acids as substrates but does not react with D-amino acids [47]. The structures of LAAO from 
Rhodococcus opacus (roLAAO) with different ligands have been determined (Figure 1.9b) [47]. The 
overall topology of roLAAO is very similar to that of DAAO from pig kidney, although they share very 
low sequence identity (15.3%). The two enzymes are both composed of a substrate-binding domain and a 
FAD-binding domain except that LAAO contains an extra helical domain (colored yellow in Figure 1.9b), 
which is involved in the dimerisation of the enzyme [47]. How these enzymes precisely recognize the 
stereospecificity in their substrates has become an interesting topic. Detailed comparison of the structures 
of DAAO and LAAO has revealed a mirror-symmetrical relationship through the plane perpendicular to 
the isoalloxazine ring between their active sites, which will be responsible for their different enantiomeric 
selectivity [45]. Meanwhile, similar composition and arrangement of the active site residues have been 
observed between the D- and L- amino acid oxidases, which may explain the similarities in their func-
tions. Moreover, a different mode of mirror-symmetrical relationship for opposite stereospecificity has 
been observed between DAAO and flavocytochrome b2, which oxidizes L-lactate to pyruvate [82]. The 
active sites of the two enzymes are mirrored through the plane of isoalloxazine ring. The ligand binds to 
the re side of FAD in pDAAO, while it binds to the si side of FAD in flavocytochrome b2 [74]. 
1.2.3 D-Arginine Dehydrogenase 
Endogenous D-amino acids are normally converted to L-amino acids by racemases [66]. In 2009, 
Li et. al reported a novel 2-component amino acid racemase involved in D-to-L inversion in Pseudomo-
nas aeruginosa, which is an opportunistic human pathogen [83]. A dauBAR operon was found to be high-
ly induced by D-arginine from the DNA microarray analysis. Mutagenesis study showed that mutations at 
dauA or dauB prevented the bacteria from using D-arginine as sole carbon source. Further studies have 
identified two coupled dehydrogenases: D-arginine dehydrogenase, which is encoded by dauA and cata-
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lyzes the conversion of D-arginine into 2-ketoarginine and ammonia, and L-arginine dehydrogenase, 
which is encoded by dauA and converts 2-ketoarginine to L-arginine (Figure 1.10) [83]. Enzymatic stud-
ies on 19 D-amino acids have revealed that DADH has broad substrate specificity, with D-arginine and 
D-lysine as the two best substrates [45, 84].  
In order to understand the reaction mechanism and substrate specificity of DADH, the crystal 
structure of DADH was determined at the atomic resolution of 1.06 Å, while the structures of DADH 
crystallized in the presence of iminoarginine, iminohistidine, iminolysine, iminomethionine, 
iminophenylalanine and iminoproline were also determined at the resolutions of 1.03 Å to 1.30 Å. Well-
defined electron densities for the non-covalently bound FAD and imino intermediates of the reaction al-
lowed detailed analysis of the enzyme active site. Alternative conformations have been observed for a 
loop region near the DADH active site, suggesting its involvement in substrate binding and product re-
lease. Iminoarginine and iminohistidine bind to the active site in distinct modes, which is in agreement 
with detailed kinetic analysis on substrate specificity reported previously [84]. The structural characteris-
tics described here will provide insights into substrate recognition and the catalytic reaction mechanism of 
DADH.  
DADH contains one molecule of FAD as a cofactor and is composed of a substrate-binding do-
main and a FAD-binding domain, while the active site is located at the interface of the two domains (Fig-
ure 1.11a). Sequence of this enzyme showed that it shares very low sequence identity (<20%) with other 
FAD-containing enzymes such as L-proline dehydrogenase (18.5% [50]), DAAO (17.2%, [74]), and 
LAAO (16.4%, [47]). However, the three-dimensional structure of DADH highly resembles those of oth-
er flavoenzymes (see detailed comparison in chapter 3). The FAD-binding domain of DADH adopts the 
rossmann fold that is predominant in the GR flavoenzyme family as discussed in above. It consists of a 
central six-stranded β-sheet  surrounded by five α-helixes on one side and a three-stranded anti-parallel β-
sheet with two α-helixes on the other side (Figure 1.11b). The substrate binding domain is composed of 
an eight-stranded β-sheet and two short antiparallel β-strands forming a sandwich surrounded by four α-
helices. 
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Examination of the electron density map demonstrated that the reaction product imino acids were 
captured in the active sites of the determined crystal structures. Further comparison of structures of the 
ligand-free DADH and its complexes with imino acids has revealed that the protein active site undergoes 
major conformational change upon binding of the ligand. It possesses a ligand-free conformation in the 
free enzyme but shows a product-bound conformation upon binding of the ligand. Residues 50-56 were 
designated as an active site lid controlling the substrate accessibility to the active site. This active site lid 
structure has been reported in many flavoenzymes, such as D-amino acid oxidase (residues 216-228 [48]), 
pyranose 2-oxidase (residues 454-457 [85]), and choline oxidase (residues 64-95 [86]) (Figure 1.12). The 
loop composed of residues 216-228 in DAAO have been proposed to act as a lid that is able to switch 
from closed and open conformation to control substrate binding and product release [74]. This hypothesis 
is supported by the experiment that proteolysis of the peptide bond between loop residues 221-222 is pre-
vented by inhibitor binding, suggesting a conformational alternation upon binding of a ligand [87]. The 
closed conformation of DAAO active site lid has been observed in several structures of DAAO in com-
plexes of different ligands [74-75]. However, the open conformation has never been captured in crystal 
structure based on our knowledge. The ligand-free and product-bound conformations observed in the 
DADH helped confirm the hypothesis about this active site lid. Not only it is involved in ligand binding 
and releasing, it may also play a role in the substrate specificity of DADH [45].  
DADH is characterized by broad substrate specificity, being able to oxidize basic and hydropho-
bic D-amino acids of various sizes, but not reacting with acidic D-amino acids [45, 84]. D-amino acids 
are converted enzymatically to imino acids, which then dissociate from the enzyme and are hydrolyzed to 
keto acids in a nonenzymatic reaction. Steady-state kinetic studies with D-arginine or D-histidine as sub-
strate have established a ping-pong bi-bi kinetic mechanism for this enzyme [88]. A product release ex-
periment with D-arginine indicated that the release of imino product is partially rate limiting for the over-
all turnover of the enzyme, which is in agreement with the observation that imino acids were trapped in 
the crystal structure. DADH has been suggested to be a true dehydrogenase due to its lack of oxygen reac-
tivity [88]. Structural analysis suggested that the access of O2 to the flavin C4a atom is blocked by the 
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Ala46 and the absence of positive charge proximal to the flavin C4a and N1-C2 atoms is also responsible 
for its poor oxygen reactivity. A mutation of DAAO Gly52, which is located at the corresponding posi-
tion of DADH Ala46, to Val leads to the loss of DAAO reactivity with oxygen due to the steric hindrance 
blocking the oxygen access [89]. Furthermore, substitution of the structurally equivalent Ala113 with Gly 
in L-galactono-γ-lactone dehydrogenase increased the reactivity of the reduced flavin with oxygen by 
about 400-fold [44]. 
The structural studies on DADH presented here may facilitate knowledge of the mechanism of 
catabolism of D-amino acids in vivo. The conformational change at the active site lid has been clearly 
shown in the atomic resolution structure of DADH, suggesting a role in controlling the substrate binding 
and product releasing. This active site lid has been proposed in other enzymes such as DAAO but with no 
direct evidence. The ionic interaction of iminoarginine with Glu87 in DADH is suggested to be critical 
for the enzyme specificity for basic D-amino acids. This is supported by the kinetic study showing that D-
arginine and D-lysine are the two best substrates and the kcat/KArg value is about 1000-fold higher than the 
kcat/KHis value. Moreover, the structural analysis of DADH in complexes with hydrophobic imino acids 
revealed the hydrophobic residues responsible for the binding of bulky hydrophobic substrates. Further 
comparison of DADH with other functional related enzymes like DAAO and L-amino acids oxidase has 
revealed some key components and structural arrangement that are responsible for their specificity toward 
different enantiomers and different amino acids [45]. Detailed structural comparison of DADH with D-
amino acid oxidase and D-aspartate oxidase indicated that although they share active site similarities in 
terms of recognition of D-amino acids, different arrangement and composition of the key structural fea-
tures determine very distinct substrate specificities. Overall, the high-resolution structures of DADH will 
provide useful information for future studies of similar flavin-dependent enzymes. 
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1.3 A Deterministic-Stochastic Crossover Algorithm 
1.3.1 Systems Biology 
Systems biology is an interdisciplinary science of experimental and computational research 
studying biological functions and mechanisms [90]. Rapid development in molecular biology especially 
for genome sequencing and high-throughput measurements has greatly facilitated the advancement of 
systems biology [91]. Meanwhile, significant advances in computational software and hardware allowed 
the creation of models and investigation by in silico simulation of complex and still realistic biological 
systems. Systems biology studies focus on the understanding of the whole system’s structure and dynam-
ics, while the traditional molecular biology concentrates more on the properties and functions of individu-
al genes and proteins. Although many issues remain unsolved, systems biology studies are able to provide 
in-depth insights and reasonable predictions for biological networks such as the cell cycle and metabolic 
analysis.  
Biological systems, such as cells, are considered as “complex systems”, in which large numbers 
of various elements selectively interact with each other to produce complex behaviors. Functions of com-
plex systems in the traditional mechanical concept are mainly determined by properties of the networks 
they form rather than properties of each element. However, functions in biological systems relay on a 
combination of the network and the specific elements involved. The protein p53 acts as a tumor suppres-
sor when involved in a network of transcription factors. Its functions are strictly regulated by modifica-
tions like phosphorylation, dephosphorylation and proteolytic degradation, which are properties that re-
flect the complexity of the element itself. Neither p53 nor the network functions as a tumor suppressor 
when taken apart [90, 92]. Molecular biology has uncovered numerous biological facts like protein prop-
erties and genome sequences in the past a few decades. However, with the dramatically growth of infor-
mation, it alone is not sufficient for interpreting the complex biological systems. Therefore, a system-
level understanding of biology is greatly needed and a combination of experimental and computational 
approaches is expected to achieve this goal. An example of the integration of systems-biology research 
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with drug discovery and treatment optimization is illustrated in Figure 1.13. Systems biology can employ 
computational modeling, systems analysis, and development of experimental techniques in to the process 
of drug discovery and treatment optimization. Therefore, it is able to significantly reduce the cost and in-
crease the success of drug discovery [90].   
Knowledge discovery and simulation-based analysis are two different branches in computational 
biology. Knowledge discovery is often known as data-mining. Hypotheses are often derived from extract-
ing the patterns from huge quantities of experimental data. Areas for which knowledge discovery has 
been widely used include predicting protein structure from sequence and investigating the gene regulatory 
networks [91, 93]. Simulation-based analysis is used to test hypotheses with in silicon experiments, which 
is then tested by in vitro and in vivo studies. Computer simulations of biological systems have been inten-
sively developed and can now replicate important biological behavior. The phages are employed as the 
initial study model due to their simplicity. Several groups have studied the lambda phage ‘switch’ [94-
95]. A successful combination of simulation and laboratory measurements has been performed on the T-7 
phage [96-97]. However, eukaryote organisms especially mammalian cells, are much more complex sys-
tems and are more difficult to study by computational simulation [98]. Many efforts have been dedicated 
in studies of cellar processes like gene expression, cellular signaling and metabolism pathways.  
1.3.2 Deterministic, Stochastic and Crossover Methods 
Two major techniques used in system simulation are deterministic methods and stochastic meth-
ods. Both techniques have their own advantages and disadvantages. For a long time the most common 
approach was deterministic method, in which the systems are assumed to be continuous or deterministic. 
Their kinetics can be described by ordinary differential equations (ODEs), which are the reaction rate 
equations derived from the classical theory of mass action kinetics. The deterministic method works well 
for large-quantity biological networks and can reasonably represent the overall dynamics of the system. 
Since the deterministic method assumes that time evolution of a chemically reacting system is both con-
tinuous and deterministic, some behaviors of the systems associated to the discreteness of molecular 
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quantities and random fluctuations in systems containing species at lower concentration, are neglected. 
Since the molecular population of reacting species can only be changed by discrete integer amounts, the 
chemical reaction is not a continuous process. Moreover, it is impossible to predict whether a reaction 
will occur without knowing the precise positions and velocities of the reacting species, suggesting that the 
chemical reaction is not deterministic either. The accuracy of deterministic method is greatly compro-
mised, especially when dealing with ecological systems, microscopic biological systems, and nonlinear 
systems driven to conditions of chemical instability [99].  
In intracellular molecule kinetics, stochasticity is significant because some molecule species exist 
in very low numbers. Gene regulation can serve as a good example because only one gene is involved in 
most of gene expressions. It has been reported that the transcription level of a single gene in Escherichia 
coli is very low by measuring mRNA levels in individual living cells [100]. Typical numbers of some 
protein molecules in a cell are less than a few hundreds. Therefore, fluctuations in these biological sys-
tems are significant at low concentrations. The stochastic methods were developed to address this prob-
lem based on the knowledge that a reaction occurs when two or more reacting species collide with each 
other. In stochastic models, the reacting species are represented as discrete number of molecules, allowing 
the dynamics of the whole system to be updated discretely rather than continuously. The stochastic simu-
lation has been widely used since its first description in 1977 [99, 101]. Efforts in accelerating simula-
tions are desired because stochastic simulation is computationally costly and it requires a significant 
amount of computer time when dealing with large models. However, accelerated simulation usually 
comes at the price of approximation and thus loss of exactness. Another disadvantage of stochastic meth-
od is that it can only take into account elementary reactions rather than more complex reactions such as 
Michaelis-Menten type reactions. These complex reactions have to be broken into elementary reactions 
before they can be simulated using the stochastic method. However, this is not easily achievable due to 
the difficulties of experimental determination of the rate constants for those elementary reactions. There-
fore, the stochastic method is hindered from being widely used for complex systems.  
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Many studies have been dedicated to improving the computational efficiency of stochastic meth-
od, while some groups have developed hybrid algorithms to facilitate the simulation by partitioning the 
system into “fast” and “slow” reactions [101-103]. Our group has developed a novel deterministic-
stochastic crossover method in order to improve the computational accuracy and efficiency of simulation 
for biochemical systems [104]. This crossover method works by introducing a certain degree of random-
ness into a deterministic simulation. First of all, each reaction in the system is treated as deterministic and 
the law of mass action can be applied to obtain ODEs. For a certain species A, its rate of changes can be 
described as the following formula: 
dA/dt = Σ f (ki, [R]i) - Σ f (kj, [R]j ) 
Here “i” stands for the reactions that generate A and “j” indicates reactions that consume A. ‘k’ is 
the reaction rate constant and [R] is the concentration of the reactants for that reaction. In other words, the 
net change (∆A) of species A in a certain time dt is denoted by the difference of generated A (Ag) and 
consumed A (Ac).   
∆A = Ag - Ac 
Therefore, the concentration of A at time t+1 (At+1) can be described as 
At+1 = At + ∆A 
However, since the reaction is treated as continuous, the calculated net change ∆A will also be a 
continuous value, a real number. This is contrary to the fact that the number of any species should be dis-
crete integers. Therefore, in this crossover method, a Bernoulli trial is conducted to determine the integer 
value of the net change. The fractional part of the real number from the deterministic method will be used 
as the success probability for Bernoulli trial. For example, the success probability will be 0.45 if the ∆A 
from deterministic step is 10.45. A true outcome will round up ∆A to 11, while a false outcome rounds it 
down to 10, ensuring the net change for each time step is always an integer. In this way, certain degree of 
randomness has been introduced into the deterministic solution, allowing the stochastic effect to be inte-
grated into this crossover method.  
The crossover method has been tested with systems such as auto
dimerization pathway [104]. It not only retains the efficiency of deterministic methods, but also reflects 
the fluctuations generally only captured by stochastic methods. However, similar to the pure stochastic 
methods, the previous version of crossover method was
ard Michaelis-Menten reaction, shown as following, will need to be broken into three elementary rea
tions: association, in which the substrate (S) binds to the enzyme (E) to form a complex (ES); 
dissociation, in which the complex dissociates back into the substrate and enzyme; 
the enzyme converts the substrate into the product (P) with the turnover number 
ever, will introduce more difficulties to the system represen
simulation. 
In this study, we have improved crossover method and allowed it to directly model Michaelis
Menten type reactions. The two types of reactions will be marked differently in the system model and 
calculated by different functions. In the crossover algorithm, 
reaction is given by the following equation, in which [E] is the enzyme concentration and [S] is the 
substrate concentration. Km is the substrate concentration at which the reaction rate is at half
and is an inverse measure of the substrate's affinity for the enzyme. 
One of the major issues of decomposing Michaelis
tions is that the kinetic parameters for the elementary reactions are often not available. The 
crossover algorithm of directly modeling Michaelis
complex systems. 
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1.3.3 Model Representation of the Crossover System 
Various representations of biological systems have been developed to fulfill different purposes. 
For example, graphical representations are useful for both visualization and analysis, while matrix repre-
sentations are more convenient for mathematical and computational analysis. However, users often need 
to combine results from different simulation or analysis tools in one project. Most of the time, the models 
and output need to be re-constructed in order for them to be used across different platforms. This process 
could be very time-consuming and error-prone. A commonly accepted software environment is greatly in 
need to allow individual research groups to easily exchange their models and reuse the code. Several un-
dergoing project including Systems Biology Markup Language (SBML http://www.sbml.org/), CellML 
(http://www.cellml.org/) and the Systems Biology Workbench are examples of efforts that aim to form a 
standard and open software platform for modeling and analysis [105-106]. The SBML developed by 
Hucka et al. is a powerful presentation for biological networks such as gene regulation, cell signaling 
pathways and metabolic pathways [107]. The CellML is a XML based standard for describing mathemat-
ical models, especially the models relevant to biology processes [108]. The Systems Biology Workbench 
is a software framework that allows different applications to communicate with each other in an efficient 
manner [109]. Such efforts have significantly facilitated the development of new generation of databases 
concerned with biological pathways by employing better formatted models. 
The SBML representation of biological networks consists of lists of functions, units, compart-
ments, species, parameters, rules, reactions, and events [107]. In order to standardize and improve the 
readability of our models, we have developed a similar but much simpler representation using eXtensible 
Markup Language (XML). We will focus on compartments, species, parameters and reactions, as these 
are fairly sufficient for describing most simple discrete stochastic models. The system design in this 
crossover algorithm is demonstrated in Figure 1.14. The model will consist of one global system, with 
the parameters like initial time, time step, total time, and report interval defined at the system level. Since 
complex biological systems are often composed of multiple components or subsystems with close interac-
tions, we have introduced the idea of multiple compartments into this crossover system. Each model may 
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contain one or more compartments. Each compartment will have its own species and reactions. The name, 
initial number and chemostat status (constant concentration for a species) will be assigned to each species, 
while every reaction will have its own kinetic parameters, input species and output species. For biological 
systems that are composed of more than one compartment, there might be transportable species between 
different compartments, which means the behavior of one compartment will affect that of others. This 
behavior is closer to reality since most of the biological systems are complex networks and one system is 
often affected by its environment. In the meantime, an event feature was also developed to represent spe-
cific activities during the simulation.  
Here we took the auto-regulatory gene network, which is typically a low concentration biochemi-
cal network whose detailed dynamics are usually captured only by stochastic algorithms, as an example to 
illustrate the difference of model representation in SBML (Figure 1.15a) and crossover algorithm (Fig-
ure 1.15b). SBML has been now widely used for electronic representation of models in systems biology 
studies. Many simulation tools have provided various levels of support for SBML. However, although it 
can represent comprehensive information for the model and is well-formatted for computers to parse and 
generate, its verbosity makes it quite inconvenient for humans to read and write [110]. From the compari-
son in Figure 1.15, it can be seen that the representation in crossover algorithm is much shorter and easier 
to understand than that of SBML when presenting the same amount of information. Therefore, the sim-
plicity of this crossover algorithm would make it easy for researchers to understand and apply across dif-
ferent applications for systems biology. 
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Figure 1.1 Domain organizations of human caspases. Different domains are indicated by colored 
blocks. (Fuentes-Prior et al., 2004) 
 
 
 
 
 
 
 
 
Figure 1.2 Activation and structure of caspase. 
thesized as inactive procaspases which contain one prodomain, one large (p20) and one small (p10) sub
nit. Cleavage at specific aspartate (Asp) sites results in an a
and two small subunits. (b) The 3D structure of caspase
(cyan and green) and two small subunits (red and magenta). N and C termini of the small and large sub
nits are indicated. 
(a) Scheme of procaspase activation. Caspases are sy
ctive heterotetramer consisting of two large 
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Figure 1.3 Extrinsic and intrinsic signaling pathways of apoptosis.
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Figure 1.4 Substract specificities of caspases. 
site. The substrate P1’-P5 are colored red. The active site S1’
the substrate is indicated by yellow arrow. (b) Crystal
DEVD in caspase-3. Surface representation is shown for the caspase
residues are labeled. (c) Specificities of caspases for positions P4
acid. 
 
 
 
 
 
 
 
 
(a) Schematic presentation of caspase substrate binding 
-S5 are colored green. The cleavage site on 
 structure of 2H5I shows the binding mode of 
-3 active groove. Substrate P1
-P1 in substrates. X refers to any amino 
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Figure 1.5 Strucutre of of FAD cofactor. 
tween the component parts FMN and AMP composing the FAD is shown. (b) Redox states of flavin. 
Modified from Ghisla et al., 1986. 
 
 
 
 
 
 
 
 
 
 
 
 
(a) Schematic presentation of FAD cofactor. The division b
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Figure 1.6 Biological functions of flavoenzymes.
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Figure 1.7 Topological diagram (left panel) and ribbon representation (right panel) of FAD-binding 
domain of the four FAD-family folds. (a) Rossmann fold adopted by the glutathione reductase (GR) 
family members. The crossover connection composed of a three-stranded antiparallelβ-sheet is colored 
blue. The red shading indicates the central five-stranded parallel β-sheet surrounded by two α-helices. The 
FAD cofactor adopts an elongated conformation. (b) Ferredoxin reductase (FR) family fold adopting a 
cylindricalβ-domain organized into two orthogonal sheets. The two antiparallel three-stranded β-sheets 
are shown in red and blue. The FAD in its bent conformation is shown with the isoalloxazine ring (black 
circles) pointing toward the FAD-binding domain. (c) The p-cresol methylhydroxylase (PCMH) family 
fold consists of two α+β subdomains. The FAD molecule adopts an elongated conformation and is located 
in between the two subdomains with the adenine ring pointing toward them. (d) The pyruvate oxidase 
(PO) family fold is similar to the double Rossmann fold found in dehydrogenases. The cofactor adopts an 
elongated conformation and lies perpendicular to the β-strands. Modified from Dym et al., 2001. 
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Figure 1.8 Optical isomers of D-alanine exist as mirror images of each other.  (John Wiley and Sons. 
Inc. 1999) 
 
 
 
 
 
 
 
 
 
Figure 1.9 Structures of DAAO and LAAO. 
(PDB entry: 1DDO) and (b) LAAO/ L
FAD-binding domain and a substrate
low color). Ligands and cofactor FAD are shown as sticks and colo
 
 
 
 
 
 
 
Cartoon representations of (a) DAAO/ iminotryptophan 
-alanine (PDB entry: 2JB1). Both enzymes are composed of a 
-binding domain, while LAAO contains an extra helical domain (ye
red red and green, respectively.
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Figure 1.10 Reaction scheme for conversion of D
LADH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-amino acids to L-amino acids by DADH and 
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Figure 1.11 Structure of DADH. 
enzyme is composed of FAD-binding domain (orange) and substrate
Iminoarginine and cofactor FAD are shown as sticks
ary structure topology for DADH. α
arrows. 
(a) Overall structure of DADH shown in cartoon representation. The 
-binding domain (cyan). 
 and colored green and red, respectively. (b) Secon
-helices are shown as cylinders whereas β-strands are indicated by 
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Figure 1.12 Active site lid in different enzymes. 
dehydrogenase (PDB: 3NYE), (b) D
1TT0), and (d) choline oxidase (PDB: 2JBV). Active site lids are c
are shown as sticks and colored green and yellow, respectively.
 
Active site lid structures (red color) in (a) D
-amino acid oxidase (PDB: 1DDO), (c) pyranose 2
olored red. Ligands and cofactor FAD 
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Figure 1.13 Linkage of a basic systems-biology research cycle with drug discovery and treatment 
cycles. Systems biology is an integrated process of computational modelling, system analysis, technology 
development for experiments, and quantitative experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 1.14 System design of the crossover algorithm. 
with the parameters such as initial time, time step, and others defined at the system level. Each system 
may contain one or more compartments with their own species and
transportable between different compartments.
The model will consist of one global system, 
 reactions. Some species may be 
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Figure 1.15 System representations of auto
crossover algorithm (b). The same amount of information from the model is shown in both systems.
 
 
 
 
 
 
 
-regulatory gene network shown in SBML.
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2 STRUCTURAL BASIS FOR EXECUTIONER CASPASE RECOGNITION OF P5 POSI-
TION IN SUBSTRATES 
(Published: Fu G, Chumanevich AA, Agniswamy J, Fang B, Harrison RW, Weber IT. Apoptosis 2008;13: 
1291-1302.) 
2.1 Abstract 
 The executioner caspases-3, -6 and -7 induce apoptosis by cleavage of many known and unknown 
protein substrates. Many studies have identified tetrapeptide (P1-P4) recognition motifs for caspases. 
Studies of caspase-3 recognition of hydrophobic P5 in pentapeptides have been extended to caspase-6 and 
-7 and the binding of peptides with polar or non-polar P5 residues has been investigated by kinetics, mod-
eling and crystallography. Caspase-3 and -6 recognize P5 in pentapeptides as shown by enzyme activity 
data and interactions observed in the 1.6 Å resolution crystal structure of caspase-3 with the aldehyde in-
hibitor Ac-LDESD-Cho and conserved interactions predicted in a model for caspase-6. Caspase-3 pre-
ferred the hydrophobic P5 in LDEVD with 50% increased activity relative to the tetrapeptide DEVD con-
sistent with observed hydrophobic contacts of P5 Leu with loop-4 residues Phe250 and Phe252, while 
caspase-6 showed a preference for polar P5 in QDEVD likely due to interactions with polar Lys265 and 
hydrophobic Phe263. Caspase-7 shows the highest activity on the DEVD tetrapeptide substrate in agree-
ment with the absence of interactions with P5 in the 2.45 Å resolution crystal structure of caspase-
7/LDESD. Also, these studies have identified a critical P5-anchoring residue in loop-3; the hydroxyl side 
chain and amide of Ser or Thr in caspase-2, -3 and -6 form hydrogen bonds with the main chain of P5 in 
the bound pentapeptide, in agreement with increased activity on the pentapeptide substrates. In contrast, 
caspase-7 has Pro at the equivalent loop-3 position, which cannot form hydrogen bonds with the P5 main 
chain atoms, consistent with the relative activity. Moreover, the initiator caspase-8, which lacks a loop-4 
and has Pro in the loop-3, had only 20% activity on the tested pentapeptides relative to DEVD. This anal-
ysis of substrate recognition will help identify the specific protein substrates and signaling pathways of 
caspases.  
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2.2 Introduction 
 Caspase family members induce apoptosis by cleavage of diverse protein substrates, although 
many of the signaling pathways and potential substrates are poorly characterized. Altered caspase-
mediated apoptosis is associated with many diseases. Increased caspase activity and apoptosis are ob-
served in stroke and neurodegenerative diseases like Alzheimer’s, Parkinson’s and Huntington’s disease 
[111-114]. Moreover, apoptosis has been suggested to be responsible for the death of cardiomyocytes dur-
ing acute myocardial infarction, as well as for the progressive loss of surviving cells in failing hearts 
[115-116]. In contrast, reduced caspase activity is associated with cancer, autoimmune diseases, and viral 
infections [29, 117-119]. Pan-caspase inhibitors are in clinical trials for acute myocardial infarction and 
liver transplants [120-121]. Therefore, knowledge of the substrate specificity of caspases is critical for 
design of selective therapeutic agents to control cell death. 
 The caspase family consists of cysteine proteases that cleave the peptide bond after an aspartic 
acid in their substrates. They are classified as inflammatory and apoptotic caspases based on their func-
tion and prodomain structure.  The apoptotic caspases are further divided into initiators and effectors of 
apoptosis. The initiator caspases-2, -8, -9, -10 and -12 activate the effector, or executioner, caspases -3, -
6, and -7 by cleaving the procaspase to form the active enzyme [10, 122]. The active caspases-3,-6, and -7 
hydrolyze many protein substrates in the signaling pathways leading to apoptosis [31]. The crystal struc-
tures have been solved for the apoptotic caspase-2, -3, -7, -8, -9, in their complexes with protein inhibi-
tors, peptide analogs and non-peptide inhibitors [36, 123-124]. The enzymatically active caspase structure 
is a heterotetramer of two large and two small subunits formed by cleavage of a procaspase dimer. Pep-
tide substrates or inhibitors bind in two similar active sites formed between the large and small subunits 
of the two heterodimers.  
 The substrate specificity of apoptotic caspases has been defined by studies of peptides. Most stud-
ies have analyzed the preference for tetrapeptides of P4-P1. Caspase-2, -3 and -7 prefer the tetrapeptide 
DEXD, while caspase-6, -8 and -9 recognize L/VEXD [10, 30]. The two effector caspases-3 and -7 are 
very similar; they share 56% sequence identity and preferentially recognize DEVD. Recently, the sub-
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strate recognition sequence was extended to P5 for caspase-2 and -3. The P5 position of substrates was 
determined to be essential for recognition by caspase-2 [36]. Similarly, caspase-3 was shown to preferen-
tially recognize pentapeptides with hydrophobic amino acids at P5 over tetrapeptides based on structural 
and kinetic data [34]. Caspase-6 shares 37 and 41% sequence identity with caspase-7 and -3, respectively. 
However, caspase-6 differs from the other two caspases by preferring the tetrapeptide sequence of LEHD 
over DEVD in substrates. The possibility of recognizing the P5 residue in substrates has not been ex-
plored for caspase-6.  
 We report structural and kinetic analysis of caspase recognition of the P5 position in peptide sub-
strates.  The specificity of the executioner caspases was investigated for polar or hydrophobic P5 residues 
using the colorimetric substrates Ac-QDEVD-pNA and Ac-LDEVD-pNA, and tetrapeptide Ac-DEVD-
pNA as a control, where Ac is the acetyl group and pNA is p-nitroanilide.  Crystal structures were solved 
of caspase-3 and -7 in their complexes with the pentapeptide Ac-LDESD-CHO, and molecular models 
were constructed for the caspase-6 complex. The relative activity on the substrates agrees with the 
caspase residues forming the S5 site and their interactions with the P5 position.  
2.3 Experimental Procedures 
2.3.1 Materials 
 Restriction enzymes were purchased from both New England BioLabs, Inc. and Stratagene. PCR 
SuperMix was purchased from Stratagene. All media were obtained from Difco or Gibco BRL. SDS–
PAGE standards were purchased from Pharmacia. Other chemicals were obtained from Sigma.  
2.3.2 Vector Construction for Caspase-6  
 Human caspase-6 (EC 3.4.22.59) was engineered as a truncated, prodomain-less, construct 
MetSerPhe25-Asn293 (similar to [32]) of the caspase-6 isoform alpha. The pOTB7 vector (Invitrogen), con-
taining full-length cDNA of caspase-6 (NCBI database ID: NM_001226, NCBI accession BC000305) 
was used as a template and amplified by PCR using the primers: 5’-
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GAATTCATGTCGTTCTATAAAAGAGAA-3’ and 3’– CTCGAGATTAGATTTTGGAAAGAAATG-
5’ to introduce EcoR1 and XhoI restriction sites, respectively. The PCR transcript was subcloned into the 
TOPO XL vector (Invitrogen) through the blunt ends. The amplified DNA was excised with EcoRI/XhoI 
endonucleases and the caspase-6 construct was recloned into the bacterial expression vector pET23b as an 
EcoRI-to-XhoI fragment by ligation reaction and expressed in Escherichia coli BL21DE3 (Stratagene Inc) 
cells with a C-terminal (His)6 tag. The sequence of the construct was confirmed by the dideoxynucleotide 
chain-termination method using primers to T7 promoter and terminator.  
2.3.3 Expression and Purification of Caspase-6 
 The expression construct was transformed into E. coli BL21DE3 cells (Stratagene Inc) according 
to the manufacture’s protocol and the cells were grown on an LB/ampicillin plate overnight. Next day, 
one colony was transferred into 10 ml LB medium containing ampicillin (100 mg/ml) and the culture was 
grown overnight at 37°C with shaking. The 1000 ml of LB medium containing ampicillin was inoculated 
with the overnight culture and incubated at 37°C with shaking until OD600 = 0.6 – 0.8 (about 3-4 h) fol-
lowed by induction with 2mM isopropyl- , D -thiogalactopyranoside (final concentration) for four hours 
at 30°C. Cells were collected by centrifugation at 5,000g for 20 min, resuspended in 40 ml working buffer 
(50 mM Tris–HCl, pH 7.4, 250 mM NaCl) and lysed by ultra-sonication without either protease inhibitors 
or lysozyme. The cellular debris was removed by centrifugation (20,000g, 25 min). The supernatant was 
examined for the presence of the caspase-6 by SDS–PAGE and stored at -20°C. The protein was purified 
from the soluble cell fraction using Ni-NTA chromatography (GE-Healthcare) according to the manufac-
turer’s standard protocol. The protein fractions eluted in 0.35-0.5 M imidazole in working buffer were 
collected, dialyzed against working buffer and concentrated to approximately 3 mg/ml using Centricon-10 
ultrafiltration (Amicon Inc). During the concentration step the caspase-6 processed (cleaved) itself into 
two subunits to become an active protease. The final purification step was done on Sephacryl S-100HR 
column (Pharmacia). The purity of caspase-6 was above 95% as estimated from Coomassie blue stained 
10-20% (w/v) polyacrylamide gels, which were done in denaturing, reducing conditions. The purified 
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protein was equilibrated with 100 mM HEPES, pH 7.25, containing 100 mM NaCl, 0.1% CHAPS, 10% 
sucrose, using Centricon-5 ultrafiltration, and stored at -20°C. The final yield of catalytically active 
caspase-6 was about 1.5 mg per liter of bacterial culture. 
2.3.4 Expression and Purification of Caspase-3, -7 and -8 
 Recombinant human caspase-3, -7 and -8 were expressed in E. coli and purified as described pre-
viously [34, 125]. 
2.3.5 Determination of Activity 
 Measurements of the caspase activity were performed with the colorimetric assay as described 
previously [34]. Caspase-3, -7, and -8 were preincubated in assay buffer (50 mM HEPES, 100 mM NaCl, 
0.1% CHAPS, 10% glycerol, 1 mM EDTA and 10 mM DTT, pH7.5) at room temperature for 5 mins prior 
to the addition of substrate at different concentrations. The assay buffer for caspase-6 was 50 mM 
HEPES, pH 7.25, containing 100 mM NaCl, 10% sucrose, 0.1% CHAPS. The p-nitroanilide released by 
the substrate hydrolysis was measured at a wavelength of 405 nm using a Polarstar Optima microplate 
reader (BMG Labtechnologies, NC). All assays were performed in triplicate and the mean values were 
plotted. Kinetic constants were calculated by direct fits of the data, obtained at less than 20% substrate 
proteolysis, to the Michaelis–Menten equation using non-linear regression analysis in SigmaPlot 9.0 
(SPSS Inc). 
2.3.6 Crystallization, X-Ray Data Collection and Refinement of Caspase-3 and -7 with 
LDESD 
 The crystals of caspase-7 complexed with inhibitor Ac-LDESD-CHO were grown by hanging 
drop vapor diffusion method at room temperature using 1:15 ratio of the enzyme to inhibitor.  The crys-
tals were obtained with a well solution of 0.1M sodium citrate buffer (pH 5.0-5.5) and 2.1 M sodium 
formate. Caspase-3 was incubated at room temperature with Ac-LDESD-CHO at 10-fold molar excess. 
Crystallization was performed by the hanging-drop vapor-diffusion method: 1 µl of protein solution (4 
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mg/ml) was mixed with an equal volume of the reservoir solution (100 mM sodium citrate, 5% glycerol, 
10 mM dithiothreitol, 14–16% (w/v) PEG 6000, pH 7.0). Crystals grew at room temperature within 24 h. 
The crystals were soaked in the mother liquor with 22% (caspase-7/LDESD) and 20% (caspase-
3/LDESD) glycerol as cryoprotectant for ~1 min and immediately frozen in liquid nitrogen. Diffraction 
data were collected at 100°K on beamline 22-ID of the Southeast Regional Collaborative Access Team 
(SER-CAT) at the Advanced Photon Source, Argonne National Laboratory. The data were integrated and 
scaled with HKL2000[126].  
 The crystal structures were solved by molecular replacement using PHASER [127] in the CCP4i 
suite of programs [128] using the starting models of caspase-7 complexed with Ac-DEVD-CHO (PDB 
code 1F1J) [123] and caspase-3 complexed with Ac-VDVAD-CHO (PDB code 2H65). The structures 
were subjected to several rounds of refinement in CNS or SHELX97 [129] for caspase-7 and -3, respec-
tively. The molecular graphics programs O 9.0 [130] and Coot 0.33 [131]  were used in model rebuilding. 
The inhibitor was fitted into unambiguous electron density. The solvent molecules were inserted at 
stereochemically reasonable positions based on the peak height of the 2Fo-Fc and Fo-Fc electron density 
maps, hydrogen bond interactions and interatomic distances. The geometry of the refined structures was 
validated according to the Ramachandran plot criteria of  [132]. Sequence alignment was performed by 
using the ClustalW server [133] and the figure was generated with GeneDoc 
(http://www.cris.com/2Ketchup/genedoc.shtml). Molecular figures were prepared with Molscript, Ras-
ter3D [134] and PyMol (http://www.pymol.org). 
 The crystal structures have been deposited in the Protein Data Bank with accession codes 3EDQ 
for caspase-3/LDESD, and 3EDR for caspase-7/LDESD. 
2.3.7 Construction of Molecular Model of Caspase-6 
 The model for caspase-6 in complex with the peptide aldehyde Ac-LDESD-CHO was constructed 
by homology modeling from the new high resolution crystal structure of caspase-3/LDESD. Sequence 
alignment for caspase-6 was performed with a profile-profile method using full dynamics programming 
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and the Kullback entropy [135] with frequency profiles obtained from Psi-BLAST [136]. The program 
AMMP [137-138] was used with the latest version of the potential set, which was reparameterized to min-
imize RMS deviation when applied to high resolution crystal structures (parameter set atoms.tuna).  All 
hydrogen atoms were included in this potential. The adducts of the catalytic cysteine 163 with P1 Asp, 
and the N-acetyl Leu (P5) residue was explicitly modeled with charges derived with the method of mo-
ments approximation [139]. Side chains were built using the analytic atom building routines in AMMP 
[140] followed by annealing over local dominating sets, minimization and conjugate gradients. 
2.4 Results and Discussion 
2.4.1 Predictions for Caspase Recognition of P5 in Pentapeptides 
 The P5 specificity of caspase-6 was predicted from comparative analysis of the sequence and 
structures of caspases. Molecular models were generated for human caspase-6 in the absence of diffrac-
tion quality crystals. Alignment of the amino acid sequences (Figure 2.1) suggested that caspase-6 shared 
the P5 binding loop observed in the known crystal structures of caspase-3 [34, 141] and caspase-2 with 
pentapeptides [36]. The hydrophobic P5 residue interacts with Phe250 and Phe252 in caspase-3 and with 
Tyr273 and Pro275 at the structurally equivalent residues of caspase-2. Caspase-6, which has Phe263 and 
Lys265 at the equivalent positions, was predicted to recognize both hydrophobic and polar P5 residues in 
substrates. In contrast, caspase-7 has the polar residues Gln276 and Asp278 in the corresponding posi-
tions of S5, and was predicted to recognize polar P5 residues. Caspase-8 was used as a control since there 
was no evidence for an S5 binding pocket in the sequence alignment or structure. Therefore, caspase-8 
was expected to recognize only tetrapeptides, although it is possible that pentapeptides can bind in a dif-
ferent manner to that observed for caspase-2 and -3. These predictions were evaluated by solving the 
crystal structures of caspase-3 and -7 with the peptide aldehyde inhibitor Ac-LDESD-CHO, and determin-
ing the activity of caspase-3, -6, -7 and -8 for the pentapeptide substrates Ac-LDEVD-pNA and Ac-
QDEVD-pNA, containing hydrophobic or polar P5 residues. 
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2.4.2 Kinetic Data for P5-Containing Substrates 
 The substrate hydrolysis was analyzed for the effector caspases-3, -6, and -7 in comparison to the 
initiator caspase-8. The effect of P5 in substrates was investigated using the pentapeptides Ac-LDEVD-
pNA containing a hydrophobic P5 residue and Ac-QDEVD-pNA with a polar P5 residue. The 
tetrapeptide substrate Ac-DEVD-pNA, which is hydrolyzed efficiently by all four caspases, was used as a 
reference. The kinetic parameters for activity of caspase-3, -6, -7 and -8 are listed in Table 2.1 and the 
relative activities are compared in Figure 2.2. Caspase-3 showed increased relative activity of 146% for 
the pentapeptide with P5 Leu, in agreement with the previous study [34], while the relative activity was 
lower (85%) for the peptide with the polar P5 Gln, due primarily to changes in Km. Caspase-6 showed 
increased activity for both pentapeptides; a small increase to 120% for LDEVD and a substantial increase 
to 150% for QDEVD, due to correlated changes in both kcat and Km values relative to the activity on 
DEVD. LEHD, however, is a better tetrapeptide substrate than DEVD for caspase-6 with 3-fold higher 
kcat/Km (0.19 min-1µM-1 and 0.058 min-1µM-1, respectively), in agreement with the known tetrapeptide 
specificity [30]. Caspase-7 showed decreases in relative activity to 56% and 67% for the substrates with 
P5 Leu and Gln, respectively, with changes in both kcat and Km. Substantial changes were observed for 
caspase-8 where the relative activity dropped sharply to about 20% for both pentapeptides compared to 
DEVD with 3 to 4-fold increased values of Km.  
2.4.3 Crystal Structures of Caspase-3/ LDESD and Caspase-7/ LDESD 
 Caspase-3 and caspase-7 were crystallized in their complexes with the peptide aldehyde inhibitor 
Ac-LDESD-CHO. The caspase-3 complex was crystallized in the orthorhombic space group of P212121 
while caspase-7 complex was crystallized in the trigonal space group of P3221. The structures were re-
fined to the resolutions of 1.61 Å and 2.45 Å, respectively. The data collection and refinement statistics 
are listed in Table 2.2. The mature caspase-3 contains two heterodimers (p17/p12)2, which are derived 
from processing of procaspase-3 (Figure 2.3). The residues 35-174 and 34-174 are visible in the electron 
density for the two p17 subunits, respectively, and 186-278 in the two p12 subunits in the heterotetramer. 
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The overall structure of caspase-3/LDESD is very similar to the previously reported structures of caspase-
3 with the canonical tetrapeptide DEVD and pentapeptide VDVAD [34], with rmsd values of 0.38 Å and 
0.17 Å for Cα atoms, respectively. The asymmetric unit of caspase-7/LDESD contains a complete cata-
lytic unit of two p20-p10 heterodimers. Residues 58-196 and 52-196 are visible in the two p20 subunits, 
respectively.  Residues 211-303 are visible in both p10 subunits in the heterotetramer. The refined overall 
structure of the caspase-7/LDESD compares very well with the previously reported structure of caspase-7 
in complex with the canonical tetrapeptide DEVD [123]. The entire catalytic domain with the two hetero-
dimers can be superposed with those of caspase-7/DEVD with rmsd values of 0.27 for 460 topologically 
equivalent Cα atoms.  
2.4.4 Interactions of Caspase-3 with LDESD 
 Most of the residues in the active site of caspase-3/LDESD are in similar position and orientation 
when compared to those of the caspase-3/VDVAD complex [34]. The reported alternate conformations of 
His121 were also observed in current structure, supporting the proposed Cys-His catalytic dyad hydroly-
sis mechanism [142]. All the residues in the peptide substrate are clearly visible in the electron density as 
shown in Figure 2.4. The pentapeptide of caspase-3/LDESD can be superimposed with those of caspase-
2/LDESD and caspase-3/VDVAD structures with RMS deviations of 0.33 (0.17) Å and 0.09 (0.18) Å for 
the 5 topologically equivalent Cα atoms, respectively. (The values in the parenthesis show the RMS devi-
ations of the inhibitor in the second catalytic site.) The interactions between caspase-3 and the peptide 
analog Ac-LDESD-CHO are summarized in Figure 2.5a. Compared to the caspase-3/VDVAD structure, 
caspase-3/LDESD has substitutions at three positions, P2 (Ala/Ser), P3 (Val/Glu) and P5 (Val/Leu). The 
interactions at the P2 position are similar in both structures. Both Ala and Ser have van der Waals interac-
tions with caspase residues Tyr204 and Trp206. However, the main chain amide, carbonyl oxygen and 
side chain oxygen of P2 Ser form hydrogen bond interactions with three water molecules since the P2 
side chain is exposed to solvent. The side chain of P3 Val in VDVAD forms van der Waals interactions 
with caspase-3 atoms.  In contrast, the negatively charged side chain of P3 Glu in LDESD forms a strong 
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ionic interaction with the side chain of Arg207 and their main chains are connected by two hydrogen 
bond interactions between the carbonyl oxygen atoms and amide groups. 
 At the P5 position, the main chain amide of Leu forms a hydrogen bond interaction with the side 
chain hydroxyl of Ser209. The carbonyl oxygen of Leu forms hydrogen bond interactions with both the 
side chain hydroxyl and main chain amide of Ser209. The hydrophobic Leu side chain is accommodated 
in the hydrophobic pocket formed by the side chains of Phe250 and Phe252, which is similar to the P5 
interactions in the caspase-3/VDVAD structure. The CD1 of P5 Leu forms van der Waals interactions 
with the aromatic side chain of Phe252. In addition, CD2 of P5 forms van der Waals interactions with the 
side chains of both Phe250 and Phe252. The acetyl group of Ac-LDESD-CHO protrudes into the solvent 
region. It has been suggested that the P5 residue is unnecessary for the efficient cleavage of caspase-3 and 
-7 substrates [33].  However, the current investigation confirms that caspase-3 possesses a hydrophobic 
S5 pocket, which plays an important role in the substrate recognition and cleavage.  
2.4.5 Predicted Interactions of Caspase-6 with LDESD 
 The modeled structure of caspase-6/LDESD showed very similar overall structure and interac-
tions with the pentapeptide as observed in the crystal structure of caspase-3/LDESD. These two caspases 
are predicted to have conserved hydrogen bond interactions with the pentapeptide, with the exception of 
the interactions with P5 (Figure 2.5b). The caspase-6 has different S5 amino acids in loop-3 and -4, form-
ing similar interactions with P5 Leu to those in caspase-3/LDESD. The main chain carbonyl oxygen and 
amide of P5 are anchored by hydrogen bonds with the amide and side chain hydroxyl of Thr222 in 
caspase-6 rather than the structurally equivalent Ser209 in caspase-3. The side chain of P5 Leu forms hy-
drophobic interactions with loop-4 residues Phe263 and Lys265 in caspase-6, which correspond to 
Phe250 and Phe252 in caspase-3.  
2.4.6 Interactions of Caspase-7 with LDESD 
 The pentapeptide inhibitor in the caspase-7/LDESD complex adopts an extended conformation as 
seen for the canonical tetrapeptide DEVD. The P5 Leu in the pentapeptide buries an additional ~ 208 Å2 
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of surface area when compared to DEVD in the caspase-7/DEVD complex. The pentapeptide of caspase-
7/LDESD can be superposed with those of caspase-2/LDESD, caspase-3/LDESD and caspase-3/VDVAD 
structures with RMS deviation of 0.54(0.48) Å, 0.22(0.35) Å and 0.31(0.43) Å for the 5 topologically 
equivalent Cα atoms, respectively. (The values within the parenthesis are those of the inhibitor in the se-
cond catalytic site.) The orientation and position of the P1-P4 residues of caspase-7/LDESD are very sim-
ilar to those in the caspase-7/DEVD complex. The only difference is the Val/Ser substitution at the P2 
position, and both side chains form similar hydrophobic interactions with Tyr230 of caspase-7 (Fig. 5c). 
The P5 Leu side chain of LDESD interacts with the residues of the loop-4 in the active site cleft. Howev-
er, the main chain amide and carbonyl oxygen of P5 Leu do not form hydrogen bonds with caspase-7, 
unlike the interactions observed in caspase-3/LDESD (Figure 2.5a). The CD1 of P5 Leu has van der 
Waals interactions with the side chain of Asp278. The P5 CD2 forms van der Waals interactions with Cα 
atom of Ser277, and the main chain carbonyl groups of both Gln276 and Ser277. The hydrogen bond in-
teraction between the main chain carbonyl of Gln276 and the P4 amide in the caspase-7/DEVD structure 
is conserved in the caspase-7/LDESD complex, while the acetyl group of Ac-LDESD-CHO is exposed to 
the solvent.  
2.4.7 Comparison of Caspase/LDESD Structures 
 The P5 interactions were compared for the pentapeptide complexes with caspase-2, -3, -6 and -7 
(Figure 2.6). The P5 Leu side chain forms similar hydrophobic interactions with the side chains of equiv-
alent residues Phe250 and Phe252 in caspase-3, Tyr273 and Pro275 in caspase-2, Phe263 and Lys265 in 
caspase-6. However, in caspase-7 the P5 Leu side chain forms van der Waals interactions with the main 
chain atoms of residues 276-277 and the side chain of Asp278.  The main chain of P5 Leu is anchored by 
the loop-3 residue Thr243 in caspase-2, Ser209 in caspase-3, and Thr222 in caspase-6. In caspase-3, the 
P5 amino acid is secured by the interaction of its main chain amide with side chain hydroxyl of Ser209, 
and by the two hydrogen bonds formed by its carbonyl with main chain amide and side chain hydroxyl of 
Ser209. Similar interactions are predicted for Thr222 in the caspase-6 complex. In caspase-2, the main 
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chain amide of Thr243 forms a hydrogen bond interaction with the carbonyl of P5 Leu and the side chain 
hydroxyl group of Thr243 interacts with the backbone amide of P5 [36].  Therefore, the hydroxyl of Ser 
or Thr of loop-3 in caspase-2, -3 and -6 forms stabilizing interactions with the main chain of the P5 resi-
due. In contrast, Pro235 is the corresponding loop-3 residue of caspase-7, which cannot form the hydro-
gen bonds that anchor P5 in the other caspases. When caspase-2/LDESD, caspase-3/LDESD and caspase-
7/LDESD structures are superposed, the residues P1-P4 of the peptides have almost identical position and 
orientation (Figure 2.7). However, the Cα of the P5 residue of caspase7/LDESD is ~2 Å further away 
from Pro235 in loop-3 when compared to the corresponding positions in the pentapeptide complexes of 
caspase-2 and caspase-3. This change is due to loss of the critical hydrogen bonds in the caspase-
7/LDESD complex. Instead, the P5 Leu side chain forms closer interactions with the loop-4 residues 
Ser277 and Asp278. Therefore, unlike caspase-2, -3 and -6, caspase-7 is not structurally suited to accom-
modate the hydrophobic P5 residue in peptides. 
 Interactions between P5 residues and S5 subsite were shown to produce conformational changes 
at loop-1 and loop-4 regions of caspase-3 when compared with the complex with tetrapeptides [34]. 
Structures of caspase-3 with tetrapeptide DEVD, pentapeptide LDESD and VDVAD were superimposed, 
and the distance between the Cα atoms of Gly60 (in loop-1) and Asp253 (in loop-4) was measured to 
show the conformational differences (Figure 2.8). The two loops have moved closer by about 3 Å in the 
structures of caspase-3/LDESD and caspase-3/VDVAD compared with that of caspase-3/DEVD. This 
conformational change partly closes the active pocket formed by the four loops and enables the P5 side 
chain to form favorable van der Waals interactions with caspase-3 residues. In the caspase-3/VDVAD 
structure, only one of the P5 Val CD atoms has hydrophobic interactions within the S5 pocket formed by 
Phe250 and Phe252 [34]. In caspase-3/LDESD structure, however, both CD atoms of the P5 Leu have 
van der Waals contacts with Phe250 and Phe252 (Figure 2.6a and Figure 2.8a). This observation con-
firms that loop-1 and loop-4 regions of caspase-3 are flexible and accommodate a variety of residues by 
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an induced-fit mechanism. However, it is not possible to determine from these static crystal structures 
whether the observed conformational differences result from entropic or enthalpic contributions. 
Similar analyses were performed for the structures of caspase-7 in complex with tetrapeptide and 
pentapeptide (Figure 2.8b). The separation of loop-1 and -4 is similar in caspase-7/DEVD and caspase-
7/LDESD (19.9 and 20.3 Å, respectively), indicating that no conformational change was induced in 
agreement with the kinetic data. The existence of a conformational change in caspase-6 upon binding of 
P5 residue cannot be verified in the absence of crystal structures. However, its preference for a P5 residue 
in kinetic study and structural similarity with caspase-3 suggested that caspase-6 also had a flexible S5 
binding site formed by the four loops.  
2.4.8 Correlation of Kinetic and Structural Data 
 Knowledge of the molecular structures of caspases has been critical for understanding their 
recognition of substrates and inhibitors. The kinetic data can be interpreted in light of the caspase residues 
in the loops of the S5 pocket interacting with the P5 residue. The caspase-3/LDESD structure showed hy-
drophobic interactions between the side chains of P5 Leu and Phe250 and Phe252 in the S5 pocket, simi-
lar to those reported for P5 Val in caspase-3/VDVAD and consistent with the increased activity (150%) 
for pentapeptides with hydrophobic P5 Leu compared to tetrapeptides of the same P1-P4 sequence (Fig-
ure 2.2 and [34]). However, the activity was similar for the tetrapeptide DEVD and the corresponding 
pentapeptide QDEVD, suggesting little preference for polar P5 residues. The putative S5 pocket of 
caspase-6 shares similarities with those of caspase-3 and -2 since Phe and Lys are present at equivalent 
positions in loop-4, and Thr is at the P5 anchoring position in loop-3 (Figure 2.6b). Moreover, the 
Phe263 in S5 can form hydrophobic contacts with P5 Leu, while the Lys265 may interact with polar P5 
residues like Gln. Hence, caspase-6 was predicted to form favorable interactions with both hydrophobic 
and polar P5 residues in agreement with the relative activity data, although there is a preference for polar 
P5 (Figure 2.2).  
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 Caspase-7 has the polar residues Gln and Asp at structurally equivalent positions in the S5 pocket 
(Figure. 2.6c) and was predicted to prefer polar residues at P5. However, caspase-7 showed lower activi-
ty for P5 Gln and P5 Leu in pentapeptides relative to DEVD suggesting no preference for polar P5 resi-
dues (Figure. 2.2). This specificity difference of caspase-7 compared to the caspase-2, -3 and -6 correlat-
ed with the observed interactions of P5 with the residue at the loop-3 anchoring position. Structural analy-
sis suggests the loop-3 residue Thr243/Ser209 in caspase-2, -3 and -6 is crucial for the recognition and 
anchoring of P5 residues. In caspase-7, the substitution of an imino acid, proline, at the structurally equiv-
alent position in the loop-3 prevents the formation of the hydrogen bond with the carbonyl of P5, while 
the nonpolar side chain of proline abolishes the other hydrogen bond with the amide of P5 that anchors 
this residue in the S5 binding pocket (Figure. 2.7). The presence of Pro rather than Ser or Thr explains 
the lower activity of caspase-7 with P5-containing substrates.  
Caspase-8 lacks the long surface loop-4 that forms the S5 pocket in the executioner caspases, 
while the P5 anchoring residue in loop-3 is proline as in caspase-7 (Figure. 2.1). Therefore, caspase-8 
strongly prefers the tetrapeptide substrate DEVD compared to the two tested pentapeptides. Comparison 
of the primary structures of other human caspases reveals that inflammatory caspase-1 and apoptotic initi-
ator caspase-9 also have proline as the S5 residue in loop-3 and hence it is likely that these caspases have 
no preference for the P5 residue in their substrates.  
 Our structural and kinetic analysis of the preference of executioner caspases for the P5 position of 
substrates will help identify the specific protein substrates and apoptotic pathways activated by each 
caspase. The P1 to P4 substrate recognition sequences of the executioner caspases are similar and hard to 
differentiate, especially between caspase-3 and -7. The P5 residue will contribute less than the P1 to P4 
residues to the overall affinity for caspases and therefore, the differences in the relative kcat/Km are also 
small. Our studies have shown that the hydrophobicity of the S5 subsite in caspase-3 and -6 is consistent 
with the relative kcat/Km for cleavage of peptides with hydrophobic or polar P5 residues, while caspase-7 
does not strongly interact with P5 of peptides. These findings are valuable in understanding the presence 
of redundant executioner caspases. Importantly, differences were identified in P5 recognition of caspase-3 
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and -7, which otherwise recognize very similar substrates, and these differences were correlated with the 
residue present in the newly defined loop-3 anchoring position and the caspase conformation with 
pentapeptides rather than tetrapeptides. Such differences in substrate recognition can be exploited in the 
rational design of selective inhibitors, which has proved a challenge, especially for caspase-3 and -7 [32, 
143]. Selective pharmacological inhibitors of specific caspases are desirable to reduce cell death for 
treatment of diseases characterized by increased apoptosis, such as stroke, heart disease and neurodegen-
erative diseases.  
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Table 2.1 Kinetic parameters of caspases for peptide substrates 
 kcat (min-1) Km (µM) kcat/Km (min-1µM-1) Relative kcat/Km (%) 
Caspase-6     
DEVD 28±3 490±60 0.058±0.01 100 
QDEVD 92±10 1070±110 0.086±0.01 148 
LDEVD 30±3 440±40 0.068±0.01 118 
Caspase-3     
DEVD 55±3 44±2 1.3±0.1 100 
QDEVD 57±3 54±3 1.1±0.1 85 
LDEVD 53±3 28±1 1.9±0.1 146 
Caspase-7     
DEVD 77±4 44±2 1.8±0.1 100 
QDEVD 63±3 51±3 1.2±0.1 67 
LDEVD 58±3 61±3 1.0±0.1 56 
Caspase-8     
DEVD 14±1 34±3 0.40±0.02 100 
QDEVD 11±1 151±8 0.07±0.01 18 
LDEVD 9±1 107±5 0.08±0.01 20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
58 
Table 2.2 Crystallographic data collection and refinement statistics 
 
 
Caspase3/ 
Ac-LDESD-CHO 
Caspase7/ 
Ac-LDESD-CHO 
Space group P212121 P3221 
a (Å) 
b (Å)  
c (Å) 
β (°) 
67.37 
93.56 
97.62 
90 
88.64 
88.64 
187.71 
120 
Resolution range 50-1.61 50-2.45 
Total observations 358,844 175,449 
Unique reflections 72,895 28,712 
Completeness 90.1 (63.9)a 90.3 (57.3)a 
<I/σ(I)> 15.3 (2.4) 18.5 (2.7) 
Rsym (%)b 7.5 (41.6) 9.5 (38.9) 
Refinement statistics   
  Resolution range 10-1.61 10-2.45 
  Rcryst (%)c 17.4 20.1 
  Rfree (%)d 22.3 24.8 
  Mean B-factor (Å2) 32.4 64.2 
  Number of atoms   
    Protein 3803 3777 
    Inhibitor 84 84 
    Water 276 82 
r.m.s. deviations    
    Bond length (Å) 0.009 0.006 
    Angles  0.029(Å)e 1.35(°)f 
aValues in parentheses are given for the highest resolution shell 
bRsym = Σhkl|Ihkl - 〈Ihkl〉|/ΣhklIhkl. 
 cR = Σ|Fobs-Fcal|/ΣFobs. 
dRfree = Σtest(|Fobs|-|Fcal|)2/Σtest|Fobs|2. 
e
 The angle rmsd in SHELX97 is indicated by distance in Å. 
f
 The angle rmsd in CNS is indicated by angle in degree. 
 
 
 
 
 
 
 
Figure 2.1 Sequence homology among five caspase family members.
loop-4 in small subunits are compared. The residues involved in P5 substrate
colored in red. 
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Figure 2.2 Relative activity on substrates.
Ac-QDEVD-CHO and Ac-LDEVD
 
 
 
 
 
 
 
 
 
 
 
 The relative kcat/Km values are shown for Ac
-CHO. 
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-DEVD-CHO, 
Figure 2.3 Overall structure of caspase
are shown in a ribbon representation with the large and small subunits colored cyan and pink, respectiv
ly. The inhibitor Ac-LDESD-CHO is colored by element type. Side chains of the caspase
interact with P5 Leu are colored in red. The N and C termini are indicated for the 12 kDa and 17 kDa 
chains. L1 to L4 indicate loops 1 to 4 that form the substrat
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e binding site. 
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-3/LDESD 
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Figure 2.4 Structure of peptide analog inhibitor Ac
contoured at a level of 1.6 σ for Ac
Cys163 of caspase-3 forms a hemithioacetal bond with the aldehyde group of the inhibitor.
 
 
 
 
 
 
 
 
 
 
 
-LDESD-CHO. 2Fo – Fc electron density map 
-LDESD-CHO in the caspase-3/LDESD complex. The active s
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Figure 2.5 Interactions of caspase
pase-6/LDESD.  (c) Caspase-7/LDESD. Thicker lines represent the peptide analog inhibitor. The inhibitor 
is covalently bonded to the catalytic cysteine. Dashed lines represent hydrogen bonds and ion pairs, while 
curved lines indicate van der Waals interactions. 
 
-3, 6 and 7 with Ac-LDESD-CHO. (a) Caspase-3/LDESD. (b) Ca
 
63 
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 Figure 2.6 Interactions of P5 Leu in S5 subsite of caspases.
6/LDESD. (c) caspase-7/LDESD. (d) caspase
gen bond interactions are represented by broken lines and the van der Waals contacts are shown in dotted 
lines. 
 
 
 
 
 
 
  (a) caspase-3/LDESD. (b) caspase
-2/LDESD. The atoms are colored by element type. Hydr
64 
 
-
o-
Figure 2.7 Superposition of pentapeptide substrate analogs in the cas
and the critical loop-3 residue that fixes the P5 position in structures of caspase
es with LDESD are shown in green, red, element type and yellow, respectively. Hydrogen bonds between 
P5 and loop-3 residue (in caspase-2, 
the loop-3 of caspase-7 results in loss of crucial hydrogen bonds that fixes the P5 residue.
 
 
 
pase active site.
-2, -3, - 
-3 and -6) are indicated by broken lines. The substitution of Pro in 
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  The inhibitor 
6 and -7 complex-
 
Figure 2.8 Comparison of caspase comlexes with pentapeptides and tetrapeptides.
of Cα backbone of caspase-3 with LDESD (red), VDVAD (green) and DEVD (yellow). Distances b
tween atoms are shown by broken lines. Conformational change is indicated by 
tween loop-1 and loop-4. The S5 binding site (boxed region) is shown in detail, where Phe250 and 
Phe252 form hydrophobic interactions with the P5 residues. (b) Superposition of C
caspase-7 with LDESD (cyan) and DEVD (ma
two complexes of caspase-7.  
the altered distances b
genta). No significant structural change is observed in the 
66 
 
 (a) Superposition 
e-
e-
α backbone of 
67 
3 CASPASE-3 BINDS DIVERSE P4 RESIDUES AS REVEALED BY CRYSTALLOGRAPHY 
AND STRUCTURAL MODELING 
(Published: Fang B, Fu G, Agniswamy J, Harrison RW, Weber IT. Apoptosis. 2009; 14(5):741-752.) 
3.1 Abstract 
 Caspase-3 recognition of various P4 residues in its numerous protein substrates was investigated 
by crystallography, kinetics, and calculations on model complexes. Asp is the most frequent P4 residue in 
peptide substrates, although a wide variety of P4 residues are found in the cellular proteins cleaved by 
caspase-3. The binding of peptidic inhibitors with hydrophobic P4 residues, or no P4 residue, is illustrated 
by crystal structures of caspase-3 complexes with Ac-IEPD-Cho, Ac-WEHD-Cho, Ac-YVAD-Cho, and 
Boc- D(OMe)-Fmk at resolutions of 1.9–2.6  Å. The P4 residues formed favorable hydrophobic interac-
tions in two separate hydrophobic regions of the binding site. The side chains of P4 Ile and Tyr form hy-
drophobic interactions with caspase-3 residues Trp206 and Trp214 within a non-polar pocket of the S4 
subsite, while P4 Trp interacts with Phe250 and Phe252 that can also form the S5 subsite. These interac-
tions of hydrophobic P4 residues are distinct from those for polar P4 Asp, which indicates the adaptability 
of caspase-3 for binding diverse P4 residues. The predicted trends in peptide binding from molecular 
models had high correlation with experimental values for peptide inhibitors. Analysis of structural models 
for the binding of 20 different amino acids at P4 in the aldehyde peptide Ac-XEVD-Cho suggested that 
the majority of hydrophilic P4 residues interact with Phe250, while hydrophobic residues interact with 
Trp206, Phe250, and Trp214. Overall, the S4 pocket of caspase-3 exhibits flexible adaptation for different 
residues and the new structures and models, especially for hydrophobic P4 residues, will be helpful for 
the design of caspase-3 based drugs.  
3.2 Introduction 
 Caspases are key effectors in the processes of apoptosis and inflammation. The family of cysteine 
aspartyl proteases comprises 14 mammalian caspases that are divided into three groups according to their 
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roles in the apoptotic and inflammatory pathways. The first group consists of inflammatory caspase-1, 4, 
5, and 11 [144]. They play essential roles in cytokine maturation and inflammatory responses. The second 
and the third groups are involved in the apoptotic process. Caspase-2, 8, 9, 10, and 12 are called initiator 
caspases because they are located on the upstream of the signaling pathway. They initiate the apoptotic 
cascade upon receiving interior or exterior death signals. Caspase-3, 6, 7, and 14 are downstream caspases 
that are activated by initiator caspases during apoptosis. The mature proteins are called executioner 
caspases because they selectively hydrolyze cellular proteins in the pathways leading to cell death. Sever-
al hundred different proteins have been found to be caspase substrates, as reviewed in [31-32].  
 Caspase activity is highly regulated in the cell. Some natural caspase regulators have been identi-
fied, such as caspase recruitment domains (CARD) and inhibitor of apoptosis proteins (IAPs), however, 
the entire regulatory machinery is very complicated and not yet fully understood. Dysregulation of 
caspase activity is associated with many severe human diseases. For example, neuronal crush injury, 
stroke, and neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases are 
associated with increased activities of caspases [111-113]. On the other hand, suppression of caspase ac-
tivity is implicated in cancer, autoimmune diseases and viral infections [29, 119, 145]. The development 
of caspase inhibitors as potential drugs has attracted great attention. Several non-peptide caspase inhibi-
tors are currently in clinical trials, such as IND6556 and VX-740 [146-147].  
 Caspase recognition of substrates has been investigated in order to identify the caspase-mediated 
pathways leading to cell death as well as to facilitate drug development. Early studies on peptides showed 
that caspases recognize at least four residues from P1 to P4, and they exclusively require aspartic acid at 
P1 in their substrates. From P2 to P4, different caspases have distinct preferences. Caspase-1, 4, and 5 
were shown to prefer the tetrapeptide sequence WEHD. Caspase-2, 3, and 7 prefer DEXD, whereas, 
caspase-6, 8, and 9 prefer (L/V)EXD [10, 148]. However, a series of recent studies have questioned these 
preferences. For example, the application of substrate-phage approach implied that DLVD was hydro-
lyzed up to 170% faster than canonical caspase-3 substrate DEVD [149]. A computer based virtual screen 
found a potent caspase-3 inhibitor Ac-DNLD-Cho with comparable inhibition to Ac-DEVD-Cho. Simi-
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larly, Ac-DFPD-Cho was found to be the best tetrapeptide inhibitor for caspase-7 [150]. Moreover, a non-
polar P5 residue was shown to facilitate substrate recognition of caspase-2 and 3, while polar P5 is pre-
ferred by caspase-6 [34, 151]. Considering the number of native caspase substrates identified with diverse 
non-canonical cleavage site sequences [152], it is apparent that the substrate selectivity of caspases is far 
from well understood. 
 Caspase-3 is one of the critical executioner caspases. In our previous study, the S2, S3 and S5 
pockets of caspase-3 were analyzed using aldehyde peptidyl inhibitors Ac-DEVD-Cho, Ac-DMQD-Cho, 
and Ac-VDVAD-Cho. Analysis of the P5 interaction in S5 was extended to the Ac-LDESD-Ac complex 
[153]. The complexes with non-canonical P4 residues in the S4 pocket of caspase-3 have not been ana-
lyzed, due to the assumption that P4 Asp was critical for substrate binding [35]. Although P4 Asp is 
common, many other amino acids can be found at the P4 position in the known protein substrates of 
caspase-3, including hydrophobic residues [31]. Evidently, P4 Asp is not essential for substrate recogni-
tion and hydrolysis. In addition, the analysis of non-polar residues in the S4 pocket is important for in-
hibitor and drug development, because hydrophobic moieties provide better cell permeability in drugs. 
Therefore, the binding of P4 residues was studied with the dual aims of helping to identify natural 
caspase-3 substrates and to design new inhibitors and drugs. The plasticity of the S4 pocket was studied 
in four caspase-3 crystal structures with inhibitors Ac-IEPD-Cho (IEPD), Ac-WEHD-Cho (WEHD), Ac-
YVAD-Cho (YVAD), and Boc-D(OMe)-Fmk (BocD). This crystallographic analysis was combined with 
energy calculations on structural models of P4 residues as well as enzyme inhibition data, and suggested 
that S4 pocket of caspase-3 can accommodate a variety of residues with different affinities.     
3.3 Materials and Methods 
3.3.1 Plasmids and Recombinant Proteins 
 The cloned full length human caspase-3 cDNA was expressed in E.coli BL21(DE3). The over-
expressed protein was purified using nickel affinity chromatography, ion exchange chromatography, and 
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gel-filtration chromatography as previously described [34]. Protein was concentrated to 4mg/ml and 
stored at -80°C. The purity was determined to be over 99% by SDS-PAGE. 
3.3.2 Enzyme Kinetic Assays  
 The catalytic activities of three caspase-3 mutants were determined using the colorimetric 
caspase-3 substrate Ac-DEVD-pNA (Biomol, PA), where Ac is the acetyl group and pNA is p-
nitroanilide. Mutant caspase-3 was preincubated in reaction buffer (50 mM HEPES, 100 mM NaCl, 0.1% 
CHAPS, 10% glycerol, 1mM EDTA and 10 mM dithiothreitol, pH 7.5) at room temperature for 5 mins 
prior to the addition of substrate at various concentrations. p-nitroanilide released by enzyme cleavage 
was measured at a wavelength of 405 nm using a Polarstar Optima microplate reader (BMG 
Labtechnologies, NC). SigmaPlot 9.0 (SPSS Inc. IL) was used to obtain the Km and Vmax values by fitting 
reaction velocities as described [154].  
 The inhibition constants of reversible aldehyde caspase-3 inhibitors Ac-IEPD-Cho, Ac-WEHD-
Cho, and Ac-YVAD-Cho were measured using the same protocol as previously described [34]. Briefly, 
caspase-3 was preincubated with its inhibitors in reaction buffer at room temperature for 30 mins. Then, 
substrate was added and reaction velocity was calculated according to substrate cleavage. The inhibition 
constants of each inhibitor were determined by a dose-response curve described by the equation: Ki = 
(IC50-0.5[E])/(1+[S]/Km), where [E], [S] and IC50, respectively, correspond to active enzyme concentra-
tion, substrate concentration, and the inhibitor concentration needed to suppress half enzyme activity 
[155]. The inhibition profile of irreversible inhibitor BocD was obtained using the same method and 30 
mins preincubation. Time dependence of the initial velocity was measured using 300nM of caspase-3 and 
a constant amount (2µM) of BocD after preincubation for times from 0 to 60 mins.  
3.3.3 Crystallographic analysis  
 The inhibitors were dissolved in dimethylsulfoxide. Caspase-3 was incubated at room tempera-
ture with the inhibitor at 10 to 20-fold molar excess. Crystallization was performed by the hanging-drop 
vapor diffusion method. Specifically, 1 µl of protein solution (4 mg/ml) was mixed with an equal volume 
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of mother liquid (100 mM sodium citrate, 5% glycerol, 10 mM dithiothreitol, and 14-18% PEG6000, pH 
6.5). Crystals grew within 24 hrs at room temperature. The crystals were frozen in liquid nitrogen with 
20% glycerol as a cryoprotectant. X-ray diffraction data were collected on the SER-CAT beamline at the 
Advanced Photon Source, Argonne National Laboratory.  
 The diffraction data were processed with HKL2000 [156]. The structures were solved by molecu-
lar replacement with the program AmoRe [157]. The structure of caspase-3/DMQD (PDB code 2H5J) 
was used as the initial model for all the structures in this study. All the structures were refined using CNS 
[158]. The molecular graphics program O 8.0 [159] was used to display the electron density map and to 
refit structures. Water molecules and alternate conformations of caspase-3 residues were modeled when 
observed in the election density maps. Structural figures were made by Weblab viewer pro (Accelrys Inc., 
MA) and images of electron density map were obtained using Molscript [160-161]. The crystal structures 
have been deposited in the RCSB Protein Data Bank with accession codes 3GJT for caspase-3/IEPD, 
3GJQ for caspase-3/WEHD, 3GJS for caspase-3/YVAD, and 3GJR for caspase-3/BocD. 
3.3.4 Molecular Modeling 
 Models of caspase-3 complexes with inhibitors of the form Ac-XEVD-Cho, where X is one of the 
20 amino acids, were built using the program AMMP[162]. The models were generated from the crystal 
structure of caspase-3/DEVD [34], which comprises the DEVD inhibitor bound to one large and one 
small subunit of a caspase-3 heterodimer.  The other P4 residues were introduced into the inhibitor using 
Coot [131]. The hydrogen atoms were built with the sp4 potential set using 15 cycles of the analytic mod-
el building algorithm in AMMP [140, 163], followed by conjugate gradients minimization of the non-
bonded and geometrical terms. Finally, each caspase-3/inhibitor complex was optimized by 1000 steps of 
conjugate gradients energy minimization. The total non-bonded interaction energy was calculated for 
each caspase-peptide model. Structural models were examined with the molecular graphics program 
RasMol [164] on Linux PCs. The experimental binding energy was calculated as ∆G = RTlnKi from the 
seven measured inhibition constants for correlation with the calculated interaction energies. The regres-
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sion line from this correlation was used to predict Ki values for the peptides with other P4 residues from 
the peptide-caspase interaction energies calculated by the modeling program.  
3.4 Results 
3.4.1 Analysis of P4 Residues in Known Caspase-3 Substrates 
 The frequency of occurrence of different P4 amino acids was analyzed for 182 natural substrates 
of caspase-3 listed in [31]. Almost all amino acids can be found at least once at the P4 position as shown 
by the relative occurrence (Figure 3.1). Aspartic acid was the most frequent residue in this position ap-
pearing in 55% of the substrate cleavage sites. The other cleavage sites had sixteen different residues at 
the P4 position, comprising 29% polar and 16% nonpolar residues. Glu and Ser are ranked second and 
third in frequency after Asp, appearing in 10% and 9 % of cleavage sites, respectively. Hydrophobic resi-
dues appear in the relative frequency of Val > Ala > Leu > Met > Phe > Ile/Cys. None of the 182 proteins 
had Arg, Lys, or Gln at P4, so these positively charged or polar amino acids are likely to be rare in 
caspase-3 cleavage sites. Therefore, in normal physiological conditions, the S4 pocket of caspase-3 can 
accommodate a variety of residues including the preferred negatively charged Asp, small polar and a va-
riety of hydrophobic side chains. 
3.4.2 Inhibition Constants of Caspase-3 Inhibitors 
Seven substrate analog reversible inhibitors of caspase-3 are commercially available. They were 
divided into two groups based on their P4 residues. DEVD, DQMD, and DMQD are caspase-3/7 inhibi-
tors with the standard motif of DxxD; while IEPD, ESMD, WEHD, and YVAD possessing different P4 
residues are optimal inhibitors of initiator caspase-8 and inflammatory caspases. The kinetic study was 
performed using the canonical caspase-3 substrate Ac-DEVD-pNA with the Km value determined as 
62.5±2.5 µM. The inhibition constants of the seven inhibitors against caspase-3 are listed in Table 2. The 
first group of inhibitors with the standard P4 Asp exhibited potent inhibition with Ki values from 1.2 nM 
for DEVD to 12 nM for DMQD, whereas the second group of inhibitors had Ki values approximately a 
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thousand times weaker. In the second group, IEPD was the most potent with the Ki value of 1.2 µM, 
while YVAD was the weakest with Ki of 10 µM. The inhibition values are comparable with those of pre-
vious studies with fewer inhibitors showing Ki values of 0.2-1nM for DEVD, 195 nM for IETD, 1.9 µM 
for WEHD and 10-12 µM for YVAD [33, 125, 165].  
BocD is a pan-caspase irreversible inhibitor widely used for in vivo studies. Its inhibitory profile 
was compared with IEPD as shown in Fig. 3.2a. At low inhibitor concentration, the enzyme activity was 
insensitive to the inhibitor. However, a substantial decrease of enzyme activity was observed when the 
inhibitor concentration was raised to 1 µM. The sigmoidal dependence of inhibition upon inhibitor con-
centration suggests that BocD has a cooperative or two-state binding as described for another irreversible 
inhibitor in [166]. The two-states may reflect different binding modes of BocD in the same site, or bind-
ing to the two active sites in the caspase heterotetramer. The inhibition increased when the BocD was in-
cubated longer with the caspase-3 before the activity was assayed (Figure 3.2b). The time dependency 
suggests that BocD acts as a slow binding inhibitor.  
3.4.3 Overall Structures of Four Caspase-3 Complexes 
 Caspase-3 was crystallized in complex with three tetrapeptide aldehyde inhibitors, IEPD, WEHD, 
and YVAD, as well as one modified monopeptide inhibitor BocD. The crystallographic data and refine-
ment statistics are summarized in Table 3.1. The proteins were crystallized in two space groups: primitive 
orthorhombic space group P212121 and primitive monoclinic space group P21. The four structures were 
refined to the resolutions of 1.9-2.6Å with R factors of 21.4-24.4%. All the four complexes consist of two 
p17/p12
 
heterodimers in their asymmetric units. The main chain conformations of caspase-3 in the four 
complexes are essentially identical and they closely resemble our previously reported structure of 
caspase-3\DEVD (2H5I) with overall rmsd of 0.41-0.49 Å for Cα atoms. 
 The three tetrapeptide inhibitors were bound in extended conformations in the S1-S4 substrate 
binding sites of caspase-3 (Figure 3.3a). The 2Fo-Fc electron density map of inhibitor YVAD is shown 
in Figure 3.3b. A thiohemiacetal bond was formed between the aldehyde group (-CHO) of the inhibitor 
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and the mercapto group (-SH) of the catalytic site Cys163. The main chain atoms of all three inhibitors 
shared similar positions and their Cα atoms superimposed very well with average rmsd of 0.27 Å for four 
Cα atoms. On the other hand, significant conformational variations were observed when side chain atoms 
were compared. Compared with the canonical inhibitor DEVD, the three weaker inhibitors differ mainly 
at P2 and P4 positions, and the structural differences will be explained in the later sections. 
 Caspase-3 was crystallized with the inhibitor BocD in order to study the unliganded S4 pocket. 
BocD was observed in a unique mode of binding. The Fo-Fc map in the substrate binding site clearly in-
dicated that this inhibitor only occupied the S1 and S2 pockets of caspase-3 (Figure 3.3c). A zwitterionic 
intermediate was formed between the fluoromethyl ketone (-FMK) on the inhibitor and the mercapto 
group (-SH) of Cys163. Although it has been claimed that this inhibition could be reversed in certain 
conditions, such as high DTT (1,4-dithio-threitol) [167], this class of inhibitors is conventionally consid-
ered to be irreversible caspase inhibitors in physiological conditions.     
3.4.4 Inhibitor Interactions in the S1-S3 Subsites 
 The peptidic inhibitors formed a series of hydrogen bond and ionic interactions in the caspase 
active site cavity, as shown in Figure 3.4. The interactions in each subsite are described separately. 
Caspases are known to have a stringent requirement for aspartic acid at the P1 position of their substrates. 
In agreement, the P1 Asp of the three tetrapeptide inhibitors bound in the S1 pocket in very similar con-
formations. The major interactions in S1 include both ionic bonds and hydrogen bonds formed between 
P1 Asp and Arg64, Arg207, Gln161, and Ser205. Although P1 Asp is critical for tight binding of pep-
tides, its negative charge is undesirable in potential drugs. The inhibitor BocD shows one way to improve 
cell permeability by methylation of one side chain oxygen atom of the P1 Asp. The methyl-Asp occupied 
the S1 pocket of caspase-3 in a comparable conformation to the P1 Asp of the canonical inhibitor DEVD 
(Figure 3.4a) except that the methyl group extended into the pocket towards Gln161. The neutralized P1 
group has hydrogen bond interactions instead of ionic interactions with the positively charged Arg64 and 
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Arg207 (Figure 3.4d). From the protein perspective, the conformations of S1 residues were conserved in 
all four complexes. 
 The S2 subsite is formed by three hydrophobic residues, Tyr204, Trp206, and Phe256. Its plas-
ticity was explored using the residues Pro and His, as well as the hydrophobic moiety Boc (tert-
butoxycarbonyl) in the new structures. In the structure of caspase-3/IEPD, the P2 Pro neatly fitted into the 
S2 subsite. Although its side chain is smaller than Val in the canonical DEVD, three S2 residues shifted 
their side chains towards the P2 Pro reducing the size of the S2 pocket. Consequently, proline has favora-
ble van der Waals interactions with these three S2 residues (Figure 3.5b). Compared with proline, 
histidine was not expected to be an attractive P2 residue due to its bulky side chain. However, in the 
structure of caspase-3/WEHD, the P2 histidine was accommodated in the S2 pocket with its aromatic ring 
pointing into the solvent (Figure 3.5c). All the side chain carbon atoms formed van der Waals interac-
tions with the three hydrophobic S2 residues. Compared with P2 valine of canonical DEVD, the Cα atom 
of histidine moved a little further from the S2 residues, which was likely due to the larger size of the 
histidine side chain. In the caspase-3/BocD complex, the hydrophobic Boc group occupies the equivalent 
P2 position. Unexpectedly, the electron density map clearly showed that the Boc group was directed out 
of the S2 subsite, (Figure 3.3c; 3.5d). Although the terminal carbon atoms of the Boc group had interac-
tions with Tyr204, the interactions with Trp206 and Phe256 were lost. This analysis suggests that the S2 
subsite of caspase-3 prefers small hydrophobic moieties like Val or Pro, and the Boc group is too bulky 
for optimal fit. 
 The primary interactions in the S3 pocket are the main chain hydrogen bonds formed between the 
P3 residue and Arg207. They are conserved independent of the type of amino acid at P3. In these struc-
tures of caspase-3 with IEPD, WEHD, and YVAD, Glu and Val formed similar main chain interactions in 
the S3 pocket as described in an earlier study [34]. Therefore, P3 Val can be accommodated in the S3 
subsite, although earlier binding studies showed that caspase-3 preferred hydrophilic residues, with the 
highest affinity for P3 Glu in peptides [148]. The side chain of P3 Glu formed hydrogen bond interactions 
with the side chain hydroxyls of Ser65 and Ser209 in caspase-3/WEHD, however, the P3 Glu in IEPD 
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only retained the interaction with Ser65 while the side chain of Ser209 rotated to interact with its neigh-
bor Lys210. A water mediated hydrogen bond was formed between P3 Glu and Arg207 in both structures. 
In contrast, the side chain of P3 Glu in the canonical inhibitor DEVD formed a direct hydrogen bond with 
Arg207 but had no hydrogen bonds with Ser65 and Ser209 (Figure 3.5e). These differences imply that 
the interactions of the P3 side chain depend on the type of amino acid at positions P2 and P4, however, 
further studies are necessary to address this question.  
3.4.5 S4 Subsite 
 In our previously reported structure of caspase-3/DEVD, the P4 Asp interacted with the main 
chain atoms of Phe250 and Asn208 through its side chain oxygen atoms and main chain amide group. 
Those polar interactions tightly anchored the P4 Asp in the S4 subsite. In contrast, the three hydrophobic 
P4 residues in the new structures showed no direct hydrogen bonds with S4 residues, except for the hy-
drogen bond between the amide of P4 Ile in IEPD and the carbonyl oxygen of Phe250 (Figure 3.4a). In 
caspase-3/YVAD a water mediated hydrogen bond interaction was found between the side chain hydroxyl 
of P4 Tyr and the main chain atoms of Gln248. Despite the paucity of polar interactions, the three P4 res-
idues formed favorable hydrophobic interactions in two separate regions of the S4 pocket. In the structure 
of caspase-3/IEPD, the side chain of Ile was rotated slightly into the S4 subsite compared with the con-
formation of P4 Asp in caspase-3/DEVD, and fitted in a non-polar pocket formed by the aromatic side 
chains of Trp206 and Trp214 (Figure 3.5f). Similarly favorable van der Waals interactions between P4 
Ile and two Trp residues were also observed in the complex of caspase-7/IEPD [168]. Also, the S4 subsite 
of initiator caspase-8 is formed by two aromatic residues, Trp420 and Tyr412, consistent with the prefer-
ence for Ile at P4 position. In the complex of caspase-3/YVAD, the P4 Tyr lay in the S4 pocket with its 
side chain hydroxyl directed out of the substrate binding groove. The P4 Tyr formed favorable van der 
Waals bonds with Trp214 and Trp206 (Figure 3.5g). The terminal acetyl oxygen of YVAD formed hy-
drogen bonds with the main chain and side chain of Ser209, whereas, the acetyl group of IEPD formed a 
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water-mediated interaction with the side chain of Ser209, which also contribute to the binding affinity 
(Figure 3.6).  
 In the complex of caspase-3/WEHD, the P4 Trp binds in the S4 subsite in a unique manner. The 
entire side chain of Trp and the acetyl group were rotated by about 90° (Figure 3.5h). Consequently, the 
aromatic ring of P4 Trp interacted with the hydrophobic side chains of Phe250 and Phe252 that were pro-
posed to form the S5 pocket of caspase-3 [34]. Because of the rotation, the acetyl oxygen formed a hy-
drogen bond with the main chain amide of Phe250 instead of the interaction with Ser209 seen in the other 
complexes (Figure 3.4b). Moreover, the interaction of P4 Trp with Phe250 and 252 in the S5 subsite ap-
peared to trigger a closure of about 0.9 Å of the loops 1 and 4, similar to the conformational change and 
induced fit mechanism proposed in our previous studies of caspase-3 with P5-containing pentapeptides 
[34].  
Although BocD does not possess a P4 residue, a glycerol molecule was found in the S4 subsite in the 
crystal structure of caspase-3/BocD. The glycerol molecule was positioned to form two hydrogen bonds 
between glycerol oxygen O1 and O2 and the side chain nitrogen of Trp214 as well as the amide group of 
Phe250, respectively (Figure 3.5i). The binding of glycerol reflects the hydrophilic nature of the S4 
subsite. In the absence of P4-containing ligand, S4 is highly accessible for water and other polar solvent 
molecules.  
 Overall, the structures showed that the different P4 residues can bind with only small conforma-
tional changes in the caspase residues, similar to the observations for caspase-7 [168]. The divergent 
binding modes of the various P4 residues imply that, although polar residues bind favorably in the S4 
subsite, non-polar residues can be accommodated without triggering substantial conformational change. 
Two distinct hydrophobic pockets provide interactions with hydrophobic P4 in the S4 region. Trp206 and 
Trp214 form an inner subsite, which is suitable for smaller non-polar side chains while Phe250 and 
Phe252 form an outer pocket, which is suitable for larger hydrophobic P4 side chains like Trp or P5 resi-
dues like Val or Leu. The binding modes of P4 Trp and P4 Tyr in YVAD and WEDH, respectively, illus-
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trate the two distinct pockets (Figure 3.6). This structural analysis explains why some natural substrates 
of caspase-3 have hydrophobic P4 resides, such as Ile and Leu in CREB and DCC, respectively [152].  
3.4.6 Correlation of Structural Interactions with Inhibition 
 The three substrate analog inhibitors share the same P1 Asp residue. They exhibit comparable 
conformations for P1 and have similar interactions with S1 residues. In the next subsite, all three different 
P2 residues exhibited favorable van der Waals interactions with S2 residues. Therefore, the variations of 
P3 and P4 are the primary factors influencing inhibitory potency. The three tetrapeptide inhibitors showed 
weak inhibition compared with canonical inhibitor DEVD (Table 3.2). IEPD is the strongest among three 
with a Ki value of thousand times higher than for DEVD. The weakest inhibitor YVAD is ten-fold weaker 
than IEPD. Structural analysis suggests that Ile is the most favorable of the three P4 residues because it 
preserves a main chain hydrogen bond interaction with Phe250. Tyr is the next most favorable since its 
side chain has a water mediated hydrogen bond with Gln248. The Trp is ranked last because of two rea-
sons. First, it has no polar interactions with S4 residues unlike the other two residues. Second, the binding 
to the S5 pocket requires rotation of its entire bulky side chain. At the P3 position, Glu is clearly more 
favorable than Val in the S3 subsite. The positively charged Arg207 and hydrophilic Ser65 firmly an-
chored the negatively charged Glu in the S3 pocket. On the contrary, the Val side chain has no favorable 
interaction with S3 residues. Since hydrogen bond interactions are stronger than van der Waals interac-
tions, the variation of P3 is the primary reason for the inhibitory differences of the three inhibitors. Over-
all, the substitution of P4 Asp with hydrophobic residues resulted in dramatic drop in inhibitory potency. 
IEPD was the best because P4 Ile has a better fit in S4 than other two and P3 Glu is favorable. YVAD 
showed the weakest inhibition mainly because of the mismatch of P3 Val in the S3 subsite. Although, 
WEHD had the least favorable P4 residue, the favorable P3 Glu interaction still made a stronger inhibitor 
than YVAD. Moreover, the side chain of P3 Glu in WEHD formed a hydrogen bond with Ser209 and a 
more direct ionic interaction with Arg207 relative to P3 Glu in IEPD. This analysis illustrates the effects 
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of combining sequence variations at the P4 and P3 positions, which is expected to alter the efficiency of 
hydrolysis of proteins with different sequences at their cleavage sites.   
 From the viewpoint of numbers of favorable interactions with caspase-3, BocD should exhibit the 
lowest binding affinity as reflected in our inhibition assay. The methylated P1 Asp is uncharged and less 
favorable than the negatively charged Asp for binding the positively charged S1 pocket. The consequence 
is that a higher concentration of the inhibitor needs to be accumulated in order to effectively block the 
active site of the enzyme. Hence, the poor performance of BocD observed in the low concentration range. 
In the higher concentration range, Boc-D-Fmk was a stronger inhibitor than WEHD and YVAD because 
it can irreversibly inactivate caspase-3.  
3.4.7 Predicted Binding of Diverse P4 Residues 
 The analysis of mode of binding and inhibition of P4 residues was extended to all 20 amino acids 
by molecular modeling. 20 residues at the P4 position in peptide inhibitor XEVD were modeled in their 
complexes with caspase-3. The program AMMP [162] was used for modeling with the crystal structure of 
caspase-3/DEVD (2H5I) comprising one inhibitor bound to one large and one small caspase subunit as 
the initial template. The structural 49 interactions and the interaction energies were predicted for the pep-
tides in the molecular models of caspase-3/XEVD. Importantly, the predicted conformations of the P4 Ile, 
Trp and Tyr in the inhibitor XEVD closely resemble those observed in our crystal structures (Figure. 
3.7).   
 The accuracy of the energy calculation was examined using the seven commercial caspase 
tetrapeptide inhibitors with Ki values determined in our caspase-3 activity assay (Table 3.2). To our 
knowledge, this is the most complete set of aldehyde tetrapeptide inhibitors of caspase-3 at present. As 
shown in the Figure 3.7a, the observed free energies (∆G) derived from experimental Ki values for the 
seven inhibitors showed excellent correlation (R of 0.83) with the calculated interaction energies for the 
models. The calculated interaction energy is an estimate of ∆U, which is assumed to dominate the chang-
es in free energy. In these calculations on a single configuration the effects of entropy and energy of solv-
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ation are assumed to be small or similar for the series of inhibitors. Therefore, the estimate for ∆U can be 
used to estimate trends in ∆G for different peptides. The high correlation indicates that our structural 
models and energy calculations are reliable.  
 In order to estimate relative binding affinities for all 20 P4 residues in the peptide XEVD, struc-
tural models were also made with Asp, Ile, Trp, and Tyr in the P4 position using the same procedure. The 
predicted Ki values of inhibitors XEVD, which were derived from mapping the calculated interaction en-
ergies onto the regression line in Figure 3.8a, are shown in Figure 3.8b. The P4 Asp showed the highest 
affinity in the prediction, in agreement with experimental results. The inhibitor with P4 Glu was predicted 
as the second strongest one. Arg and Asn were predicted to be the next best at P4 in this tetrapeptide, alt-
hough Lys and His were among the weaker inhibitors. Among the hydrophobic P4 residues, aliphatic res-
idues were predicted to show better binding than aromatic residues. These results are consistent with the 
previous experimental analysis of caspase-3 substrate preference [148]. The predicted trends in binding 
affinity showed general agreement with the residue ranking in our analysis of natural substrates (Figure 
3.1), although deviations appeared for some residues such as Arg and Asn. The predictions for relative 
inhibition from the energy calculations assume that changes in entropy and solvation energy are negligi-
ble. Also, the binding affinity depends on the entire substrate and the models used tetrapeptides with op-
timal residues at P1–P3 instead of the full-length protein substrates with a variety of residues at these po-
sitions. Therefore, experimental data for proteins with different cleavage site sequences are required in 
order to more fully understand the substrate specificity of caspase-3.  
 The model complexes were analyzed for the binding mode of the different P4 residues (Figure 
3.9). Most of the sixteen residues showed similar conformations with interactions depending on the type 
of side chain at P4. The eight polar P4 residues Arg, Lys, Glu, Asn, Gln, His, Ser and Thr were predicted 
to form at least one side hydrogen bond interaction with caspase residues. Most of them interacted with 
the main chain atoms of Phe250 (Figure 3.9). The P4 Arg and Lys were predicted to form hydrogen 
bonds with the main chain of Glu248 and the side chain of Asn208, and P4 His formed a hydrogen bond 
with Ser209. On the other hand, Pro and six hydrophobic residues Ala, Cys, Val, Leu, Met, Phe interacted 
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with S4 subsite through van der Waals interactions with distance cutoff of 3.8-4.2 Å. All of them interact-
ed with Trp206, P4 Leu, Met and Phe interacted with Phe250, and P4 Leu also interacted with Trp214. 
Glycine is not shown in the figure since it does not have a side chain. Most acetate groups on the inhibi-
tors formed hydrogen bond interactions with Ser209, as observed for crystal structures of caspase-3/IEPD 
and YVAD (Figure 3.4). An exception was observed in the model with P4 Phe, where the acetate inter-
acted with Asn208 and Trp214. This change was because the side chain of P4 Phe had rotated towards 
Phe250 and Phe252 similar to the rotated conformation seen for P4 Trp in the crystal structure of caspase-
3/WEHD (Figure 3.6).  
 Independent of the predicted binding affinities, most P4 residues were accommodated without 
greatly changing the conformation of the S4 pocket. His and Phe were only two P4 residues that showed 
considerable conformational change when bound to the enzyme, which is consistent with their higher es-
timated Ki compared with others. Our results imply that the S4 subsite is capable of accommodating vari-
ous P4 residues. Hydrophilic P4 is most likely to interact with F250 and N208, whereas hydrophobic P4 
is most likely to interact with W206 and F250. According to the calculated interaction energy, most sub-
stitutions of P4 resulted in a hundred fold decrease in the binding potency compared with inhibitor 
DEVD. The binding affinity, however, will also depend on the residues present at other positions, such as 
P3. Further analysis will be needed to explore the effect of variations at other positions in the cleavage 
sites. Moreover, a substrate protein with a significantly lower binding affinity can still effectively bind to 
caspase-3 and be hydrolyzed in physiological conditions. That explains why a large number of non-
canonical substrate sequences have been found.   
3.5 Discussion 
 Since the original work of Thornberry and Talanian [148, 169], the idea of consensus recognition 
sequences was established as the basis of the current substrate and inhibitor research of caspases. DxxD 
was considered the classic substrate recognition motif for caspase-3 and -7 from studies of short peptides. 
This information, however, is misleading in searching for natural caspase substrates because a substrate 
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protein does not have to bind with the highest affinity. Numerous natural substrates of caspases have been 
discovered by in vitro kinetic studies, in vivo cleavage studies, and mutagenesis studies. Among 59 natu-
ral caspase-3 substrates listed in Backes’ study, 27 substrates have different P4 residues rather than Asp at 
their cleavage sites [152]. In fact, 10 out of those 27 substrates possess hydrophobic P4 residues. We have 
extended the statistics on natural substrates of caspase-3 and found that 45% of 182 reported natural 
caspase-3 substrates possess residues distinct from Asp, and over a third of them are non-polar residues. It 
challenges our old knowledge about substrate recognition of caspase-3 suggested by earlier in vitro kinet-
ic studies. Crystal structures of caspase-substrate complexes can help us to better understand this problem 
by providing direct evidence of whether a putative substrate can bind and how it binds.  
 Our structures with three substrate analog inhibitors have demonstrated the binding modes of non 
classical residues from P2 to P4 positions. The hydrophobic S2 subsite of caspase-3 was suggested to 
preferentially recognize aliphatic residues. Nevertheless, some natural caspase-3 substrates have aromatic 
residues at P2, such as PAPD in CAMK4 (calcium/calmodulin dependent protein kinase IV) and DRHD 
in NFKBIA (nuclear factor of Kappa light peptide gene enhancer in B-cells inhibitor, alpha). In our struc-
tures, the aromatic side chain of His and hydrophobic Pro were both accommodated in the S2 subsite. 
This observation is consistent with a previous screening study where proline was found to be of the best 
P2 residues [149]. Furthermore, the pyrrolidine ring has been successfully utilized at P2 position in the 
development of caspase-3/7 inhibitors, such as the isatin sulfonamide inhibitors [170]. Clearly, the S2 
subsite of caspase-3 can accommodate both aliphatic residues and aromatic residues. At the P3 position, 
our study confirmed previous studies that various residues can bind, among which Glu is the best. 
 At the P4 position, the three groups of caspases exhibit distinct preferences. Initiator caspases 
prefer Leu/Ile/Val, inflammatory caspases prefer Trp, while executioner caspases demonstrate a strong 
preference for Asp at P4 position and any substitution resulted in thousand-fold difference in the binding 
affinity. This characterization was challenged by several previous studies where caspase-8 was shown to 
tolerate P4 Asp [171] and caspase-7 was shown to accommodate hydrophobic P4 residues such as Trp 
[168]. The cleavage sites of many caspase-3 natural substrates, such as YVPD in CDC2L1 (cell division 
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cycle 2 like 1 protein) and ILND in CREB (cAMP response element-binding protein) underlined the natu-
ral capability of caspase-3 to bind diverse P4 residues in vivo. Several polar residues have showed tight 
interactions with S4 in our predictions, including Asp, Glu, Asn and Ser. Although hydrophobic residues 
showed weaker interactions in the S4, most of them can be accommodated in favorable conformations in 
our models as well as in the crystal structures. Our previous studies revealed that the S4 subsite of 
caspase-7 has dual functionality with a hydrophilic area and a hydrophobic area [168]. In the current 
study, the same feature was also found in the S4 subsite of caspase-3. The side chain of P4 Ile in IEPD 
and P4 Tyr in YVAD interacted with a hydrophobic pocket formed by Trp206 and Trp214 deep inside the 
S4 subsite. In contrast, the side chain of P4 Trp in WEHD extended out of the S4 subsite and made con-
tact with the reported hydrophobic S5 residues [34]. The physiological function of hydrophobic S5 was 
reflected in the crystal structure of XIAP bound with caspase-3 [172], where Ile149 and Ile153 of XIAP 
interacted with S5 residues. In the absence of structural information for natural caspase substrates, the 
functions of Trp206 and Trp214 in the S4 subsite were not understood before. Nevertheless, their capabil-
ity of interacting with non-polar residues was revealed in this study. Van der Waals interactions between 
hydrophobic P4 residues and Trp206 were also conserved in our structural models. This analysis supports 
the existence of the inner non-polar pocket of the S4 subsite. The discovery of dual functionality of S4 
subsite as well as the binding modes of diverse P4 residues provides the structural basis for binding of 
non-polar residues in S4 subsite. Small aliphatic non-polar residues such as Ala, Val, and Leu are more 
likely to bind to the inner pocket of S4. Aromatic residues may need more conformational adjustments. 
This explains why aliphatic non-polar residues appear more frequently than aromatic ones at P4 in the 
caspase cleavage sites. Of course, it is likely that caspase-3 recognition of non-polar P4 residues will de-
pend on other conditions, such as early stage binding between enzyme and its targets. In such way, non-
polar interactions at P4 can become more favorable when the cleavage site is buried in the active site 
groove and becomes less exposed to the solvent. This may explain why many natural substrates with non-
polar P4 can be cleaved efficiently in physiological conditions. Although the real mechanism may be 
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more complex, it is clear that some non-polar P4 residues such as Ala, Val, and Leu, must be considered 
when searching for potential caspase-3 substrates.  
 Last but not least, the information on binding of non-polar P4 residues to caspase-3 can help the 
development of new inhibitors and drugs. Current drug design for caspse-3 is mostly limited to the P1, P2 
and P3 positions. Introduction of a hydrophobic P4 moiety could not only facilitate the binding, but also 
improve the cell permeability. Compound IDN-6556 is one such example [173]. Although the structure of 
its complex with caspase is not available, the aromatic moiety at its N terminus is likely to bind in the S4 
of caspase-3 [174]. This oxamyl peptide compound showed inhibition of all caspases and is currently un-
der phase II clinical trials in patients with liver transplants [121]. The results from this study should be 
considered in the future development of therapeutic compounds. Material and Methods. 
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Table 3.1 Crystallographic data collection and refinement statistics. 
 
 
Caspase3/ 
Ac-YVAD-Cho 
Caspase3/ 
Ac-IEPD-Cho 
Caspase3/ 
Ac-WEHD-Cho 
Caspase3/ 
Ac-D(Me)-
Fmk 
Space group P21 P212121 P212121 P21 
a (Å) 
b (Å) 
c (Å) 
β(°) 
50.4 
70.3 
93.4 
102.4 
68.2 
88.3 
96.9 
90 
69.1 
88.2 
96.6 
90 
50.4 
69.7 
93.4 
102 
Resolution range 50-1.9 50-2.2 50-2.6 50-2.2 
Completenessa 85.7(52.0) 99.7(99.3) 99.7(99.7) 95.1(75.0) 
<I/σ(I)> 13.18(3.0) 21.3(10.7) 12.3(7.0) 11.9(2.8) 
Rsym (%)b 7.3(21.4) 7.6(17.9) 11.2(33.1) 11(30.5) 
Refinement statistics     
Resolution range 10-1.9 10-2.2 10-2.6 10-2.2 
Rcryst (%)c 21.6 24.4 23.6 21.4 
Rfree (%)d 24.8 28.8 29.0 25.3 
Average B factor (Å2) 25.3 25.5 31.2 20.7 
No. protein atoms 3908 3786 3776 3774 
No. water atoms 299 134 49 181 
Bond length rmsd (Å)  0.007 0.007 0.007 0.007 
Angles rmsd (°) 1.3 1.3 1.3 1.3 
aValues in parentheses are given for the highest resolution shell. bRsym = Σhkl|Ihkl - 〈Ihkl〉|/ΣhklIhkl. cR = Σ|Fobs-
Fcal|/ΣFobs. dRfree = Σtest(|Fobs|-|Fcal|)2/Σtest|Fobs|2.  
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Table 3.2 Inhibition constants 
Inhibitor Ki (nM) 
Ac-DEVD-Cho 1.2 ± 0.05 
Ac-DQMD-Cho 11.0 ± 0.5 
Ac-DMQD-Cho 12.0 ± 0.5 
Ac-IEPD-Cho 170 ± 7 
Ac-ESMD-Cho 1.2×103 ± 48 
Ac-WEHD-Cho 4.7×103 ± 190 
Ac-YVAD-Cho 10.2×103 ± 410 
Caspase-3 was preincubated with its inhibitors in reaction buffer (50 mM HEPES, 100 mM 
NaCl, 0.1% CHAPS, 10% glycerol, 1mM EDTA and 10 mM dithiothreitol, pH 7.5) at room 
temperature for 15 mins. Substrate was then added and reaction product p-nitroanilide was 
measured at a wavelength of 405 nm. The inhibition constants were determined by using the 
equation: Ki = (IC50-0.5[E])/(1+[S]/Km), where [E], [S] and IC50, respectively, correspond to 
active enzyme concentration, substrate concentration, and the inhibitor concentration needed to 
suppress half enzyme activity. The enzyme concentration was determined by active site titration. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.1 The occurrence of different amino acids at P4 in the cleavage sites of natural substrates 
of caspase-3. Different residues are represented in different colors.
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Figure 3.2 Inhibition characterizations of caspase
hibitors IEPD (▲) and BocD (●). The fractional inhibition is calculated as V/V0×100%, where V and V0 
refer to velocities with and without inhibitor respectively.
reaction buffer (50 mM HEPES, 100 mM NaCl, 0.1% CHAPS, 10% glycerol, 1mM
dithiothreitol, pH 7.5) at room temperature for 30 mins. Inhibition profile of IEPD was fitted using hype
bola equation: Inh=Inhmax[I]/(Kd+[I]), while inhibition profile of IEPD was fitted using sigmoidal equ
tion: Inh=Inhmin+(Inhmax- Inhmin)/(1+10^(logEC50
tion, inhibitor concentration, and the inhibitor concentration
moidal inhibition profile of BocD suggests a cooperative binding mechanism. BocD may bind
steric site on caspase-3, which in turn facilitates the binding of BocD in the active site of the protein. (b) 
Time dependence of the initial velocity was measured using 300 nM of caspase
preincubation for 0 to 60 mins. Because time
ically follow exponential decay, data in the graph was fitted into the
equation: V=Vmin+a*exp(-bt), where V and t refer to initial reaction velocity and time,
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 Caspase-3 was preincubated with inhibitors in 
 EDTA and 10 mM 
-[I])). Inh, [I], and EC50 refer to fractional inhib
 provides the halfway inhibition. The si
-3 and 2µ
 dependence inhibition profiles of irreversible inhibitors ty
 exponential decay curve defined by 
88 
 
-3 in-
r-
a-
i-
g-
 to an allo-
M of BocD after 
p-
 respectively.  
Figure 3.3 Binding conformations of inhibitors.
binding site of caspase-3. Inhibitors IEPD (blue), WEHD (magenta), YVAD (yellow),
are shown in stick representation. The 
electron density map of inhibitor YVAD contoured at a level of
inhibitor BocD in the complex of caspase
tor covalently binds to active site Cys163. The
illustrated as ribbons. 
 
 
 (a) Superposition of four inhibitors in the
 
 inding surface of S1-S4 subsites is shown in pale blue. (b) 2Fo
 1.4σ. (c) Fo-Fc electron density map of 
-3/BocD. The map was contoured at a level of 1.4σ
 backbone of loops forming the substrate binding site is 
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 substrate 
and BocD (green) 
-Fc 
. The inhibi-
Figure 3.4 Schematic representation of hydrogen bond and ionic interactions between caspase
and the inhibitors. (a) IEPD, (b) WEHD, (c) 
inhibitors are in black. Interactions are indicated in dashed lines. 
 
 
 
 
 
YVAD, and (d) BocD. The protein residues are in blue and 
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Figure 3.5 Comparison between subsites in four new complexes (color) and published structure of 
caspase-3/DEVD (grey) (2H5I). (a) The methylated P1 Asp of BocD and S1 residues. (b)
Pro, His, and Boc moiety, respectively are shown in S2. (e) The empty
(f)-(h) The binding of P4 Ile, Tyr, and Trp, respectively, in S4. (i) The unbound S4 has glycerol in the 
BocD complex. Hydrogen bonds are represented by dashed lines. The boxed caspase
with inhibitors.  
 
 
 
 S3 subsite of the BocD complex. 
-
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-(d) P2 residues 
3 residues interact 
Figure 3.6 P4 binding site on caspase
in either the S5 pocket formed by Phe250 and 252 (orange) or another non
Trp206 and 214 (orange). 
 
 
 
 
 
 
 
 
-3. P4 residues Ile (green), Tyr (cyan), and Trp (yellow) can bind 
-polar pocket formed by 
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Figure 3.7 Superposition of inhibitors in the crystal structures (green) and structural models (pur-
ple). (a) IEPD/IEVD (b) YVAD/YEVD (c) WEHD/WEVD 
 
Figure 3.8 Predicted binding affinities for diverse P4 residues.
mental binding energies and calculated interaction energies. (b) The occurrence of different P4 residues 
found in caspase-3 natural substrates normalized to occurrence of P4 Asp. (c) Predicted Ki values of i
hibitors Ac-XEVD-Cho. 
 
 
 
 (a) The correlation between exper
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Figure 3.9 Predicted binding conformations of fifteen different P4 residues in caspase
P4 residue is located in the center in the stick representation, while caspase residues are shown as lines. 
The letter in the left top corner indicates the residue name. Hydrogen bond interactions are indicated by 
dash lines. Caspase residues involved in polar i
van der Waals interactions are labeled in blue.
nteractions are labeled in black while those involved in 
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4 CONFORMATIONAL CHANGES AND SUBSTRATE RECOGNITION IN PSEUDOMO-
NAS AERUGINOSA D-ARGININE DEHYDROGENASE 
(Published: Fu, G., Yuan, H., Li, C., Lu, C., Gadda, G. and Weber, I., (2010) Biochemisty 49: 8535-
8545.) 
4.1 Abstract 
 DADH catalyzes the flavin-dependent oxidative deamination of D-amino acids to the correspond-
ing α-keto acids and ammonia. Here we report the first X-ray crystal structures of DADH at 1.06 Å reso-
lution, and its complexes with iminoarginine (DADHred/iminoarginine) and iminohistidine 
(DADHred/iminohistidine) at 1.30 Å resolution. The DADH crystal structure comprises an unliganded 
conformation and a product-bound conformation, which is almost identical to the DADHred/iminohistidine 
crystal structure. The active site of DADH was partially occupied with iminoarginine product (30% occu-
pancy) that interacts with Tyr53 in the minor conformation of a surface loop. This flexible loop forms an 
“active site lid”, similar to those seen in other enzymes, and may play an essential role in substrate recog-
nition. The guanidinium side chain of iminoarginine forms a hydrogen bond interaction with the hydroxyl 
of Thr50 and an ionic interaction with Glu87. In the structure of DADH in complex with iminohistidine, 
two alternate conformations were observed for iminohistidine where the imidazole groups formed hydro-
gen bond interactions with the side chains of His48 and Thr50 and either Glu87 or Gln336. The different 
interactions and very distinct binding modes observed for iminoarginine and iminohistidine are consistent 
with the 1000-fold difference in kcat/Km values for D-histidine and D-arginine. Comparison of the kinetic 
data for the activity of DADH on different D-amino acids and the crystal structures in complex with 
iminohistidine and iminoarginine establishes that this enzymes characterized by a relatively broad sub-
strate specificity, being able to oxidize positively charged and large hydrophobic D-amino acids bound 
within a flask-like cavity. 
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4.2 Introduction 
 All the standard amino acids except glycine can exist as either L- or D- optical isomers. L-amino 
acids are predominant in proteins synthesized by all living organisms. D-amino acids are important for 
bacteria as fundamental elements of the bacterial cell wall peptidoglycan layer [63]. Several D-amino ac-
ids, D-leucine, D-methionine, D-tyrosine and D-tryptophan, were recently reported to regulate disassem-
bly of bacterial biofilms [64]. Also, specific D-amino acids have been discovered in many physiological 
processes in vertebrates, including humans [66]. Dunlop et al. identified D-aspartate in the brain and other 
tissues of mammals and suggested it may play a role in regulating the development of these organs [67]. 
D-serine was identified at significant levels in rat brain, at about a third of the level of L-serine [68]. 
Moreover, D-serine in the rat brain is distributed in close association with N-methyl-D-aspartate (NMDA) 
and it may act as an endogenous agonist of the NMDA receptor in mammalian brains [68]. 
 Conversion of L- and D- amino acids in living organisms is commonly catalyzed by racemases. 
Various aminoacid racemases have been identified in bacteria, archaea, and eucaryotes including mam-
mals. These racemases are classified into two groups: pyridoxal 5’-phosphate (PLP) -dependent and -
independent enzymes [66]. In mammals, D-serine racemases and D-aspartate racemases are the most in-
tensively studied enzymes due to their involvement in cell aging and neural signaling [69-70]. In bacteria, 
D-amino acids are deaminated by flavin-dependent dehydrogenases [73], allowing the bacteria to grow 
using D-amino acids as the sole carbon, nitrogen and energy source, in a concentration-sensitive manner, 
since some D-amino acid analogs have toxic effects on bacterial growth [71-72]. 
 Pseudomonas aeruginosa, an opportunistic human pathogen, can grow with D-arginine as the 
sole source of carbon and nitrogen [175]. D-to-L arginine racemization by two coupled dehydrogenases 
serves as prerequisite of D-arginine utilization through L-arginine catabolic pathways [83, 176]. One en-
zyme is an FAD-dependent catabolic DADH and the other is an NAD(P)H-dependent anabolic LADH. 
DADH catalyzes the conversion of D-arginine into 2-ketoarginine and ammonia, and LADH converts 2-
ketoarginine to L-arginine. In order to understand the reaction mechanism and substrate specificity of 
DADH, the crystal structure of DADH was determined at the atomic resolution of 1.06 Å, while the struc-
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tures of DADH crystallized in the presence of D-arginine and D-histidine were both determined at 1.30 Å 
resolution. Well-defined electron density for the non-covalently bound FAD and imino intermediate of 
the reaction allowed detailed analysis of the enzyme active site. A loop region with alternative confor-
mations was identified in the DADH structure and is involved in substrate binding. Very distinct binding 
modes were observed for iminoarginine and iminohistidine, in agreement with detailed kinetic analysis on 
substrate specificity reported previously [84] and in this paper. The structural characteristics described 
here provide insights into substrate recognition and the catalytic reaction mechanism of DADH.  
4.3 Experimental Procedures 
4.3.1 Materials 
 D-amino acids and L-amino acids were from Alfa Aesar and Sigma-Aldrich (St. Louis, MO). pms 
and PMSF were obtained from Sigma-Aldrich (St. Louis, MO). All of the other reagents were of the 
highest purity commercially available. 
4.3.2 Expression and Purification of DADH and SeMet-DADH 
Hexa-histidine-tagged DADH was expressed in Escherichia coli TOP10 and purified as described 
previously [83]. No FAD was added during expression and purification. The selenomethionine (SeMet) 
DADH protein was prepared following a protocol with slight modifications as described in a previous 
study [177]. 10-20 mM DTT was incorporated in the buffer throughout the purification steps in order to 
avoid oxidation of selenium. Mass spectrometry confirmed that about 88% of the eight methionines were 
replaced by Se-Met. 
4.3.3 Crystallization and X-ray Data Collection 
 Purified DADH and SeMet-DADH were concentrated to 6 mg/mL and 3 mg/mL, respectively, in 
50 mM Tris at pH 7.5. Crystals were grown by the hanging drop vapor diffusion method using a well so-
lution of 0.1M 2-(N-morpholino)-ethanesulfonic acid (MES) pH 6.5-7.0, 5% glycerol, and 6-10% (w/v) 
PEG6000. Crystals can grow to a size about 0.1-0.2 mm3 within two weeks. DADH was co-crystallized 
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with D-arginine or D-histidine under similar conditions using a 1:10 molar ratio of the enzyme 
(~0.15mM) to substrate. The crystals were soaked in the reservoir solution with 20% glycerol as 
cryoprotectant for ~1 min and frozen immediately in liquid nitrogen. X-ray data were collected at 100 K 
on beamline 22-ID of the Southeast Regional Collaborative Access Team (SER-CAT) at the Advanced 
Photon Source, Argonne National Laboratory. Single-wavelength anomalous diffraction (SAD) data for 
SeMet-DADH were collected at the wavelength of 0.97182 Å (high energy remote) on beamline 22-BM 
of SER-CAT at Argonne National Laboratory. 
4.3.4 Structure Determination and Model Refinement 
 The X-ray data were integrated and scaled using HKL2000 [178]. Program SGXPRO was used to 
perform phasing and automatic tracing with scaled but unmerged SeMet-DADH data [179]. With this ap-
proach, 331 of the 381 residues (375 amino acids residues of the enzyme and the N-terminal hexa-
histidine tag) (~87%) were successfully built. This model was then used for automated model building by 
ARP/WARP [180], in which 96% of the structure was fit. The structure of SeMet-DADH was then em-
ployed to solve the native DADH data set (1.06 Å) by molecular replacement using PHASER [127] in the 
CCP4i suite of programs [128]. Notably, all the FAD atoms were distinctly visible in the electron density 
maps. FAD was refined with 100% occupancy. The structure of DADH was used to solve the structures 
of DADH co-crystallized with D-arginine or D-histidine by molecular replacement. Crystal structures 
were refined with SHELX97 [129]. Manual adjustments and rebuilding were performed using the mo-
lecular graphics program COOT [131]. The structures of DADH co-crystallized with D-arginine and D-
histidine showed difference density for iminoarginine and iminohistidine, respectively, bound at the en-
zyme active site, as observed for D-amino acid oxidase crystallized in the presence of D-tryptophan [75]. 
The D-amino acids are converted enzymatically to imino acids (R-C=NH), which then dissociate from the 
enzyme and are hydrolyzed to the final keto acids (R-C=O) in a non-enzymatic reaction. The 
iminoarginine was refined with 100% occupancy, while two alternate conformations were visible for the 
iminohistidine that refined to relative occupancies of 60% and 40%. Further analysis showed that the 
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structure of DADH, which was crystallized without added D-amino acids, contained extra density for a 
low occupancy iminoarginine adjacent to a disordered loop showing two alternate conformations. This 
structure was refined with two conformers corresponding to 70% occupancy of a ligand-free, open con-
formation DADH, and 30% occupancy of iminoarginine bound to a closed conformation of DADH. 
Higher peaks in the 2Fo-Fc electron density (>5σ) were observed for the two main-chain oxygen atoms of 
iminoarginine, while smaller density peaks (~1.3σ) were visible for other atoms. Therefore, in the ligand-
free conformation, two molecules of water were refined at the locations of the carboxylate oxygen atoms 
of iminoarginine. Solvent molecules were inserted at stereochemically reasonable positions based on the 
peak height of the 2Fo–Fc and Fo–Fc electron density maps, hydrogen bond interactions and interatomic 
distances. Anisotropic B-factors were refined for all the structures. Hydrogen atom positions were includ-
ed in the last stage of refinement using all data. 
 Sequence similarity searches were performed using BLAST [181]. Protein structures were super-
imposed on Cα atoms by using the secondary structure matching (SSM) module in COOT [182]. Figures 
of the structures were generated with PYMOL (http://www.pymol.org). 
4.3.5 Enzyme Assay 
The determination of the apparent steady state kinetic parameters was carried out by measuring ini-
tial rates of reaction with an oxygen electrode at varying concentrations of the D-amino acid substrate and 
a fixed concentration of 1 mM for PMS as electron acceptor. The reaction mixture (1 mL) was first equil-
ibrated with organic substrate and PMS at the desired concentrations before the reaction was started by 
the addition of DADH. Enzyme assays were conducted in 20 mM Tris-Cl, pH 8.7, 25 ̊C. All reaction rates 
are expressed per molar concentration of enzyme-bound flavin1. 
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4.4 Results 
4.4.1 Overall Structure of DADH 
 The DADH was crystallized without the addition of FAD or D-amino acid, and the structure was 
solved in the orthorhombic space group P212121with one molecule per asymmetric unit using single 
anomalous dispersion (SAD) phasing and automated tracing. The structure was refined to an R-factor of 
13.2% at 1.06 Å resolution. Structures were obtained also for DADH crystallized with substrates D-
arginine or D-histidine under similar conditions. The structures were solved in the same space group 
P212121 by using molecular replacement with the DADH structure as a template, and were both deter-
mined at the resolution of 1.30 Å and refined to R-factors of 13.4% and 12.8%, respectively. The crystal-
lographic data and refinement statistics are summarized in Table 4.1. In the three structures, all 375 
DADH residues and N-terminal hexa-histidine tag were defined clearly in the electron density map. Fur-
ther analysis of the N-terminus of the structure revealed that the His-tag residues form several direct or 
water-mediated polar interactions with residues from symmetry related molecules, which stabilize the 
flexible terminus. Overall, the three structures are almost identical with pairwise RMSD values of 0.10-
0.11 Å for 381 Cα atoms. The protein folds into two domains: an FAD-binding domain and a substrate-
binding domain (Figure 4.1). The FAD-binding domain includes residues 1-82, 147-217 and 309-375. It 
consists of a central six-stranded β-sheet surrounded by five α-helices on one side and a three-stranded 
anti-parallel β-sheet with two α-helices on the other side. The substrate-binding domain is formed by resi-
dues 83-142 and 218-297, and consists of an eight-stranded β-sheet and two short antiparallel β-strands 
forming a sandwich surrounded by four α-helices. The substrate binding site was identified near the re 
face of the FAD 7,8-dimethyl-isoalloxazine ring at the interface of the two domains. 
4.4.2 FAD-Binding Site 
 DADH contains a non–covalently bound FAD cofactor as identified in the X-ray crystal struc-
tures. All non-hydrogen atoms of the FAD were clearly visible in the electron density map (Figure 4.2A). 
The flavin adopts an elongated conformation with the adenine ring buried inside the FAD-binding domain 
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and the isoalloxazine ring located at the interface of the two domains. The adenine portion of the cofactor 
points toward the flavin binding domain and the 7, 8-dimethyl-isoalloxazine ring is directed towards the 
interface of the two domains, similar to the FADs observed in other flavin-dependent enzymes, such as L-
proline dehydrogenase [50], D-amino acid oxidase [74] and L-amino acid oxidase [47, 183]. As illustrat-
ed in Figure 4.2B, the ribose ring moiety has hydrogen bond interactions with the side chain of Glu32, 
two water molecules and the main chain amide of Arg33. Numerous hydrogen bonds are present between 
the phosphate groups and the peptidyl atoms of Ala14, Thr42, Gly331 and 5 water molecules. The central 
part of the conserved glycine-rich sequence GXGXXG in the N-terminal region of the polypeptide is part 
of an α-helix (residues 13-25) that points toward the phosphate group and is assumed to contribute to the 
stabilization of the two negative charges of the diphosphate[55]. The 2'-OH and 4'-OH of the ribityl moie-
ty of the cofactor establish hydrogen bond interactions with hydroxyl groups of Ser41 and Thr42. The 3'-
OH group interacts with peptidyl atoms of Gly331 and Gly334 and one water molecule. 
 The 7,8-dimethyl-isoalloxazine is sharply bent between the two planes containing the benzene 
and pyrimidine moieties, defining a 15o angle along the N5-N10 axis. This conformation is in agreement 
with several other crystallographic structures of flavin-dependent enzymes in which the flavin is in the 
reduced state [184]. The pyrimidine portion of the 7,8-dimethyl-isoalloxazine ring interacts through sev-
eral hydrogen bonds with backbone atoms of the protein (i.e. C2=O atom with N atom of Ile335, Gln336, 
N3-H atom with the O atom of His48 and a water molecule, and C4=O atom with the N atom of His48). 
The benzene portion of the 7,8-dimethyl-isoalloxazine ring is excluded from solvent and interacts with 
residues Arg44, Ser45, Ala46, Arg222, Tyr249, Gly303 and Arg305. 
4.4.3 Interactions of DADH with Iminoarginine 
 In order to investigate the structural basis for the substrate recognition of DADH, the enzyme was 
crystallized with D-arginine that was converted to iminoarginine. Iminoarginine binds with the plane 
formed by its Cα atom, carboxylate group and imino group approximately parallel to the re face of the 
flavin, while the side chain points away from the FAD (Figure 4.3A). The α-carbon of the iminoarginine 
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is 3.3 Å away from the FAD N5 atom, which is compatible with direct involvement of these atoms in the 
arginine oxidation catalyzed by DADH. The iminoarginine imino group is pointed out of the plane of the 
carboxylate atoms and can form a 2.9 Å long hydrogen bond interaction with the FAD O4 atom (Figure 
4.3B). Several DADH residues form extensive polar interactions with the two main-chain carboxyl oxy-
gen atoms of iminoarginine that anchor the ligand in the active site. One of the iminoarginine carboxyl 
oxygen forms hydrogen bonds with the side-chain hydroxyl of Tyr53, the guanidinium side chain of 
Arg305, and the carbonyl oxygen of Gly332. The other ligand carboxyl oxygen forms hydrogen bonds 
with the side-chain nitrogen of Arg222 and side-chain hydroxyl of Tyr249. Two water molecules are lo-
cated near the ligand imino group, and form a hydrogen bond network extending to the imidazole side 
chain of His48. The side chain of iminoarginine forms hydrophobic interactions with the Val242 side 
chain, and a hydrogen bond interaction with the hydroxyl of Thr50. A strong ionic interaction (2.5 Å dis-
tance between pairs of O and N atoms) was observed between the guanidinium group of iminoarginine 
and the carboxylate group of Glu87. Hence, Glu87 may play an important role in the high specificity of 
DADH for D-arginine, in agreement with the kinetic analysis on substrate specificity of DADH reported 
previously [84] and performed in this study (vide infra). 
4.4.4 Interactions of DADH with Iminohistidine 
 The structure of DADH was also determined for crystals grown in the presence of D-histidine, 
thereby yielding a DADHred/iminohistidine complex. The iminohistidine binds to the DADH active site in 
two discrete conformations with clear density for the overlapping Cα atoms and carboxylate groups and 
weaker density for the alternate positions of the side chains (Figure 4.3C). The two conformations are 
like overlapping mirror images. In fact, there might be two additional conformations that are indistin-
guishable in this structure due to the potential 180º rotation of the imidazole ring. The imidazole orienta-
tion showing more hydrogen bond interactions with DADH is illustrated in Figure 4.3D.  The 
iminohistidine atoms of conformation B (40% occupancy) all lie nearly parallel to the isoalloxazine ring 
of FAD. The main-chain atoms of conformation A (60% occupancy) lie on the same plane, whereas its 
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imidazole side chain is rotated by about 30º. DADH residues Tyr53, Arg222, Tyr249, Arg305, and 
Gly332 form conserved polar interactions with the ligand main-chain oxygen atoms in both confor-
mations (Figure 4.3D). The imino group of the ligand forms a polar interaction with Gly332 in confor-
mation A and with the hydroxyl of Tyr249 in conformation B. In both conformations the side chain of 
iminohistidine forms hydrogen bonds with the side chain of His48 and the hydroxyl of Thr50. The imid-
azole group also interacts with the side chain of Glu87 and the O4 of FAD in conformation A, and the 
side chain of Gln336 in conformation B. When the imidazole is rotated by 180º the interactions with 
His48, Thr50 and Gln336 are retained for conformation B. The interactions of conformation A with 
Glu87 and FAD are lost, however, suggesting they are not critical since they appear in only one of four 
possible conformations of iminohistidine.  
4.4.5 Conformational Flexibility of the Active Site 
 No substrate or other ligand was added to the protein solution during crystallization of the 
DADH. However, the solved ligand-free structure contained weaker density at the substrate-binding site 
that was fit by 30% occupancy of the iminoarginine reaction product. It is possible that the ligand was 
trapped during the bacterial expression of the protein, as observed for other enzymes, for example, a tet-
rahedral reaction intermediate was discovered in the crystal structure of bacterial Est30 [177]. The 
iminoarginine lies adjacent to residues 50-56 of loop L1 with two alternate conformations that were re-
fined with 0.7/0.3 relative occupancy (Figure 4.4A). This loop had a single well-defined conformation in 
the electron density for structures of DADH with iminoarginine and iminohistidine that corresponds to 
the higher occupancy conformation in the ligand-free structure. Therefore, the crystal structure of DADH 
contains both ligand-free and product-bound conformations, which suggests that a conformational change 
occurs in the adjacent loop regions upon binding of the substrate. Comparison of the two conformations 
of DADH revealed distinct changes in two regions of loop L1: the residues 50-56 adjacent to the imino 
product and the residues 45-47 near the flavin ring of FAD.  
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 One of the major conformational changes between the ligand-free and the product-bound confor-
mations in the DADH structure was observed at the substrate binding site for residues 50-56 of loop L1 
region (Figure 4.4B). Four loops (L1, residues 33-56; L2, 244-248; L3, 261-276; L4, 329-336) form a 
flask-like substrate binding pocket. The binding pocket has a small entrance but expands at the bottom 
near FAD. The iminoarginine product binds to DADH in a similar manner as observed in the structures of 
pDAAO/iminotryptophan [75] and hDAAO/iminoserine [185]. In the ligand-free conformation, the side 
chain of Tyr53 points away from the active site and forms a hydrogen bond with Thr137, whereas in the 
structure of the product-bound enzyme, the aromatic ring of Tyr53 moves into the active site and forms 
hydrogen bonds with the carboxyl oxygen of the imino acid and also the side chains of Glu246 and 
Arg305. Other residues also form different interactions in the two conformations of this loop. In the lig-
and-free conformation, the side chain of Thr50 forms hydrogen bonds with Asp39 and Ala52, while 
Gly54 and Thr55 both form polar interactions with Arg59. In the product-bound conformation, Thr50 
interacts with Glu87 and Gln336, and its main-chain peptidyl oxygen forms a hydrogen bond with the 
main-chain amide of Tyr53. The hydroxyl side chain of Thr55 forms a hydrogen bond with Asp312. The 
interactions of Tyr53 and Thr50, in particular, stabilize the ligand bound in the active site, suggesting that 
this flexible loop L1 region may act as a lid controlling substrate accessibility to the active site. The shape 
and flexibility of the active site enables DADH to control the entrance of substrates and accommodate a 
variety of substrates. 
 The second region showing significant differences in the ligand-free and product-bound confor-
mations comprised residues 45-47 at the N-terminal end of loop L1, which is located at the si face of the 
flavin ring (Figure 4.4C). This region possesses two conformations in the DADH structure and shows a 
single well-defined conformation in the structures of DADH with high occupancy products. In the ligand-
free conformation, the Ser45 hydroxyl group forms a hydrogen bond with the flavin N5 atom, and the 
side chain of Ala46 is pointed away from FAD. In the product-bound conformation, this region is flipped 
about 90º with the side chain of Ser45 pointed away from FAD and the Ala46 side chain approaching 
closer to the FAD. This structural change causes the loss of the hydrogen bond interaction between Ser45 
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and FAD and, instead, a new hydrogen bond is formed between the main-chain amide of Ala46 and the 
N5 of FAD. A similar interaction was reported between the Ala49 of pDAAO and its FAD N5 atom [74-
75]. Due to the conformational changes of residues 50-56 and 45-47 in loop L1 region, the active site of 
DADH shrinks by about 3.8 Å when the product is bound. The distances between the Cα atoms of Ala46 
and Tyr53 are 17.5 Å and 13.7 Å in the ligand-free conformation and product-bound conformation, re-
spectively (Figure 4.4B). Loop L2 also has a slight conformational change and moves about 0.7 Å closer 
to loop L1 based on the distances between the Cα atoms of loop L1 Tyr53 and loop L2 Asp245. 
4.4.6 Substrate Specificity 
 The steady state kinetic parameters were determined by measuring initial rates of reaction with 
various D-amino acids in 20 mM Tris-Cl, pH 8.7 at 25 °C. The concentration of the electron acceptor 
PMS was kept fixed at 1 mM PMS, ensuring saturation of the enzyme2. As illustrated in Table 4.2 the 
enzyme showed substrate preferences for amino acids with positively charged side chains, of which D-
arginine appears to be the best substrate. D-lysine, D-tyrosine and D-methionine were also good sub-
strates. In contrast, D-glutamate, D-aspartate, L-arginine and glycine were not detectably oxidized by the 
enzyme. Cysteine could not be assayed due to its non-enzymatic reaction with PMS in the enzyme reac-
tion mixture.  
4.4.7 DADH Recognition of Iminoarginine and Iminohistidine 
 Comparison of the structures of DADH in complex with iminoarginine and iminohistidine reveals 
the molecular basis for the relatively broad substrate specificity of this enzyme. The internal cavity of the 
substrate-binding site has a triangular cross-section with a narrow entrance at the top, as shown in Figure 
4.5 (DADH residues Tyr53, Gly332 and Gln336 were removed to view the internal site). The bottom of 
the cavity extends about 14.9 Å from loop L1 to loop L3 and 14.1 Å from loop L2 to loop L4. The depth 
of this substrate-binding pocket is about 10 Å from the Cα atom of Gly54 in loop L1 to the FAD O2 at-
om. The main chain of iminohistidine is located almost on the same plane and parallel to the isoalloxazine 
ring of FAD. The main-chain atoms of iminoarginine are very close to those of iminohistidine, and form 
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similar polar interactions with the DADH residues Tyr53, Arg222, Tyr249, Arg305, and Gly332. Since 
the binding pocket interactions with the main chain of the substrate are conserved, DADH has a broad 
substrate specificity for a variety of D-amino acids, as shown in Table 4.2, which is also supported by the 
kinetic studies reported previously [84]. The different side chain interactions with DADH are presumed to 
be responsible for the specificity differences. The longer D-arginine side chain fits well in the large sub-
strate-binding pocket of DADH, while the smaller D-histidine cannot fill the cavity, which is consistent 
with the differences in catalytic activity for the two substrates.  
4.4.8 Structural Comparison with Related Proteins 
 Determination of the crystal structure of DADH allows a detailed comparison with other mecha-
nistically related flavin-dependent oxidoreductases. Analysis of the sequences and structures showed that 
DADH shares low sequence identity (<20%) but similar three-dimensional structures with L-Proline de-
hydrogenase β subunit (18.5% sequence identity, RMSD 2.2 Å for 342 Cα atoms, [50]), heterotetrameric 
sarcosine oxidase (18.4% sequence identity, RMSD 2.2 Å for 339 Cα atoms, [186]), porcine D-amino 
acid oxidase pDAAO (17.2% sequence identity, RMSD 2.4 Å for 270 Cα atoms, [74]) and L-amino acid 
oxidase LAAO (16.4% sequence identity, RMSD 3.0 Å for 245 Cα atoms, [47]). For a detailed compari-
son of the overall structure and active site geometry, we have chosen the structures of the enzyme com-
plexes with dicarboxylate ligands: pDAAO from pig kidney in complex with iminotryptophan (PDB entry 
1DDO, [75]) and LAAO from Rhodococcus opacus in complex with L-alanine (PDB entry 2JB1, [47]).  
 pDAAO and LAAO both are homodimeric enzymes formed by two subunits interacting through 
their helical domain or substrate binding domain, respectively [47, 74, 183]. Structural superimposition 
indicates that the overall structure of DADH resembles the monomer structures of pDAAO and LAAO 
(Figure 4.6). DADH and LAAO share the same topology for the FAD binding domain in which a central 
β-sheet is surrounded by α-helixes on one side and a three-stranded anti-parallel β-sheet on the other side. 
However, in the FAD-binding domain of pDAAO, an α-helix is observed instead of the three-stranded 
anti-parallel β-sheet located in DADH (Figure 4.6A). All three enzymes contain a large β-pleated sheet in 
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the substrate binding domain, while the orientation of this β-sheet in LAAO is significantly different from 
those in DADH and pDAAO. Two extra β-strands are observed for LAAO at the Gly57-Cys70 region 
(Figure 4.6B). Furthermore, the helical domain involved in dimerization of LAAO is absent from the 
structures of DADH and pDAAO. 
 The substrate binding sites of these three enzymes are all located near the re face of the FAD 
isoalloxazine ring at the interface of the FAD-binding and substrate-binding domains. Despite the oppo-
site orientation of L-alanine bound to LAAO compared to the binding mode of ligands in the DADH and 
pDAAO complexes, similar protein-ligand interactions are retained among the three enzymes. The specif-
ic arrangement of active site residues is suggested to be responsible for the strict enantioselectivity of 
each enzyme [47, 74-75, 183]. In the pDAAO/iminotryptophan complex, the carboxylate group of the 
ligand forms a salt bridge with the guanidinium side chain of Arg283 (Figure 4.7A). Similar interactions 
are formed between L-alanine and Arg84 in the structure of LAAO/L-alanine (Figure 4.7B). However, in 
the DADHred/iminoarginine complex, this ionic interaction is replaced by interactions between the ligand 
and two arginines: Arg222 and Arg305. The carboxylate oxygen atoms of the ligands also form polar in-
teractions with Tyr53, Tyr249 and Gly332 of DADH and Tyr224, Tyr228 and Gly313 of pDAAO, re-
spectively. L-alanine forms similar interactions with the polar residues Gln228 and Tyr371 of LAAO. The 
side chains of these ligands form distinct interactions with enzyme residues. In DADH iminoarginine 
forms strong ionic interactions with Glu87 and a hydrogen bond with Thr50. In contrast, in pDAAO the 
indole side chain of iminotryptophan is surrounded by several hydrophobic residues (Ala49, Leu51, 
Ile215, Ile230, and Tyr228). The short side chain of L-alanine interacts with several hydrophobic residues 
Trp426, Ala466 and Trp467 of LAAO. These similarities and differences in interactions are presumed to 
be important determinants of their different substrate specificities.  
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4.5 Discussion 
4.5.1 An “Active Site Lid” Controls Substrate Accessibility 
 A loop covering the active site in the DADH structures shows conformational change with sub-
strate binding. A similar loop region described as “active site lid” was reported in the structure of pDAAO 
(residues 216-228, [74]). It is hypothesized that this lid switches between closed and open conformations 
to allow substrate binding and product release [74]. Importantly, this atomic resolution DADH crystal 
structure demonstrates two loop conformations corresponding to the ligand-bound and ligand-free forms. 
Once the substrate binds to the enzyme, it is sandwiched between the FAD isoalloxazine and the active 
site lid. After the enzymatic reaction is completed, this loop region is expected to switch back to the open 
conformation allowing the product to exit the cavity. A similar “loop-and-lid” structure has been assigned 
in some of the glucose-methanol-choline (GMC) family members, including glucose oxidase (residues 
76-97, [187]), cholesterol oxidase (residues 95-109, [188]), pyranose 2-oxidase (residues 452-456, (34)), 
and the flavoprotein domain of cellobiose dehydrogenase (residues 289-299 [189]). Besides its role as a 
gate in opening and closing the enzyme active site, the active site lid may be important in determining the 
substrate specificity of DADH. The conformational change of the lid, especially for Tyr53, may allow 
DADH to accommodate bulky residues like D-phenylalanine or D-tryptophan. Similar interactions have 
been observed in pDAAO (Tyr224, [75]) and flavocytochrome b2 (Tyr254, [82]). Furthermore, closing of 
the lid shields the active site and the FAD from solvent. An increase of the active site hydrophobicity 
caused by loop closure may facilitate the hydride transfer step leading to substrate oxidation in pDAAO 
[75]. Similar phenomena have been described in several NAD(P)H-dependent dehydrogenases [190]. Fur-
ther insight into the functionality of this active site lid may be obtained by protein engineering studies on 
DADH. 
4.5.2 Substrate Specificity 
 DADH is characterized by a broad substrate specificity, being able to oxidize basic and hydro-
phobic D-amino acids of various size [84]. This conclusion is supported by comparison of the structures 
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of DADH in complex with iminoarginine and iminohistidine, and kinetic analysis. Iminoarginine forms a 
strong ionic interaction with the side chain of Glu87 and a hydrogen bond with Thr50, whereas the side 
chain of iminohistidine extends in a different direction and forms hydrogen bonds with His48, Thr50 and 
Gln336. Steady state kinetics data summarized in Table 4.2 are also consistent with this conclusion. In-
deed, the large kcat/KArg value in the range of 106 M-1s-1 is 1,000-fold higher than the kcat/KHis value. Kinetic 
data for other D-amino acids further indicate that the negatively charged side chain of Glu87 is the major 
determinant for the specificity of DADH for positively charged substrates. Strong electrostatic interac-
tions formed between the ligand and Glu87 allow D-arginine and D-lysine to be the two most effective 
substrates for DADH. A notable example of similar case can be found from the well defined substrate 
specificity of trypsin, in which the enzyme residue Asp189 is responsible for its narrow selection for posi-
tively charged arginine and lysine [191-192]. In addition, the hydrophobic walls (Tyr53, Met240, Val 242 
and Tyr249) of the DADH active site pocket create a favorable environment for the long aliphatic and 
unbranched parts of the basic D-arginine and D-lysine. Furthermore, D-tyrosine, D-methionine and D-
phenylalanine may form favorable van der Waals contacts with the hydrophobic walls of the active site 
and are also good substrates for DADH. In contrast, DADH shows low or undetectable activities toward 
other D-amino acids, especially the negatively charged D-glutamate and D-aspartate. 
4.5.3 The Ser/Ala Switch in the FAD Binding Site 
 The Ser45-Ala47 region also has two conformations corresponding to the ligand-free and prod-
uct-bound conformations in the DADH structure, while this region has a well-defined single conformation 
in the structures of DADHred/iminoarginine and DADHred/iminohistidine. Comparison of the two confor-
mations indicates that, upon substrate binding, the side chain of Ala46 rotates from the ligand-free con-
formation to approach closer to the isoalloxazine of FAD in the product-bound conformation, while main-
taining a hydrogen bond with the N5 of the flavin. A hydrogen bond (OSer45—N5FAD) in the ligand-free 
conformation is replaced by another polar interaction (NAla46—N5FAD) in the product-bound conformation 
(Figure 4.4C). Furthermore, interactions of the FAD N5 atom with a residue structurally equivalent to 
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Ala46 of DADH are conserved among different FAD-dependent enzymes, such as pDAAO (Ala49, [74]), 
yeast D-amino acids oxidase (Gly52, [193]), L-proline dehydrogenase (Gly48, [50]), flavocytochrome b2 
(Ala198, [82]), and L-galactono-γ-lactone dehydrogenase (Ala113, [44]). Human DAAO shares the same 
sequence (V47AAGL51) with pDAAO near the si face of FAD ring. However, this region has a conforma-
tional shift in hDAAO, resulting in the loss of a hydrogen bond between Ala49 and the FAD N5 atom. 
This conformational change in hDAAO has been suggested to be responsible for its low binding affinity 
for FAD as well as the slower rate of flavin reduction [185]. Furthermore, the structurally equivalent 
Ala113 in L-galactono-γ-lactone dehydrogenase has been reported to play a substantial role in the enzyme 
activity with oxygen. Site-directed replacement of Ala113 with glycine increased the reactivity of the re-
duced flavin with oxygen by about 400-fold [44]. Therefore, the functional significance of this Ser/Ala 
switch in DADH remains unclear; it might be involved in structural stability and also the enzymatic prop-
erties of this protein. Further studies are required to elucidate its function. 
4.5.4 Two Conformations of D-Histidine in the Complex with DADH 
 The iminohistidine binds to the DADH active site in two discrete conformations, while 
iminoarginine shows a single conformation. The main chain atoms of the two iminoacids are bound in 
similar positions as shown in Figures 4.3 and 4.5, however, the side chains extend in different directions. 
The iminoarginine side chain lies almost perpendicular to the isoalloxazine ring of FAD, whereas the side 
chain of iminohistidine is more parallel to the flavin. The length and charge of the ligand side chain may 
both contribute to the different binding modes of the two imino acids. The long iminoarginine side chain 
extends to form strong electrostatic interactions with Glu87 and a hydrogen bond with Thr50. Instead, the 
flexibility of the shorter iminohistidine results in conserved interactions with His48, Thr50, while alter-
nate conformations interact with Glu87 or Gln336. The substrate carboxylate group is essential for bind-
ing of D-amino acids to the DADH active site. Therefore, these atoms maintain the same positions be-
tween different conformations of iminohistidine, while the side chains have more freedom to move. Simi-
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larly, the ligand side chains display two discrete conformations in the structures of monomeric sarcosine 
oxidase in complex with methylselenoacetate and methyltelluroacetate [194]. 
4.5.5 Structural Comparison with Related Proteins 
 Structural comparison of DADH with pDAAO and LAAO revealed that the active site residues of 
DADH are more similar to those of pDAAO (Figure 4.7), in agreement with their specificity for D-amino 
acids rather than L-amino acids [84]. The spatial arrangement of active residues is critically related to the 
enzyme enantiomeric selectivity. A mirror-symmetrical relationship of active sites has been described 
among enzymes with opposite stereospecificities and two different modes have been reported. One is ob-
served between pDAAO and flavocytochrome b2, in which the active sites of the two enzymes are mir-
rored through the plane of isoalloxazine (on the re side in pDAAO, on the si side of flavocytochrome b2) 
[74]. Another situation is that the substrate binding sites are mirrored through the plane perpendicular to 
the isoalloxazine ring, which is observed in the comparison between pDAAO and LAAO [183]. The ac-
tive site of DADH is highly similar to that of pDAAO, and mirror-symmetrically related to that of LAAO 
(Figure 4.7). This observation is in agreement with the kinetic study described previously [84] and in this 
paper showing that DADH can oxidize a variety of D-amino acids but not L-arginine. A similar active site 
arrangement has been observed in other flavoenzymes like glycolate oxidase [195], L-glutamate oxidase 
[196] and L-aspartate oxidase [197], suggesting these enzymes employ a common mechanism to control 
enantioselectivity. 
 In addition to their specificity toward different enantiomers of amino acids, DADH, pDAAO and 
LAAO display other distinct features. For example, the ligands are held in the active site by a salt bridge 
formed with an arginine in pDAAO and LAAO, while two active site arginines are involved in DADH. 
The active sites of DADH and pDAAO are covered by a loop termed the “active site lid”. This feature 
was not reported in the structure of LAAO, and a funnel-shaped entrance for substrate binding was pro-
posed instead [198]. In addition to the polar interactions between the ligands and the enzyme active site 
residues, a hydrophobic environment has been observed in all three enzymes. In fact, all the enzymes in-
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teract with a wide range of hydrophobic amino acids [75, 84, 199]. Overall, the different composition and 
arrangement of active site residues determine differences in substrate specificity, while critical interac-
tions for catalysis are conserved among these mechanistically related enzymes. 
4.6 Conclusions 
 Comparison of the crystal structures of DADH and its complexes with iminoarginine and 
iminohistidine has highlighted important structural differences that rationalize the catalytic activities and 
substrate specificity of the enzyme. The imino products of D-arginine and D-histidine bind to the active 
site in very distinct side-chain conformations. Glu87 forms strong electrostatic interactions with 
iminoarginine, which is likely responsible for the high selectivity of DADH for positively charged resi-
dues like D-arginine and D-lysine. A loop region has been designated as an active site lid controlling the 
substrate accessibility to the active site, similar to those reported in other flavin-dependent enzymes. 
Structural comparison of DADH with other related flavin-dependent enzymes reveals that the spatial ar-
rangement of active site residues is essential for the differences in enzyme enantioselectivity, while some 
specific interactions needed for catalysis are conserved among the enzymes. Overall, the high-resolution 
structures for DADH described in this study will provide new guidelines for future studies of similar 
flavin-dependent enzymes. 
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Table 4.1 Crystallographic Data Collection and Refinement Statistics 
 SeMet DADH DADH DADH/ 
D-Arg 
DADH/ 
D-His 
Data Collection Statistics     
Redox state of flavin   Mixture Reduced Reduced 
Wavelength (Å) 0.97182 a 0.99999 1.00000 1.00000 
Space group P212121 P212121 P212121 P212121 
a (Å) 
b (Å) 
c (Å) 
62.65 
78.21 
89.47 
62.18 
78.08 
89.72 
62.17 
78.43 
89.95 
62.10 
78.15 
89.59 
Resolution range (Å) 50-1.50 50-1.06 50-1.30 50-1.30 
Total observations 1016,247 1258,212 600,949 627,618 
Unique reflections 70270 190,545 98,021 97,110 
Completeness 99.7 (98.0)b 96.2 (69.1) 90.6(53.9) 90.4(54.7) 
<I/σ(I)> 27.6(16.6) 26.5(2.3) 18.5(2.7) 31.8(3.2) 
Rsym (%) 7.6(18.1) 6.2(41.4) 8.2(37.3) 4.9(30.6) 
    Figure of merit 0.72  
 
 
    f' -4.2234  
 
 
    f'' 3.7853  
 
 
Refinement Statistics   
 
 
  Resolution range (Å)  10-1.06 10-1.30 10-1.30 
  Rwork (%)  13.2 13.4 12.8 
  Rfree (%)  15.9 16.6 16.3 
  Mean B-factor (Å2)  16.0 15.9 17.5 
    Protein  14.4 14.6 16.1 
    FAD  7.3 6.5 8.3 
    Ligand  29.5 37.0 16.3 
    Water  27.9 29.7 31.8 
  Number of atoms   
 
 
    Protein  3102 2961 2971 
    FAD  53 53 53 
    Ligand  12 12 22 
    Water  467 358 367 
r.m.s. deviations    
 
 
    Bond length (Å)  0.017 0.013 0.012 
    Anglec  0.035 0.031 0.030 
aThe SeMet DADH data were collected at the wavelength of high energy remote. 
bValues in parentheses are given for the highest resolution shell. 
cThe angle RMSD in SHELX97 is indicated by distance in Å. 
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Table 4.2 Steady State Kinetics of DADHa 
substrates kcat/Km, M-1s-1 kcat, s-1 Km, mM 
D-arginine (3.4 ± 0.3) × 106 204 ± 3 0.06 ± 0.01 
D-lysine (5.3 ± 0.2) × 105 141 ± 3 0.26 ± 0.01 
D-tyrosine 27,600±3,800 23±1 0.8 ± 0.1 
D-methionine 14,800±600 154±3 10 ±1 
D-phenylalanine 6,900±300 75±3 11±1 
D-histidine 3,140 ± 30 35 ± 1 11 ± 1 
D-leucine 515±60 6.4± 0.3 12± 1 
D-proline 420 ± 10 -b - 
D-tryptophan 245 ± 3 - - 
D-isoleucine 195 ± 3 - - 
D-valine 47 ± 1 - - 
D-alanine 41 ± 1 - - 
D-glutamine 186 ± 3 - - 
D-asparagine 16 ± 1 - - 
D-serine 3.8 ± 0.1 - - 
D-threonine 0.75 ± 0.01 - - 
D-glutamate - - - 
D-asparate - - - 
L-arginine - - - 
Glycine - - - 
D-cysteine ndc nd nd 
aEnzyme activity was measured at varying concentrations of substrateand 1 mM PMS in 20 mM Tris-
Cl, pH8.7, at 25 oC. bCannot be saturated with the substrate, thereby kcat and Km values are not report-
ed.c Not determined. PMS was reduced by cysteine. 
 
 
 
Figure 4.1 Overall structure of DADH with iminoarginine.
representation. Iminoarginine and cofactor FAD are shown as sticks and colored 
tively. Loops that contribute to the active site are colored green. 
 
 The DADH structure is shown in cartoon 
magenta and
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 red, respec-
Figure 4.2 Cofactor FAD in DADH.
lustrates the high quality of the 1.06 Å resolution structure. FAD (colored by element type) adopts an 
elongated conformation. (B) Schematic diagram of the flavin
bound DADH conformation. Hydrogen bonds are indicated by dashed lines. The flavin c
blue. For clarity, H atoms are not shown.
 
 (A) The 2Fo-Fc electron density map of FAD contoured at 2
-apoprotein interactions in the product
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σ il-
-
ofactor is colored 
Figure 4.3 DADH interactions with iminoarginine (A, B) and iminohistidine (C, D).
colored yellow for DADH active site residues and
isoalloxazine ring in magenta. Omit map of ligand is indicated as blue mesh and contoured at 3
lines represent hydrogen bonds and ionic interactions.
 
 
 
 
 
 
 
 green for the imino acids. FAD is represented by its 
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 Carbons are 
σ. Dashed 
(a) 
(b) 
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(c) 
Figure 4.4 Conformational flexibility of DADH structure.
conformers: a 30% occupied population with iminoarginine product, and 70% one without ligand. The 
iminoarginine and its adjacent loop region with low occupancy (product
as green sticks. The omit map of this region (red mesh) is contoured at 2.5
region with high occupancy (ligand
ligand-free conformation (green) and product
in DADH structure. Ala46, Tyr53 and iminoarginine are represented as sticks. A hydrogen bond (black 
dotted line) is formed between Tyr53 and iminoarginine in the product
Conformational change of residues Ser45
free conformation (green carbon atoms) forms a 3.0 Å hydrogen bond with the FAD N5 atom (gray 
carbon atoms). Ala46 forms a 3.3 Å long hydrogen bond with the N5 atom of FAD in the product
conformation (magenta carbon atoms).
 
 
 
 
 
 (A) The DADH structure comprises two 
-bound conformation) are shown 
σ. The corresponding loop 
-free conformation) is shown as blue sticks. (B) Comparison of 
-bound conformation (magenta) at loop L1 and L2 regions 
-bound conformation. (C) 
-Ala46-Ala47 at the si face of flavin ring. Ser45 in the ligand
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-
-bound 
Figure 4.5 Comparison of DADH structures in complex with iminoarginine and iminohistidine.
DADH active site residues (green sticks) line the interior of the 
and Gln336 were omitted for clarity). Iminoarginine (red) and iminohistidine (blue) bind to the active site 
in very distinct conformations. FAD is represented by its isoalloxazine ring in green. 
 
 
 
 
 
 
 
 
 
substrate binding pocket (Thr53, Gly332 
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Figure 4.6 Structural comparison of DADH with pDAAO (A) and LAAO (B).
green cartoon representation while pDAAO and LAAO are colored in light blue with red regions indica
ing their major structural differences compared to DADH. 
blue corresponding to the compared structures. 
iminotryptophan in pDAAO (orange) and L
 
 
 
 
 DADH is shown in 
FAD is represented by sticks in green and light 
The ligands are: iminoarginine in DADH (
-alanine in LAAO (orange). 
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t-
magenta), 
Figure 4.7 Comparison of the active sites of DADH, pDAAO and LAAO.
(yellow) is superimposed on that of pDAAO (a, lightblue) and LAAO (b, lightblue) along the FAD 
isoalloxazine ring. Iminoarginine in DADH (magenta carbon atoms) and iminotryptophan in pDAAO 
(cyan carbon atoms) and L-alanine in LAAO 
isoalloxazine ring.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 The active site of DADH 
(cyan) are shown as sticks. FAD is represented by its 
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5 ATOMIC RESOLUTION STRUCTURE OF AN N(5) FLAVIN ADDUCT IN D-ARGININE 
DEHYDROGENASE 
 
(Published: Fu, G., Yuan H., Wang S., Gadda, G. and Weber, I. (2011). Biochemistry 50(29): 6292-6294.) 
 
5.1 Abstract 
 D-Arginine dehydrogenase (DADH) catalyzes the flavin-dependent oxidative deamination of D-
arginine and other D-amino acids to the corresponding imino acids. The 1.07 Å atomic resolution struc-
ture of DADH crystallized with D-leucine unexpectedly revealed a covalent flavin N(5) adduct, instead of 
the expected iminoleucine product in the active site. This acyl adduct has been successfully reproduced by 
photoreduction of DADH in the presence of 4-methyl-2-oxopentanoic acid (ketoleucine). The 
iminoleucine may be released readily due to weak interactions in the binding site, in contrast to 
iminoarginine, converted to ketoleucine, which reacts with activated FAD to form the covalently linked 
acyl adduct. 
5.2  Introduction 
 D-arginine dehydrogenase was first identified as the catabolic enzyme of a novel 2-enzyme-
coupled system for D-to-L inversion of D-arginine [83]. This 2-component racemase allows Pseudomo-
nas aeruginosa, which is a common opportunistic human pathogen, to grow with D-arginine as the sole 
source of carbon and nitrogen [83-84]. DADH noncovalently binds FAD as a prosthetic group and cata-
lyzes the oxidative deamination of many D-amino acids to their corresponding imino acids with concomi-
tant reduction of FAD. The imino acid is released into the solvent and nonenzymatically hydrolyzed to 
the corresponding α-keto acid and ammonia. Iminoarginine is then converted to L-arginine by the anabol-
ic enzyme of the system, an NAD(P)H-dependent L-arginine dehydrogenase (LADH). Our group recently 
reported the crystal structure of DADH and the complex of DADH with iminoarginine or iminohistidine 
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at or close to atomic resolution (1.06-1.30 Å) [45]. Further investigation of this enzyme by performing 
steady-state kinetic studies has established a ping-pong bi-bi kinetic mechanism [88]. A loop region of 
DADH (residues 50-56) was designated as an active site lid controlling the substrate accessibility to the 
active site, similar to those reported in other flavin-dependent enzymes. The DADH Glu87 forms strong 
ionic polar interactions with iminoarginine and may play a crucial role for the strict preference of DADH 
for basic D-amino acids.  
5.3 Results and Discussion 
 In order to further investigate the substrate specificity of DADH, we have performed crystallo-
graphic study on DADH in complex with a hydrophobic substrate, D-leucine. However, an acyl adduct 
rather than the imino products observed in previous DADH structures has been identified in this structure, 
which forms a covalent bond between the decarboxylated keto product Cα atom and the FAD N(5) atom. 
It has been reported that α-keto acids with small hydrophobic side chains are competitive inhibitors of 
DAAO [200]. Furthermore, these compounds are able to react with flavins and form a covalent bond be-
tween their Cα atoms and the flavin N(5) atom in the presence of light [75, 201]. The structural properties 
of this reaction byproduct have been thoroughly characterized by analyzing the atomic-resolution struc-
ture and its formation is studied by photoreduction of oxidized DADH in the presence of kLeu. 
 DADH was crystallized with the hydrophobic substrate D-leucine during our investigations into 
the substrate specificity of this enzyme. The structure was determined in the orthorhombic space group 
P212121 with one molecule per asymmetric unit. It was solved by molecular replacement using the struc-
ture of DADH/iminoarginine as template (PDB entry: 3YNE [45]), and refined to the atomic resolution of 
1.07 Å and R-factor of 13.1%. The crystallographic data and refinement statistics are summarized in Ta-
ble 5.S1. The overall structure closely resembles the structure of DADH/iminoarginine with RMSD value 
of 0.14 Å for 381 Cα atoms. Unlike the imino acid products observed in the other DADH structure [45], 
however, an acyl adduct was identified at the active site of this structure (Figure 5.1A). The adduct is 
assumed to arise from a nucleophilic substitution in which the N(5) atom of the reduced flavin formed in 
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the X-ray beam reacts with the Cα of ketoleucine, yielding 4-methyl-2-pentanone-FAD and CO2 (Scheme 
S1). A similar structure has been described in the complex of D-amino acid oxidase (DAAO) with 3-
methyl-2-oxobutyric acid (kVal) (PDB entry: 1DAO, 3.20 Å, [75]). However, DAAO was deliberately 
soaked with kVal to form the complex in the previous study, while the acyl adduct in this report is an un-
expected byproduct of co-crystallizing DADH with D-leucine. This result is consistent with previous 
studies showing that α-keto acids bearing small hydrophobic side chains are competitive inhibitors of 
DAAO and can form FAD N(5) adducts in the presence of light [75, 200-201]. Formation of this acyl ad-
duct results in an additional bending of the flavin over that seen in the DADH/iminoarginine structure, 
characterized by a 20° angle between the pyrimidine and benzene moieties. 
 The decarboxylated kLeu is covalently linked to the N(5) atom of FAD. The oxygen atom of acyl 
group forms hydrogen bonds with the Arg222 and Tyr249 side chains (Figure 5.1B). Its aliphatic side 
chain points away from the FAD isoalloxazine ring and interacts with several hydrophobic residues in-
cluding Tyr53, Met240 and Tyr249. Interestingly, a water molecule is found to mediate a hydrogen bond 
network between the acyl oxygen and the enzyme residues Tyr53, Arg305 and Gly332. The polar interac-
tion between this water molecule and Tyr53 appears to be important for holding the active site lid in its 
closed conformation and no significant conformational change is observed for this loop region when 
compared to the structures of DADH with other D-amino acids. A water molecule is also found at the 
structurally corresponding position of DAAO/kVal structure, which forms polar interactions with DAAO 
Gln53, Tyr224 and Gly313, but not with the acyl oxygen of kVal [75]. Tyr224 is located on the active site 
lid of DAAO and is functionally equivalent to Tyr53 in DADH. Therefore, this water molecule may have 
an important role in maintaining the active site conformation when the carboxylate group is absent from 
the ligand.  
 The formation of the acyl N(5) adduct in solution was confirmed by photoreduction of DADH 
and 4-methyl-2-oxopentanoic acid followed by confirmation of the adduct structure by ESI mass spec-
trometry. The DADH in a solution of 10 mM potassium phosphate in the presence of 50 mM EDTA and 
43 mM 4-methyl-2-oxopentanoic acid was slowly reduced, as shown in Figure 5.2A. The bleaching of 
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the yellow color and the decreased absorbance at 450 nm indicate photoreduction of the flavin. The 
DADH was separated on a Sephadex G-25 PD-10 column and the flavin adduct was extracted with 50% 
acetonitrile. The spectrum of the flavin adduct (inset of Figure 5.2A) shows an absorbance peak in the 
~420 nm region, which is consistent with formation of a reduced flavin-N(5) adduct with an oxo-
compound [75, 201]. In the presence of light, the 4-methyl-2-oxopentanoic acid was decarboxylated and 
reacted with the flavin, yielding a covalently linked adduct between the Cα of the acid and N(5) atom of 
flavin, as shown in Figure 5.2B. 
 The structure of the isolated flavin was analyzed by negative ESI mass spectrometry. As shown in 
Figure 5.2C, the electrospray ion source produced a doubly charged flavin complex due to the adenosine 
diphosphate group of FAD. Based on the mass measurement and Figure 5.2B, the peak with m/z of 434.6 
corresponding to a molecular weight of 871.6 indicates the addition of C5H10O to FAD. Indeed, the calcu-
lated flavin adduct with doubly charged m/z is 434.8 and the difference of 0.2 mass units corresponds to a 
mass measurement accuracy of 0.046%. Thus, the ESI-MS measurement has confirmed the process of 
N(5) adduct formation. 
 The active site geometry and interactions of DADH with kLeu were compared to those in the 
iminoarginine complex. The active sites of these two structures were superimposed along the FAD 
isoalloxazine ring (Figure 5.3). The kLeu Cα atom forms a covalent bond of 1.4 Å with the FAD N(5) 
atom. This covalent link between kLeu and FAD results in a slight shift of Tyr53, Arg222 and Tyr249 
towards the FAD isoalloxazine ring. In the structure of DADH/iminoarginine, the main chain of the lig-
and is slightly shifted so that its Cα is about 3.4 Å away from FAD N(5). The main chain of 
iminoarginine is held in position by the polar interactions of its two carboxylate oxygen atoms with the 
residues Tyr53, Arg222, Tyr249, Arg305 and Gly332 of DADH. kLeu forms fewer polar interactions; its 
acyl oxygen atom forms direct hydrogen bonds with the side chains of Arg222 and Tyr249, and a water 
molecule mediates a hydrogen bond network with Tyr53, Arg305 and Gly332 (Figure 5.1B). The 
charged side chain of iminoarginine forms strong polar interactions with Glu87 and Thr50, while the long 
aliphatic part of its side chain forms hydrophobic interactions with Tyr53, Met240, Val242, and Tyr249. 
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In contrast, the short hydrophobic side chain of kLeu can only form hydrophobic interactions with Tyr53, 
Met240, and Tyr249 and has lost contact with Val242, which displays two alternate conformations in the 
structure. Also, the water mediated interaction between the iminoarginine and His48 is absent in the 
DADH/kLeu structure. Overall, the weaker interactions of kLeu are in agreement with the kinetic data 
showing that the kcat/KArg value is about 6600-fold higher than the kcat/KLeu value [45, 84].  
5.4 Conclusion 
 In conclusion, our crystal structure of DADH with an FAD N(5) adduct solved at the atomic reso-
lution of 1.07 Å is possibly the highest resolution for such an acyl adduct. Furthermore, photoreduction of 
DADH in the presence of kLeu successfully reproduced this acyl adduct, which apparently requires either 
intense synchrotron X-radiation or activation by light. D-leucine is a much poorer substrate of DADH by 
almost 4 orders of magnitude compared to the best substrate D-arginine. Comparison of the DADH com-
plexes suggests that, in contrast to iminoarginine, the relatively small side chain of iminoleucine will form 
weaker interactions within the binding site. Therefore, iminoleucine may be partially dissociated from the 
enzyme and become hydrolyzed to ketoleucine, which then decarboxylates and reacts with photoactivated 
FAD to form the covalently linked acyl adduct.   
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5.6 Experimental procedures (Supporting Information) 
5.6.1 Materials 
 4-methyl-2-oxopentanoic acid was purchased from VWR. All other reagents were of the highest 
purity commercially available. 
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5.6.2 Expression and Purification of DADH 
 The Escherichia coli strain TOP10 bearing hexa-histidine-tagged DADH was kindly provided by 
Dr. Chung-Dar Lu, Georgia State University. Protein expression and purification were as described previ-
ously [83]. No FAD was added during expression and purification. 
5.6.3 Crystallization and X-ray Data Collection 
 Purified DADH was concentrated to 6 mg/mL, in 50 mM Tris at pH 7.5. DADH was co-
crystallized with D-Leucine by the hanging drop vapor diffusion method at 4 ˚C using a well solution of 
0.1M 2-(N-morpholino)-ethanesulfonic acid (MES) pH 6.5-7.0, 5% glycerol, and 6-10% (w/v) PEG6000. 
A 1:10 molar ratio of the enzyme (~0.15mM) to substrate was used. Crystals can grow to a size of 0.1-0.2 
mm3 within two weeks. The crystals were soaked in the reservoir solution with 20% glycerol as 
cryoprotectant for ~1 min and frozen immediately in liquid nitrogen. X-ray data were collected at 100 K 
on beamline 22-ID of the Southeast Regional Collaborative Access Team (SER-CAT) at the Advanced 
Photon Source, Argonne National Laboratory.  
5.6.4 Structure Determination and Model Refinement 
 The X-ray data were integrated and scaled using HKL2000 [178]. The structure of 
DADH/iminoarginine (PDB: 3YNE [45]) was employed to solve the new DADH structure by molecular 
replacement using PHASER [127] in the CCP4i suite of programs [128]. Surprisingly, the electron densi-
ty of the ligand was quite different from those observed in other DADH structures. Further analysis sug-
gested that a covalent bond is formed between Cα atom of ketoleucine and the flavin N(5) atom, forming 
a FAD N(5) adduct. A small amount of extra density was observed near the ligand acyl group, suggesting 
that iminoleucine may also exist at a very low occupancy in the crystal structure. Crystal structures were 
refined with SHELX97 [129]. Manual adjustments and rebuilding were performed using the molecular 
graphics program COOT [131]. Solvent molecules were inserted at stereochemically reasonable positions 
based on the peak height of the 2Fo–Fc and Fo–Fc electron density maps, hydrogen bond interactions 
and interatomic distances. Anisotropic B-factors were refined for all the structures. Hydrogen atom posi-
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tions were included in the last stage of refinement using all data. The crystallographic statistics are shown 
in Table 5.S1. Protein structures were superimposed on Cα atoms by using the secondary structure 
matching (SSM) module in COOT [182]. Figures of the structures were generated with PYMOL 
(http://www.pymol.org). 
5.6.5 Anaerobic Light Irradiation 
 DADH was expressed and purified as previously described in [88]. Photoreduction studies were 
performed as described by Massey [202]. DADH was subjected to gel filtration with Sephadex G-25 col-
umn (PD-10, Amersham-Pharmacia Biotech) using 10 mM potassium phosphate and 50 mM EDTA, pH 
8.0. The enzyme solution then mixed with final concentration of 43 mM 4-methyl-2-oxopentanoic acid, 
0.2 µM FAD, 2 µM methyl viologen. Solutions contained in the anaerobic spectrophotometer cell were 
made anaerobic by repeated cycles of degassing and flushing with argon. The anaerobic cuvette was then 
placed in a water bath at 4 oC. The light irradiation was carried out by 100W tungsten light and spectra 
were recorded at intervals using an Agilent Technologies Hewlett-Packed 8453A diode array spectropho-
tometer. Complete photoreduction was attained with 710 min irradiation. The enzyme mixture and excess 
reactant were separated through Sephadex G-25 PD-10 column equilibrated with H2O. Fractions contain-
ing DADH were collected and pooled together. The flavin adduct was extracted by denaturing the enzyme 
with 50% acetonitrile. After centrifugation to remove denatured protein, the supernatant containing the 
extracted flavin was used for mass spectrometry analyzing. 
5.6.6 ESI TOF mass spectrometry studies 
 The flavin adduct sample was analyzed by mass spectrometry on an ESI at the Mass Spectrome-
try Laboratory of the Georgia State University, Atlanta. The mass spectrometry analysis was performed 
on a Waters Q-TOF micro mass spectrometer equipped with electrospray ionization source (ESI) in nega-
tive ion mode (Waters Corporate, Milford, MA). The mass spectrometer was calibrated with sodium 
formate and the sample was analyzed with Leucine Enkephalin as internal standard (m/z=554.2615 Da). 
The mass range was from 100-1000 Da. The sample was introduced into the ion source through direct 
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infusion at 5 µl/min flow rate.  The instrument parameters were as follows: capillary voltage of 3000 V, 
cone voltage of 30 V, desolvation temperature of 100 oC and source temperature of 70 oC. Nitrogen was 
used as nebulizing and drying gas. Data were analyzed using MassLynx 4.1 software. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.1 Interaction between flavin N(5) adduct and DADH.
structure. Carbons are colored gray for DADH active site residues and green for kLeu part of the acyl a
duct. Water molecule is shown as red sphere. 
blue mesh and contoured at 3σ. (B) Schematic diagram of the interactions between DADH and the flavin 
N(5) adduct (blue color). Hydrogen bonds are indicate
der Waals interactions. 
 
 
 
 
 (A) Active site of the DADH/kLeu 
Fo-Fc omit map of the flavin N(5) adduct is indicated as 
d by dashed lines, while curved lines indicate van 
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Figure 5.2 Anaerobic light irradiation of DADH.
anaerobic conditions in the presence of 43 mM 4
methyl viologen. Curves for top to bottom represent 0 min, 70 min, 165 min, 280 min, 370 min, 460 min, 
525 min, 585 min, 620 min, and 710 min. Further irradi
tral changes. The inset shows the extracted flavin adduct in 50% acetonitrile. The spectrum of the flavin 
adduct is estimated by multiplying by a factor of 3. Panel B: Formation of 4
through reductive decarboxylation of FAD and 4
C: Negative ion ESI mass spectrum of the isolated flavin adduct. The peak at m/z 434.6 corresponds to 
the (M-2H)2- ion of the 4-methyl-2
2H)2- ion region 434-437 of the mass spectrum. 
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Figure 5.3 Comparison of the active sites of DADH structures in complex with iminoarginine and 
kLeu. Residues from DADH/iminoarginine forming similar interactions in both structures are shown as 
gray sticks. The ligands, water and the residues showing differences in interactions are colored red for 
kLeu adduct and green for iminoarginine. Water molecules 
actions with several DADH residues as shown by interatomic distances (dotted lines labeled in Å). The 
water mediated interaction of iminoarginine with His48 (green dashed lines) is absent in the DADH/kLeu 
structure. Also, kLeu forms a water
iminoarginine (Tyr53 was omitted for clarity). 
 
 
 
 
 
 
 
are indicated by spheres. kLeu has lost inte
-mediated hydrogen bond with Tyr53, unlike the direct interaction of 
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Table 5.1 Crystallographic Data Collection and Refinement Statistics (S1) 
 DADH/D-Leu 
Data Collection Statistics  
Redox state of flavin Reduced 
Wavelength (Å) 0.80000 
Space group P212121 
a (Å) 
b (Å) 
c (Å) 
62.07 
77.93 
89.31 
Resolution range (Å) 50-1.07 
Total observations 2,025,781 
Unique reflections 187,536 
Completeness 98.6(80.8) a 
<I/σ(I)> 32.9(2.3) 
Rsym (%) 6.7(43.8) 
Refinement Statistics  
  Resolution range (Å) 10-1.07 
  Rwork (%) 13.1 
  Rfree (%) 15.4 
  Mean B-factor (Å2)  
    Protein 12.7 
    FAD 5.9 
    Ligand 14.8 
    Water 23.3 
  Number of atoms  
    Protein 3010 
    FAD 53 
    Ligand 6 
    Water 363 
r.m.s. deviations   
    Bond length (Å) 0.017 
    Angleb 0.034 
aValues in parentheses are given for the highest resolution shell. 
bThe angle RMSD in SHELX97 is indicated by distance in Å. 
 
 
 
 
 
 
 
 Scheme 5.S1. Proposed mechanism for the formation of 4
DADH and ketoleucine. Red defines the 4
DADH. R1 is adenosine diphosphate ribose; R
 
 
 
 
 
 
 
 
 
 
-methyl-2-pentanone-FAD from reduced 
-methyl-2-pentanone-FAD observed in the active site of 
2 is –CH2CH(CH3)2. 
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6 PROBING THE SUBSTRATE SPECIFICITY OF D-ARGININE DEHYDROGENASE BY 
CRYSTALLOGRAPHY AND COMPUTATIONAL MODELING 
 
Guoxing Fu, Robert W. Harrison and Irene T. Weber 
 
6.1 Abstract 
 D-Arginine dehydrogenase (DADH) catalyzes the flavin-dependent oxidative deamination of D-
amino acids to the corresponding imino acids. In order to investigate the molecular basis for the high ac-
tivity of DADH on basic and hydrophobic D-amino acids crystal structures of DADH complexes with 
reaction products iminolysine, iminomethionine, iminophenylalanine and iminoproline were solved at 
atomic resolution (1.03-1.09 Å). The structure of DADH/iminolysine confirms that DADH residue Glu87 
forms ionic interactions with positively charged D-amino acids. The hydrophobic side chains of 
iminophenylalanine and iminomethionine form hydrophobic contacts with DADH residues Tyr53, 
Met240, Val242 and Tyr249 lining the binding pocket. The structure of DADH/iminoproline shows fewer 
ligand contacts within the binding pocket and alternate conformations for residues 46-48 and 50-52 of the 
active site lid. Molecular mechanics calculations on DADH with 16 imino acids gave excellent agreement 
with measured kinetic data with a correlation coefficient of 0.84 after estimating the relative populations 
of charged and neutral states for the side chain of the trapped product (the correlation coefficient is 0.77 
without this estimate). Finally, comparison of DADH with D-amino acid oxidase and D-aspartate oxidase 
gave new insights into key structural features contributing to the distinct substrate specificity of these en-
zymes.  
6.2 Introduction  
 D-amino acids and their metabolizing enzymes have important, but poorly understood, roles in 
living organisms compared to those of L-amino acids, which are the predominant form in biologically 
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synthesized proteins. In bacteria, D-amino acids are fundamental elements of the cell wall peptidoglycan 
layer [63], while D-leucine, D-methionine, D-tyrosine, and D-tryptophan were reported to regulate disas-
sembly of bacterial biofilms [64]. In eukaryotes, specific D-amino acids such as D-aspartate and D-serine 
have critical roles in regulating several physiological processes [66]. Catabolism of D-amino acids is 
commonly catalyzed by D-amino acid oxidases or dehydrogenases, which have been identified in bacte-
ria, archaea, and eukaryotes. D-amino acid oxidase (DAAO) has been the focus of numerous studies and a 
paradigm for flavin-dependent oxidases since its identification in 1935 [48]. In bacteria, D-amino acids 
are deaminated by flavin-dependent dehydrogenases [73], which allows the bacteria to grow using D-
amino acids as a nutrient [71-72]. 
 D-arginine dehydrogenase was identified as the catabolic enzyme of a novel 2-enzyme-coupled 
system for D-to-L inversion of D-arginine. This 2-component racemase allows Pseudomonas aeruginosa, 
which is a common opportunistic human pathogen, to grow with D-arginine as the sole source of carbon 
and nitrogen [175]. DADH noncovalently binds FAD as a prosthetic group and catalyzes the oxidative 
deamination of many D-amino acids to their corresponding imino acids with concomitant reduction of 
FAD. The imino acid is then released into the solvent and nonenzymatically hydrolyzed to the corre-
sponding α-keto acid and ammonia. Iminoarginine is then converted to L-arginine by the coupled anabol-
ic enzyme, an NAD(P)H-dependent L-arginine dehydrogenase (LADH).  
 Our group recently reported the crystal structure of DADH determined at the atomic resolution of 
1.06 Å, while the structures of DADH with iminoarginine and iminohistidine reaction products were de-
termined at 1.30 Å resolution [45]. Further investigation of this enzyme by steady-state kinetic studies has 
established a ping-pong bi-bi kinetic mechanism [88]. A loop region of DADH (residues 50-56) was des-
ignated as an active site lid controlling the substrate accessibility to the active site, similar to those report-
ed in other flavin-dependent enzymes [75, 188]. Moreover, the residues Ser45-Ala46 were observed to 
switch conformation between the ligand-free and product-bound structures of DADH. Distinct side-chain 
conformations were observed for the imino products of D-arginine and D-histidine bound in the active 
site. Glu87 of DADH formed ionic interactions with iminoarginine, which is likely responsible for the 
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high activity of DADH for positively charged residues. The different interactions and binding modes ob-
served for iminoarginine and iminohistidine are consistent with the 1000-fold difference in kcat/Km values 
for D-arginine and D-histidine. 
 DADH is characterized by broad substrate specificity, being able to oxidize basic and hydropho-
bic D-amino acids of various sizes, but not reacting with acidic D-amino acids [45, 84, 203-204]. Similar-
ly, DAAO acts on many neutral and basic D-amino acids but not acidic D-amino acids. The oxidative de-
amination of acidic D-amino acids, such as D-aspartate and D-glutamate, is specifically catalyzed by D-
aspartate oxidase (DDO), which is widely distributed in a variety of eukaryotes, but has not been identi-
fied in bacteria or plants yet [205]. In this study, we co-crystallized DADH with basic and hydrophobic 
D-amino acids: D-lysine, D-methionine, D-phenylalanine and D-proline. The atomic resolution crystal 
structures facilitated detailed analysis of the enzyme-substrate interaction. Additionally, we performed 
molecular mechanics energy calculations on DADH with 19 imino acids to further explore the molecular 
basis for the substrate specificity of DADH. Finally, structural and functional comparison of DADH with 
DDO and DAAO has given insights into the key residues responsible for the recognition of different D-
amino acids.  
6.3 Experimental Procedures 
6.3.1 Expression and Purification of DADH 
 The Escherichia coli strain TOP10 bearing hexa-histidine-tagged DADH was kindly provided by 
Dr. Chung-Dar Lu, Georgia State University. Protein expression and purification were as described previ-
ously [83].  
6.3.2 Crystallization and X-ray Data Collection 
 Purified DADH was concentrated to 6 mg/mL in 50 mM Tris at pH 7.5. DADH was co-
crystallized with selected D-amino acids by the hanging drop vapor diffusion method at 4 ˚C using a 1:10 
molar ratio of the enzyme (~0.15mM) to substrate. The well solution was 0.1 M 2-(N-morpholino)-
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ethanesulfonic acid (MES) pH 6.5-7.0, 5% glycerol, and 6-10% (w/v) PEG6000. Crystals can grow to a 
size of 0.1-0.2 mm3 within two weeks. The crystals were soaked in the reservoir solution with 20% glyc-
erol as cryoprotectant for ~1 min and frozen immediately in liquid nitrogen. X-ray data were collected at 
100 K and a wavelength of 0.85 Å on beamline 22-ID of the Southeast Regional Collaborative Access 
Team (SER-CAT) at the Advanced Photon Source, Argonne National Laboratory.  
6.3.3 Structure Determination and Model Refinement 
 The X-ray data were integrated and scaled using HKL2000 [178]. The crystal structure of 
DADH/iminoarginine (Protein Data Bank (PDB) entry: 3YNE) was employed to solve the structures of 
DADH in complexes with iminolysine, iminomethionine, iminophenylalanine and iminoproline by mo-
lecular replacement using PHASER [127] in the CCP4i suite of programs [128]. Notably, all the FAD 
atoms were distinctly visible in the electron density maps. Crystal structures were refined with SHELX97 
[129]. Manual adjustments and rebuilding were performed using the molecular graphics program COOT 
[131]. The active site lid and the Ala46-Ser48 region of the DADH/iminoproline complex were refined 
with two alternate conformations where the major (~70% occupancy) and minor conformations (~30% 
occupancy) corresponded to the product-bound and ligand-free conformations in the first reported DADH 
structure (PDB entry: 3NYC [45]). Solvent molecules were inserted at stereochemically reasonable posi-
tions based on the peak height of the 2Fo–Fc and Fo–Fc electron density maps, hydrogen bond interac-
tions and interatomic distances. Anisotropic B-factors were refined for all the structures. Hydrogen atom 
positions were included in the last stage of refinement using all data. Protein structures were superim-
posed on Cα atoms by using the secondary structure matching (SSM) module in COOT [182]. Figures of 
the structures were generated with PYMOL (http://www.pymol.org).  
6.3.4 Molecular Modeling of DADH 
 Models of DADH complexes with different imino acids were built using the program AMMP 
[29]. The models were generated from the crystal structure of DADH/iminoarginine. The other imino ac-
ids were generated from the main-chain atoms of iminoarginine. The template and restraints for FAD 
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were generated from the crystal structure. The hydrogen atoms were built with the tuna potential set [153] 
using 15 cycles of the analytic model building algorithm in AMMP [137, 206], followed by conjugate 
gradients minimization of the non-bonded and geometrical terms. The charges for each imino acid were 
generated by using the method of moments atomic charge calculation implemented in AMMP before en-
ergy minimization [163]. Finally, each DADH/imino acid complex was optimized by 1,000 steps of con-
jugate gradients energy minimization. The total non-bonded interaction energy was calculated for each 
protein-ligand model. The experimental binding energy was calculated as ∆G = -RT ln (kcat/Km) from the 
16 measured kinetic constants [45]. Only the data from 16 imino acids with experimentally determined 
kinetic parameters (omitting iminocysteine, iminoglutamate and iminoaspartate) were used to calculate 
the correlation with calculated energies.  
6.3.5 Molecular modeling of DDO 
 Due to the lack of an experimental structure of DDO, a theoretical model of the mouse DDO 
structure was constructed for comparison with DADH. Sequence similarity searches with available crystal 
structures were performed by BLAST [181] and the AMMP structure prediction server 
(http://bmcc3.cs.gsu.edu) [137]. The structure of porcine DAAO showed the highest sequence identity 
(40.3%) with DDO. Therefore, the crystal structure of porcine DAAO (PDB entry: 1DDO [75]) was sub-
mitted to the AMMP structure prediction server to construct the initial model of DDO. FAD was then in-
corporated into the model and hydrogen atoms were generated by using the AMMP program. The enzy-
matic reaction product, iminoaspartate, was modeled in the active site to allow a comprehensive compari-
son with the structures of DADH. 
6.4 Results and Discussion 
6.4.1 Overall structure of DADH with four different imino acids 
 DADH was crystallized with three hydrophobic D-amino acids, D-methionine, D-phenylalanine 
and D-proline, as well as the basic D-amino acid D-lysine, in order to investigate the substrate specificity 
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of this enzyme. All structures were solved in the orthorhombic space group P212121 with one molecule per 
asymmetric unit and were refined to atomic resolutions of 1.03-1.09 Å and R-factors of 16.2-17.8 %. The 
crystallographic data and refinement statistics are summarized in Table 1. All 375 DADH residues were 
defined clearly in the electron density map, as well as the N-terminal hexa-histidine tag, which forms sev-
eral direct or water-mediated polar interactions with residues from symmetry related molecules. The main 
chain conformations of DADH in the four complexes closely resemble our previously reported structure 
of DADH/iminoarginine with pairwise RMSD values of 0.09-0.11 Å for 381 Cα atoms. The cofactor 
FAD adopts an elongated conformation with the adenine ring buried inside the FAD-binding domain and 
the isoalloxazine ring located at the interface with the substrate-binding domain (Figure 1), as observed 
in the reported structures [45]. 
6.4.2 Interactions of DADH with iminolysine 
 Based on the previously determined structure of DADH with iminoarginine, we proposed that 
Glu87 was critical for recognition of positively charged D-amino acids as substrates. Therefore, DADH 
was co-crystallized with D-lysine to confirm the role of Glu87. As expected, the bound iminolysine forms 
similar polar interactions with Glu87 as observed for iminoarginine. Iminolysine binds with the plane 
formed by its Cα atom, carboxylate group and imino group approximately parallel to the re face of the 
flavin, while the side chain points away from the FAD (Figure 2A). A slight difference was observed 
near the α-carbon of the iminolysine, which is 3.0 Å away from the FAD N5 atom. This distance is about 
0.4 Å longer in the structure of DADH/iminoarginine (Figure 2B), possibly due to the shorter interactions 
of iminoarginine with Glu87 relative to those of iminolysine.  
 Several DADH residues form extensive polar interactions with the two main-chain carboxyl oxy-
gen atoms of iminolysine and anchor the ligand in the active site. One of the iminolysine carboxyl oxygen 
atoms forms hydrogen bonds with the side-chain hydroxyl of Tyr53, the guanidinium side chain of 
Arg305, and the carbonyl oxygen of Gly332. The other ligand carboxyl oxygen forms hydrogen bonds 
with the side-chain nitrogen of Arg222 and side-chain hydroxyl of Tyr249. The imino group of 
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iminolysine remains on the same plane as the carboxylate atoms, unlike the out of plane imino group of 
iminoarginine, resulting in the loss of the polar interaction with the FAD O4 atom; instead, a hydrogen 
bond is formed with the carbonyl oxygen of Gly332 (Figure 2A). The two water molecules that mediate 
the hydrogen-bond network between the ligand imino group and the imidazole side chain of His48 are 
retained in both structures. The side chain of iminolysine is recognized by two hydrogen bonds (2.7 Å and 
3.0 Å long) with the carboxylate group of Glu87, which is consistent with the high activity of DADH for 
positively charged D-amino acids [45, 84, 88].  
6.4.3 Interactions of DADH with hydrophobic imino acids.  
 In order to understand its substrate specificity for hydrophobic residues, structures were also de-
termined for DADH crystallized with D-methionine, D-phenylalanine and D-proline, which have 
260~10,000-fold lower kcat/Km values when compared to that of D-arginine. The hydrophobic walls 
(Tyr53, Met240, Val242, and Tyr249) of the DADH active site create a favorable environment for hydro-
phobic D-amino acids with larger side chains. Iminomethionine and iminophenylalanine form extensive 
van der Waals interactions with the hydrophobic residues in the binding site (Figure 3A, 3B).  Interest-
ingly, the benzene ring of iminophenylalanine forms parallel-displaced π-stacking with Tyr53 and T-
shaped π-stacking with Tyr249, which are favorable arrangements for aromatic-aromatic interactions 
(π…π and C-H…π) [207-208]. Iminoproline has the smallest side chain of the three hydrophobic imino 
acids and shows fewer hydrophobic contacts with DADH (Figure 3C). The diminished interactions of 
iminoproline are in excellent agreement with the substrate specificity of DADH, since D-proline is a 
poorer substrate than the larger hydrophobic D-amino acids. Detailed examination of the 
DADH/iminoproline structure revealed conformational disorder around the enzyme active site. Residues 
Thr50-Ala52 in the active site lid show a minor alternative conformation (~30% occupancy) (Figure 4A, 
red mesh) similar to the ligand-free conformation described previously [45]. However, Tyr53, which 
forms a hydrogen bond with the ligand, has a single conformation as seen in the product-bound complex 
without visible disorder (Figure 4A, green mesh). On the si face of the flavin ring, Ala47, rather than 
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Ala46 in the previous DADH structure, displays an alternate conformation directed away from the flavin. 
This structural disorder may arise from the small side chain and weak affinity of D-proline.  
 Superimposition of the active sites of DADH illustrates the flexible conformations adopted by 
Thr50, Glu87, Met240 and Val242 in complexes with basic and hydrophobic imino acids (Figure 4B). In 
contrast, DADH residues interacting with the product main-chain atoms display almost identical confor-
mations. More variation was seen for the side chains of Thr50, Glu87 and Val242. Glu87 mainly interacts 
with iminoarginine and iminolysine, although slight structural shifts are seen in other structures. Thr50 
has the largest variation since it forms polar interactions with iminoarginine and iminolysine and has hy-
drophobic contacts with iminophenylalanine. However, Thr50 does not interact with iminomethionine, 
which has moved toward Val242. The smaller iminoproline does not form hydrophobic contacts with the 
above enzyme residues. The water-mediated hydrogen bond network depicted in Figure 2B is conserved 
in all these structures, except for the complex with iminophenylalanine, in which only one water molecule 
is visible, probably due to exclusion of the other water by the bulky phenylalanine side chain. 
6.4.4 Predicted selectivity of DADH for different D-amino acids 
 Molecular modeling calculations were employed to analyze the substrate selectivity of DADH for 
all 19 D-amino acids. The observation that imino acids are trapped in the crystal structures, and a product 
release experiment with D-arginine, suggested that the release of imino product is the rate-limiting step of 
the reaction [45, 88]. Therefore, the calculation on product complexes is likely to reflect the reaction ki-
netics. The comparison of model and crystal structure of DADH with iminoarginine showed great similar-
ity with slight differences appearing in the ligand interaction with Glu87 as shown in Figure S1. The pre-
dicted conformations of the imino acids and their interactions with protein residues closely resemble those 
observed in the crystal structures with only minor deviations, except for iminohistidine (Figure S2). 
Iminohistidine in the crystal structure showed several alternate conformations and lacked the two water 
molecules present in the binding sites for other imino acids.  These two water molecules were included in 
the models and may prevent iminohistidine forming the conformation(s) observed in the crystal structure. 
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The molecular mechanics interaction energies were calculated for the 19 imino acid products as listed in 
Table S1. The experimentally determined kinetic parameters are available for 16 D-amino acid substrates 
[45, 84]. The kinetic data excluded D-cysteine because its -SH group causes reduction of the phenazine 
methosulfate in the enzyme assay, while D-glutamate and D-aspartate are not substrates of DADH. 
Changes in the free energy of the reaction can be related to the measured kinetic parameters by using the 
equation ∆G = -RT ln(kcat/Km) [209]. The predicted trends in binding affinity showed high agreement with 
the ranking in our kinetic analysis of natural substrates [45, 84, 88]. The calculated interaction energies 
gave a respectable correlation coefficient of 0.77 with the experimentally derived binding energies (Fig-
ure 5A).  
 The charged state was analyzed further for iminoarginine and iminolysince since the calculated 
interaction energies appeared to be overestimated relative to the other imino acids. There is little direct 
information about aqueous ionization constants for imino acids since they are unstable in water and 
quickly hydrolyze into keto acids and ammonium ions [210]. Iminoarginine and iminolysine are titratable 
ligands so that the experimental binding data will reflect the population weighted average binding energy 
of both charged and neutral ligands. The initial calculations assumed fully charged states (+1), since the 
side chain pKa values for lysine (10.53) and arginine (12.48) are considerably higher than the pH of the 
kinetic experiment (8.7). The pKa of the side chain may be elevated due to the presence of the α–amino 
group on the amino acid, and it is possible that the pKa is lower in the α–imino acid. Both 
phenylguanidine and n-acetyl guanidine have lower pKa values than arginine, which is consistent with a 
shift of the pKa in an imino acid [211]. Therefore, it is necessary to consider the possibility of a mixture 
of charged and uncharged molecules for iminoarginine and iminolysine. Calculations were performed for 
the neutral species as well as the charged forms. The correlation coefficient between calculated and exper-
imental binding energies dropped from 0.77 for fully charged imino acids to 0.67 for neutral forms (Fig-
ure 5A), which is similar to the correlation coefficient of 0.66 when the basic imino acids are excluded.  
Linear combinations of the interaction energies for the neutral and fully charged side chains were used to 
estimate the relative populations of the two ionization states. The correlation between experimental data 
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and interaction energies calculated with mixed populations of ionized species was, as expected, a smooth 
curve with a single maximum (Figure 5B). The combination of 17% charged and 83% neutral gave the 
highest correlation coefficient of 0.84 (Figure 5A), which suggests that DADH stabilizes binding of the 
neutral intermediate rather than the fully charged state.  
 Overall, the observed free energies (∆G) derived from experimental kcat/Km values showed excel-
lent correlation with the calculated interaction energies for the models. This agreement verifies the accu-
racy of the calculations on DADH with the imino acid products. The calculations confirm that D-arginine 
and D-lysine are the best two substrates for DADH, while D-aspartic acid and D-glutamic acid are the 
worst.   
6.4.5 Key structural features determining substrate specificity 
 Our structural and kinetic studies have characterized the substrate specificity of DADH. This en-
zyme prefers positively charged polar residues and also interacts well with several hydrophobic residues. 
Structural analysis suggested that Glu87 is responsible for its strong preference for D-arginine and D-
lysine. Similar key structural components determining the substrate specificity have been observed in dif-
ferent enzymes from many organisms. DAAO catalyzes oxidative deamination of D-amino acids and is 
widespread in nature, from microorganisms to mammals. DAAO shows broad substrate specificity for 
neutral and basic D-amino acids but not acidic D-amino acids, with D-phenylalanine determined as its 
best substrate [212]. On the other hand, the oxidative deamination of acidic D-amino acids, D-aspartate 
and D-glutamate, is specifically catalyzed by D-aspartate oxidase [205]. To gain insights into how these 
enzymes recognize different D-amino acids, detailed sequence and structural analyses were performed on 
DADH, DAAO and DDO. 
 DADH shares rather low sequence identities with DAAO (17.2%) and DDO (16.3%), while 
DAAO and DDO are more similar (40.3% identity). Despite their low sequence similarity, DADH and 
DAAO display similar overall structures (RMSD of 2.4 Å for 270 Cα atoms). Katane et al. have investi-
gated the substrate specificity of mouse DDO [212-213]. Their kinetic and mutagenesis studies have re-
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vealed that Arg216 is critical for its restrict preference for acidic D-amino acids like D-glutamate and D-
aspartate [212]. Unfortunately, the experimental structure of mouse DDO is not available. Hence, we con-
structed a theoretical model of mouse DDO in complex with iminoaspartate by applying the DAAO struc-
ture as the template to the AMMP structure prediction server to perform structural comparison with the 
other two enzymes. 
 Comparison of the active site composition and geometry revealed significant similarities among 
the three enzymes and some key components that may be responsible for their distinct substrate specifici-
ties. In the DADH/iminoarginine complex (PDB entry: 3NYE), two arginines Arg222 and Arg305 form 
ionic interactions with the ligand carboxylate (Figure 6A), while the ligand carboxylate group forms a 
salt bridge with the guanidinium side chain of Arg283 in the pDAAO/iminotryptophan complex (PDB 
entry: 1DDO) (Figure 6B). Arg278 is predicted to be at the same location in DDO and may serve a simi-
lar function in binding to iminoaspartate (Figure 6C). The main chain carboxylate oxygen atoms of the 
ligands also form polar interactions with Tyr53, Tyr249 and Gly332 of DADH, and Tyr224, Tyr228 and 
Gly313 of DAAO. In the modeled structure of DDO, Tyr223, Arg237 and Ser308 have almost equivalent 
locations with Tyr53, Tyr249 and Gly332 of DADH and may form similar interactions with the ligand 
main-chain atoms. A previous study on mouse DDO suggested that Arg237 is possibly involved in sub-
strate recognition but may not be essential for its enzymatic activity against acidic D-amino acids [212]. 
 The three enzymes have very different residues around the ligand side chain, which may be main-
ly responsible for their distinct substrate specificities. In DADH, iminoarginine forms strong polar inter-
actions with Glu87. However, a glycine residue is found at the structurally equivalent position in both 
DAAO (Gly94) and DDO (Gly94) structures. The glycines are remote (~12 Å) from the ligand Cα in both 
enzymes and likely have little influence on the substrate specificity. It was suggested that Ile215 in 
DAAO is important for its preference for hydrophobic D-amino acids [212, 214], while Arg216 at the 
same position in DDO may play a crucial role in its high selectivity for acidic D-amino acids [212]. The 
detailed structural comparison of these enzymes indicated that although they share active site similarities 
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in terms of recognition of D-amino acids, different arrangement and composition of the key structural 
features provide very distinct substrate specificities. 
6.5 Conclusions 
 The crystal structures of DADH with different imino acids and the computational modeling anal-
ysis have highlighted important structural differences that rationalize the catalytic activities and substrate 
specificity of the enzyme. The structure of DADH with iminolysine further confirms the crucial role of 
Glu87 in the strong preference for basic D-amino acids. Moreover, the structures of DADH in complexes 
with hydrophobic imino acids revealed the hydrophobic residues responsible for the binding of bulky hy-
drophobic substrates. Our predicted structural models closely resemble the crystal structures and the pre-
dicted DADH-imino acid interaction energies showed excellent agreement with the kinetic data for D-
amino acid substrates. This computational analysis provides a powerful approach for investigating pro-
tein-ligand interactions.  Structural comparison of DADH with related enzymes suggests a few key struc-
tural components may be critical for the distinct substrate specificity of enzymes. Overall, the new high-
resolution structures and predictive molecular mechanics calculations will guide future studies of DADH 
and other flavin-dependent enzymes. 
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Table 6.1 Crystallographic Data Collection and Refinement Statistics 
 DADH/ 
D-Lys 
DADH/ 
D-Met 
DADH/ 
D-Phe 
DADH/ 
D-Pro 
Data Collection Statistics     
Wavelength (Å) 0.85 0.85 0.85 0.85 
Space group P212121 P212121 P212121 P212121 
a (Å) 
b (Å) 
c (Å) 
62.14 
78.39 
89.91 
62.11 
78.44 
90.05 
62.20 
78.40 
89.92 
62.10 
78.21 
89.85 
Resolution range (Å) 50-1.09 50-1.05 50-1.05 50-1.03 
Total observations 1080,291 1294,535 1296,946 1434,616 
Unique reflections 182,430 203,230 203,913 212,660 
Completeness 99.6 (97.1) a 99.7(99.0) 99.9(99.4) 98.7(76.8) 
<I/σ(I)> 24.3(2.2) 19.7(2.2) 26.5(2.2) 24.5(2.1) 
Rsym (%) 6.7(52.5) 8.8(64.4) 6.2(60.9) 7.2(51.0) 
Refinement Statistics   
 
 
  Resolution range (Å) 10-1.09 10-1.05 10-1.05 10-1.03 
  Rwork (%) 14.9 15.1 13.8 14.1 
  Rfree (%) 17.8 17.6 16.1 16.2 
  Mean B-factor (Å2)   
 
 
    Protein 13.2 12.7 13.7 12.5 
    FAD 6.1 5.4 6.1 5.6 
    Ligand 24.5 28.0 29.3 14.8 
    Water 27.9 19.6 26.2 23.4 
  Number of atoms   
 
 
    Protein 2993 2967 2994 2968 
    FAD 53 53 53 53 
    Ligand 10 9 12 8 
    Water 389 232 363 318 
  r.m.s. deviations    
 
 
    Bond length (Å) 0.016 0.017 0.017 0.016 
    Angleb 0.034 0.035 0.035 0.035 
aValues in parentheses are given for the highest resolution shell. 
bThe angle rmsd in SHELX97 is indicated by distance in Å. 
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Table 6.2 Calculated interaction energies of DADH with different imino acids (S1) 
substrates kcat/Km, M-1s-1 
Predicted binding ener-
gy (kcal/mol) 
D-arginine (3.4 ± 0.3) × 106 -235.34 
D-lysine (5.3 ± 0.2) × 105 -256.34 
D-tyrosine 27,600±3,800 -134.9 
D-methionine 14,800±600 -132.2 
D-phenylalanine 6,900±300 -140.5 
D-histidine 3,140 ± 30 -77.5 
D-leucine 515±60 -152.4 
D-proline 420 ± 10 -112.5 
D-tryptophan 245 ± 3 -116.8 
D-isoleucine 195 ± 3 -135 
D-glutamine 186 ± 3 -106.8 
D-valine 47 ± 1 -109.7 
D-alanine 41 ± 1 -92.6 
D-asparagine 16 ± 1 -74.5 
D-serine 3.8 ± 0.1 -77 
D-threonine 0.75 ± 0.01 -78.3 
D-cysteine nda -82.4 
D-glutamic acid -b 351.2 
D-aspartic acid - 381 
aNot determined. PMS was reduced by cysteine. bCannot be saturated with the 
substrate, thereby kcat and Km values are not reported. 
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Figure 6.1 Overall structure of DADH. The DADH structure is shown in cartoon representation. 
The enzyme is composed of an FAD-binding domain (orange) and a substrate-binding domain (cyan). 
Iminolysine and cofactor FAD are shown as sticks and colored green and magenta, respectively.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 : Crystal structure of DADH in complex with iminolysine. 
DADH and iminolysine (magenta). DADH residues form hydrophobic interactions with ligand are co
ored light orange. Fo-Fc omit map of the iminolysine is indicated as blue mesh
Structural comparison of DADH/iminoarginine (yellow) and DADH/iminolysine (magenta). The active 
sites residues from two structures are superimposed. Hydrogen bonds are represented by dashed lines.
 
 
(A) Interactions between 
 and contoured at 3
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Figure 6.3 Interactions between DADH and (A) iminomethionine (cyan), (B) iminophenylalanine 
(green), and (C) imnoproline (blue).
colored light orange. Hydrogen bonds are shown
 
 
 
 DADH residues form hydrophobic interactions with ligand are 
 as dashed lines.  
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Figure 6.4 Crystal structures of DADH with imino acids.
of DADH/iminoproline. Omit map of the alternate conformation of Ala47 and 
red mesh. Tyr53 is determined in the product
mesh. (B) Superimposition of the active sites of DADH in complexes with iminoarginine (red), 
iminolysine (green), iminomethionine (
DADH residues forming similar interactions with ligands are colored gray, while residues showing diffe
ent conformations are colored corresponding to the ligand color.
 (A) Conformational disorder in the structure 
Thr50-Ala52 are shown as 
-bound conformation and it’s omit map is shown as green 
blue), iminophenylalanine (cyan), and iminoproline (magenta). 
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r-
Figure 6.5 Computational modeling of DADH with different D
cients calculated for linear combinations ranging from neutral to fully charged side chains of basic imino 
acids. The maximum coefficient of 0.84 was obtained when 17% of the basic imino acids are charged. (B) 
The correlation between experimental binding energies and calculated interaction energies. Correlation 
has been calculated in three ionization states of iminoarginine and iminolysine: 
(green), and the combination of 17% positive and 83% neutral states (red). 
 
 
 
-amino acids. (A) Correlation coeff
positive (blue), neutral 
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Figure 6.6 Comparison of DADH with other flavin
sites of (A) DADH (yellow, iminoarginine in magenta) with (B) pDAAO (iminotryptophan in cyan), and 
(C) DDO (iminoaspartate in green). Glu87 in DADH, Ile215 in pDAAO and Arg216 in DDO are su
gested to be important for the distinct specificities of the enzymes.
 
-dependent enzymes. Comparison of the active 
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g-
Figure 6.7 Comparison of predicted structure (green) and crystal structure (grey) of DADH in 
complex with iminoarginine. (S1) 
Glu87 in the crystal structure, with slight differences appearing in the modeled structure (iminoarginine 
carbons in magenta). 
 
 Inset: Iminoarginine (carbons in cyan) forms ionic interactions with 
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Figure 6.8 Comparison of the active sites of predicted structures (green) and crystal structures 
(grey) of DADH in complexes with imino acids.
magenta, while the ligands from crystal structures are shown as grey
 
 
 
 
 
 
 
 
 
 (S2) Imino acids from predicted structures are colored 
 sticks. 
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7 A DETERMINISTIC-STOCHASTIC CROSSOVER ALGORITHM FOR SIMULATING BI-
OCHEMICAL NETWORKS 
 
Guoxing Fu, Amit Sabnis, Robert W. Harrison 
 
7.1 Abstract 
 Understanding biology at the system level has gained much more interest recently due to the rap-
id development in genome sequencing and high-throughput measurements. Mathematical descriptions of 
biological systems are normally formalized using two different approaches. The deterministic method is 
very efficient in predicting the overall behavior of the system but ignores the inherent fluctuations and 
correlations at lower concentration. The stochastic method, on the other hand, captures the intrinsic ran-
domness but is often mathematically intractable and computationally expensive. Our group has developed 
a deterministic-stochastic crossover algorithm for simulating biological networks. The biological models 
are formalized into a standard format using the eXtensible Markup Language (XML). Simulation studies 
have been performed on biological systems such as auto-regulatory gene network and glycolysis system. 
The new algorithm retains the high efficiency of deterministic method while still reflects the random fluc-
tuations at lower concentration. The ability of revealing the stochastic property with high efficiency 
makes this algorithm very useful for researches and applications based on systems biology.   
 
Categories and Subject Descriptors 
Simulation and modeling, model validation and analysis, simulation output analysis 
 
General Terms 
Algorithms, standardization, verification 
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7.2 Introduction 
 Systems biology is an interdisciplinary science of studying biological functions and mechanisms 
[90]. Rapid development in molecular biology, especially in genome sequencing and high-throughput 
measurements, has made the collection of comprehensive information of biological systems possible, 
which in turn greatly facilitated the advancement of systems biology [91]. Meanwhile, significant devel-
opment in computational software and hardware allowed the creation and investigation of complex and 
still realistic biological systems. Systems biology studies focus on the understanding of whole system’s 
structure and dynamics, while the traditional molecular biology concentrates more on the properties and 
functions of genes and proteins. Although many issues remain unsolved, systems biology studies are able 
to provide in-depth insights and reasonable predictions for biological networks such as the cell cycle and 
metabolic analysis.  
 Molecular biology has uncovered numerous biological facts like protein properties and genome 
sequences in the past a few decades. However, with the dramatically growth of information, it alone is far 
from sufficient for investigating the complex biological systems. Therefore, a system-level understanding 
of biology is greatly in need and a combination of experimental and computational approaches is ex-
pected to achieve this goal. Computer simulations of biological systems have been intensively studied and 
can now replicate important biological behavior. Successful computational studies have been performed 
on simple systems such as the lambda phage ‘switch’ [94-95] and the T-7 phage [96-97]. However, com-
plex systems such as eukaryote organisms, especially mammalian cells, are much more challenging to be 
studied by computer simulation [98]. Many efforts have been dedicated into studies of cellar processes 
like gene expression, cellular signaling and metabolism pathways.  
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 Two major techniques used in system simulation are deterministic methods and stochastic meth-
ods. The deterministic methods work well for systems with large molecular populations and can reasona-
bly represent the overall dynamics of the systems. However, it fails to capture the inherent fluctuations 
and correlations of the species at lower concentration. The stochastic methods are able to capture the fluc-
tuations at lower concentration, but are very computationally inefficient. Therefore, novel algorithms are 
needed to improve the accuracy of deterministic methods and efficiency of stochastic methods. Many 
studies have been dedicated to improving the computational efficiency of stochastic method, while some 
groups have developed hybrid algorithms to facilitate the simulation [101-103]. Our group has developed 
a novel deterministic-stochastic crossover method in order to improve the computational accuracy and 
efficiency of simulation for biochemical systems [104]. The crossover method retains the efficiency of 
deterministic methods and still reflects the fluctuations generally only captured by stochastic methods.  
 In this study, we have extended the functionality and adaptability of the deterministic-stochastic 
crossover method. First of all, we have developed the model representation for biological systems in 
XML, which makes the input and output of data easier. This feature also allows transformation of our 
models between different software platforms feasible. Moreover, we have incorporated compartment and 
event into our model design, making the models more similar to the real biological or experimental condi-
tions. Most importantly, the new algorithm is able to simulate Michaelis-Menten type reactions directly, 
which have to be broken into elementary reactions for simulation in stochastic methods and the previous 
version of deterministic-stochastic crossover method. 
7.3 The Corssover Algorithm 
7.3.1 System Design and Model Representation  
 Biological systems can be represented in various formats to fulfill different purposes. For exam-
ple, graphical representations are useful both for visualization and analysis, while matrix representations 
are more convenient for mathematical and computational analysis. However, different representations 
often make it difficult to transfer models between different software platforms. A commonly accepted 
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software environment would allow individual research groups to easily exchange their models. Several 
undergoing project including Systems Biology Markup Language (SBML http://www.sbml.org/), CellML 
(http://www.cellml.org/) and the Systems Biology Workbench are examples of efforts that aim to form a 
standard and open software platform for modeling and analysis [105-106]. Such efforts have significantly 
facilitated the development of new generation of databases concerned with biological pathways by em-
ploying machine-executable models rather than human-readable forms only. 
 The SBML developed by Hucka et al. is a powerful presentation of biological networks [107]. It 
consists of lists of functions, units, compartments, species, parameters, rules, reactions, and events. While 
it is a good format for computers to parse and generate, its verbosity makes it quite inconvenient for hu-
mans to read and write [110]. In order to standardize and improve the readability of our models, we have 
developed a similar but much simpler representation using eXtensible Markup Language. We will con-
centrate on compartments, species, parameters and reactions, as these are fairly sufficient for describing 
most simple discrete stochastic models. The system design is demonstrated in Figure 7.1. The model is 
composed of one global system, with the parameters such as initial time, time step, total time, and report 
interval defined at the system level.  
 Most of the computational biology studies are focused on single simple system. However, we 
may need to work with multiple systems or single system containing multiple compartments depending 
on the nature of the study. Therefore, we have introduced the idea of multiple compartments into this 
crossover metgod. Each compartment will contain its own species and reactions. The name, initial num-
ber and chemostat status will be assigned to each species, while every reaction will have its own kinetic 
parameters, lists of input species and output species. For biological systems that are composed of more 
than one compartment, there might be transportable species between different compartments, which 
means behavior of one compartment will affect that of others. This is more close to the reality since most 
of the biological systems are complex networks and one certain system is often affected by its environ-
ment. In the meantime, an event feature is also developed to represent specific activities during the simu-
lation, which are very common in biological processes and designed experiments at certain
when some conditions are met.  
7.3.2 Simulation of Michaelis
 The fundamental of this deterministic
vious report [104]. Deterministic functions are used to compute
ber) for each reacting species. A Bernoulli trial was then conducted to obtain an integer number for each 
species using the fractional part of the real number as the probability of success. This method has shown 
to be successful for simple systems such as auto
[104]. However, the previous crossover method was only able to handle elementary reactions similar to 
stochastic methods. A standard Michaelis
into three elementary reactions: binding, dissociation and conversion, which will increase the complexity 
and computational time of the simulation. Here E stands for enzyme; S is substrate; ES is the complex of 
enzyme and substrate; P indicates product; kcat is the turnover number.
 One of the major progresses of the current crossover method is its capability of directly modeling 
Michaelis-Menten type reactions. The two types of reactions will be marked differen
model and calculated by different functions. 
this type of reaction is given by the following equation, in which [E] is the enzyme concentration and [S] 
is the substrate concentration. Km 
maximum, and is an inverse measure of the substrate's affinity for the enzyme.
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7.4 Results and Discussion 
7.4.1 System Validation by Auto
 Since the crossover algorithm is newly implemented in Java with a few features like XML mode 
representation added, we first validated it by testing the auto
described in the previous work [104]
biochemical network whose detailed dynamics are usually captured only by stochastic algorithms [7]. 
According to the concepts of our system design, an example of system representation in XML for auto
regulatory gene network is shown as following: 
 The system is initialed with 10 molecules of “Gene” and none of the other species. Reaction vo
ume was set to 1E-15 liters. The ∆t
are compared with the results from stochastic method and deterministic method (
stochastic method was simulated by using the software Dizzy 
obtained by using XPPAUT [http://www.math.pitt.edu/~bard/xpp/xpp.html].
 The simulation solution from the crossover method is in reasonable agreement with the results 
from stochastic method and deterministic method. Similarities between the results from crossover method 
and the stochastic method indicated that the crossover method is able to reflect those fluctuations featured 
-Regulatory Gene Network 
-regulatory gene network, which has been 
. The auto-regulatory gene network is typically a low concentration 
 
 for each time step is set to 0.001s. The results from crossover method 
Figure 7.2A
[215], while the deterministic results were 
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in stochastic simulation but missed in deterministic simulation. The stoichiometric consistency of the 
crossover method is demonstrated by analyzing the species Gene and Gene.Dimer. Gene cannot be pro-
duced or degraded in this system, thus the sum of Gene and Gene.Dimer should remain constant through-
out the whole process of simulation, which is 10 molecules as shown in Figure 7.2F. 
7.4.2 Testing of Compartments by Michaelis-Menten Model 
 The Michaelis-Menten model has been widely used in biochemistry for studying the kinetics of 
many enzymes. The substrate (S) can bind to enzyme (E) forming complex (ES), which then dissociates 
to either enzyme and substrate or enzyme and product (P) (Table 7.1). Here we employed this model to 
test the multiple-compartment feature of the crossover algorithm, due to its simplicity and well-
understood dynamics. An artificial two-compartment model was defined for this system, with S and E in 
one compartment, ES and P in another (Figure 7.3A). Complex ES generated in compartment I will be 
transported to compartment II, while S and E produced by ES dissociation in compartment II are output 
into compartment I. The transportation reactions will be defined in each compartment with the transfer-
ring rate being experimentally determined or artificially chosen as in this test.  
 The simulation results from deterministic method (XPPAUT), stochastic method (Dizzy), and 
crossover method are compared in Figure 7.3. It is clear that two-compartment model of crossover meth-
od has similar dynamic behavior when compared with results from the other two methods. The conserva-
tion law holds true for this system that the sum of [E] and [ES] is constant. Taken together, this multiple-
compartment feature works properly and can be applied to more complex biological systems. 
7.4.3 Glycolysis System 
 One of the major difficulties of simulating complex systems is searching for the right combina-
tion of parameters. Traditional optimization methods often simulate simple systems by integrating the 
kinetic equations with a set of parameters and initial conditions. However, this approach does not always 
work for complex systems if many kinetic parameters are unknown. Here we have chosen the glycolysis 
system in Saccharomyces cerevisiae as the studying subject of this crossover algorithm [216]. Glycolysis 
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is the metabolic pathway that converts glucose into pyruvate and has been thoroughly studied in classical 
biochemistry, thus making it a good subject for computational studies. 
 There are 38 species and 36 reactions involved in this system (Table 7.2). The system is com-
posed of two compartments, extracellular and intracellular. Extracellular compartment includes 11 species 
and 12 reactions, while 27 species and 24 reactions are defined in the intracellular compartment. The 
chemstat statuses of extracellular glucose flow and extracellular cyanide (CN-) flow are set to true in or-
der to provide constant supply for extracellular glucose and cyanide. Species like glucose, glycerol, acet-
aldehyde and ethanol are transportable between the two compartments. Unlike the auto-regulatory gene 
network, which is composed of elementary reactions only, this glycolysis contains both elementary reac-
tions and Michaelis-Menten type reactions. Reactions such as transportation or degradation of some spe-
cies are simplified into elementary reactions, with the reaction rate mainly determined by the reaction 
constant and the concentration of the reactants. Reactions such as conversion of glucose into glucose 6-
phosphate catalyzed by hexokinase obey the Michaelis-Menten kinetics, with the reaction rate determined 
by reaction rate, reactant concentration, enzyme concentration and affinities of reactant to the enzyme.  
 The system is initialed following the conditions from the model described in previous study 
[216]. The time step is set to 0.001s with a total time of 100 seconds simulated. The results from the 
crossover method for some of the species are shown in Figure 7.4. The concentration of ATP and ADP 
decreased while that of AMP increased. After about 10 seconds, they reached an equilibrium state and did 
not show significant changes. Again, since the system is closed to ATP, the sum of ATP, ADP and AMP 
is constant throughout the simulation. Meanwhile, the crossover method is able to capture the random 
fluctuations at lower concentration for species such as 1, 3-bisphosphoglycerate and phosphoenol py-
ruvate. A fluctuation is also observed for pyruvate even its concentration is higher than other species. We 
tried to compare the simulation of this glycolysis system by crossover method, stochastic method and de-
terministic method. However, there are some limitations with XPPAUT and Dizzy when applied with 
such kind of complex system. XPPAUT and Dizzy can only take elementary reactions, thus cannot handle 
Michaelis-Menten type reactions driectly as discussed previously. They cannot simulate models with mul-
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tiple compartments. Therefore, this two-compartment model has to be converted to one-compartment 
model to be tested by other programs. Moreover, constant concentration for certain species is not support-
ed in XPPAUT and Dizzy. Due to these limitations, we were not able to obtain comparable simulation 
results from these two programs for this glycolysis system. 
7.4.4 Testing Events in Glycolysis System 
 The event feature is then tested in this glycolysis system. For each event, we need to define when 
the event will happen. What is the target of this event? For example, the number, concentration or 
chemostat status of the reactant can be altered. Here we defined two events in the intracellular compart-
ment of glycolysis system in order to test whether this event function is working properly. At 20 second, 
3000 molecules of ATP were added into the system. At 50 second, the number of NADH was adjusted to 
1000, no matter what the actual value was at that moment. The results from the system with and without 
events are compared in Figure 7.5. At 20 second, the number of ATP has been increased by 3000. Since 
ATP, ADP and AMP are convertible to each other and the system is closed to them, the numbers of AMP 
and ADP are also increased accordingly. Similar situation has been observed for NAD+ and NADH. The 
number of NAD+ was increased when the number of NADH was adjusted to 1000 at 50 second. These 
changes can be directly observed since these species are the subjects of the testing events (Figure 5A-B). 
However, indirect changes were also seen for other species in the system (Figure 5C-F). For example, a 
decrease in number of dihydroxyacetone phosphate was observed at about 50s. Most likely it is mainly 
affected by the adding of NADH at 50s since it reacts with NADH to form glycerol and NAD+. The num-
ber of 1, 3-bisphosphoglycerate has been increased during 20-60 second. This could possibly be explained 
by the increased conversion of glyceraldehydes 3-phosphate and phosphoenol pyruvate to 1, 3-
bisphosphoglycerate due to the increase of ATP and NAD+.  Almost in the same time period, the number 
of phosphoenol pyruvate has dropped, probably because its conversion to 1, 3-bisphosphoglycerate and 
pyruvate. Further, the overall simulation result for pyruvate is different from the data without the event. 
This could be the result of combined impact from multiple reactions. Overall, the test of this event system 
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was successful. It allows this crossover algorithm to simulate some of the specific activities in biological 
systems. 
7.4.5 Run-time Analysis 
 In order to test the efficiency of this crossover algorithm, we have performed different types of 
run-time analysis. The tests were performed on a desktop computer with an Intel I5-750 (2.66G) proces-
sor and 8G DDR3 memory. Each test is performed 10 times and the average value is calculated. Firstly, 
the performance of crossover algorithm and stochastic methods (Dizzy) on auto-regulatory gene network 
has been compared over different simulation time (Table 7.3). At a first glance, the crossover algorithm is 
slower than Dizzy when the total simulation time is short, such as 100s and 1000s. However, as we in-
creased the total simulation time, the advantage of crossover algorithm became more significant and 
eventually it surpassed the stochastic methods. The crossover algorithm is 10.2% faster than dizzy at 
10,000s and the difference increased to 18.5% at 100,000s, suggesting that the crossover algorithm is 
more efficient than the stochastic methods in Dizzy for long time simulation. 
 Next we compared the crossover algorithm with Dizzy over different systems (Table 7.4). The 
Michaelis-Menten model contains only 3 reactions, thus is considered as a small system here. The auto-
regulatory gene network is composed of 8 reactions and has a relatively medium size. The glycolysis sys-
tem has 36 reactions and is a more complex system. The first two systems contain only elementary reac-
tions while the glycolysis system contains both elementary reactions and Michaelis-Menten type reac-
tions. In order to eliminate the affect of data loading on the performance, we have chosen a simulation 
time of 10,000s. The crossover algorithm is 9.1% faster than Dizzy for Michaelis-Menten model, and 
10.2% faster for the auto-regulatory gene network. It is able to finish a 10,000s simulation of the glycoly-
sis system in 32.37s. A simulation of 100s of the glycolysis system by this crossover algorithm takes only 
0.361s. On the other hand, Dizzy is not able to handle such a complex system as discussed in the previous 
sessions. Therefore, the crossover algorithm is slower than Dizzy for shorter simulation time, but is faster 
169 
for longer simulation time, when small and simple systems are studied. Moreover, the crossover algo-
rithm can simulate big and more complex systems which cannot be handled by stochastic methods.  
7.5 Conclusions 
 In this study we have extended the functions of this deterministic-stochastic crossover method, 
making it more competitive for the simulation of biochemical networks in both accuracy and efficiency. 
A lot of efforts have been made to overcome the drawbacks of deterministic and stochastic methods. 
Some hybrid algorithms employing both deterministic and stochastic techniques have been developed to 
increase the computational efficiency at a small cost of accuracy [102-103, 217]. However, one of the 
major disadvantages of these hybrid systems is that they require partitioning the system into subsets of 
fast and slow reactions. The fast reactions will be treated as a continuous process and simulated by deter-
ministic method, while the slow reactions are considered as discrete events and simulated by stochastic 
algorithm. The major advantage of this crossover method over these hybrid algorithms is it does not re-
quire partition of the modeled system. It is not actually a combination of deterministic and stochastic 
methods, but a deterministic method with the randomness introduced by Bernoulli trial. At higher concen-
tration, the fluctuation induced by Bernoulli trial is neglectable; however, the effect of Bernoulli trial will 
become significant at lower concentration, thus allowing the stochastic effects to be captured. Such kind 
of “smooth” transition from deterministic (high concentration) to stochastic (low concentration) has not 
been achieved by other methods based on our knowledge. In fact, this is more similar to the condition that 
a fast reaction behaves continues at high concentration may become a slow reaction at lower concentra-
tion due to some physiological impacts, which is very common in biological systems and under some des-
ignated experimental conditions. 
 Another notable feature of this crossover algorithm is its capability of simulating more complex 
Michaelis-Menten type reactions, instead of being restricted to simple elementary reactions. Most of other 
simulation programs are not able to handle complex reactions without breaking them down into elemen-
tary reactions, which will introduce more difficulties to the system representation and add more computa-
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tional cost. This crossover algorithm made the simulation of Michaelis-Menten type reactions feasible. 
Further, the added features of compartment and event made the simulation of biological systems become 
more realistic. One of the benefits of using multiple- compartment system is the potential ability of apply-
ing parallel computing in this system. Simulation of different compartments simultaneous will greatly 
enhance the efficiency of this crossover method and will be a future direction of our study. Run-time 
analysis has indicated that this crossover algorithm is more efficient than stochastic methods for long 
simulation time and more complex systems. Overall, development of this crossover algorithm would be 
very useful for researches and applications based on systems biology. 
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7.7 Appendix: Biochemical Abbreviations 
ADH:  alcohol dehydrogenase 
ALD: aldolase 
GAPDH: glyceraldehyde 3-phosphate dehydrogenase 
PDC:  pyruvate decarboxylase 
HK: hexokinase 
PFK: phosphofructokinase-1 
PGI: phosphoglucoisomerase 
TIM: triosephosphate isomerase 
ACA: intracellular acetaldehyde 
ACAex: extracellular acetaldehyde 
ADP:  adenosine 5’-diphosphate 
AMP: adenosine 5’-monophosphate 
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ATP:  adenosine 5’-triphosphate 
DHAP: dihydroxyacetone phosphate 
BPG:  1, 3-bisphosphoglycerate 
CN-ex: extracellular CN- 
CN-exf: extracellular CN- flow 
EtOH: intracellular ethanol 
EtOHex: extracellular ethanol 
F6P: fructose 6-phosphate 
FBP: fructose 1, 6-bisphosphate 
G6P: glucose 6-phosphate 
GAP: glyceraldehyde 3-phosphate 
Glc: intracellular glucose 
Glcex: extracellular glucose 
Glcexf: extracellular glucose flow  
Glyc: intracellular glycerol 
Glycex: extracellular glycerol 
NAD+: nicotinamide adenine dinucleotide (oxidized form) 
NADH: nicotinamide adenine dinucleotide (reduced form) 
PEP:  phosphoenol pyruvate 
Pyr:  pyruvate 
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Table 7.1 Details of the Michaelis-Menten model 
Description Reaction Constant  
binding E + S  ES 1.0E-2 
dissociation ES  E + S 1.0E-4 
conversion ES  E + P 1.0E-1 
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Table 7.2 Details of the glycolysys model (See appendix for abbreviations) 
Reaction ID Reaction Reaction constant Enzyme Parameter 
r1 Glcexf  Glcex 8.0E-7   
r2 Glcex  Glcexf 8.0E-7   
r3 Glcex  Glc 1.6916E-2   
r4 Glc   Glcex 1.6916E-2   
r5 Glc  + ATP  ADP + G6P 8.6257E-1 HK KGlc  = 0.01, KATP = 0.1 
r6 G6P  F6P 8.2673E-3 PGI KG6P = 0.8, KF6P = 0.15 
r7 F6P  G6P 8.2673E-3 PGI  
r8 F6P + ATP  ADP + FBP 7.5721E-1 PFK KF6P = 0.021, KATP = 0.15 
r9 FBP  GAP + DHAP 3.6797E-2 ALD KFBP = 0.3 
r10 GAP + DHAP  FBP 1.8399E-1 ALD KGAP = 4.0, KDHAP = 2.0 
r11 DHAP  GAP 1.9394E-3 TIM KDHAP = 1.23 
r12 GAP  DHAP 1.9394E-3 TIM KGAP = 1.27 
r13 GAP + NAD
+
  BPG + NADH 1.3897E-3 GAPDH KGAP = 0.6, KNAD+ = 0.1 
r14 BPG + NADH  GAP + NAD
+
 1.3897E-3 GAPDH KBPG = 0.01, KNADH = 0.06 
r15 BPG + ADP  PEP + ATP 7.3977   
r16 PEP + ATP  BPG + ADP 2.5477   
r17 PEP + ADP  Pyr + ATP 5.7182E-5   
r18 Pyr  ACA 8.8554E-1 PDC KPyr = 0.3 
r19 ACA + NADH  EtOH + NAD
+
 1.4967E-3 ADH KACA = 0.71, KNADH = 0.1 
r20 EtOH  EtOHex 2.7866E-1   
r21 EtOHex  EtOH 2.7866E-1   
r22 EtOHex  empty 8.0E-7   
r23 DHAP + NADH  Glyc + NAD
+
 1.3579E-5 
  
r24 Glyc  Glycex 3.1666E-2   
r25 Glycex  Glyc 3.1666E-2   
r26 Glycex  empty 8.0E-4   
r27 ACA  ACAex 4.1166E-1   
r28 ACAex  ACA 4.1166E-1   
r29 ACAex  empty 8.0E-1   
r30 ACAex + CN
-
ex  empty 4.7304E-2 
  
r31 CN
-
ex  CN-exf 8.0E-4 
  
r32 CN
-
exf  CN-ex 8.0E-4 
  
r33 G6P + ATP  ADP 3.7655E-5   
r34 ATP  ADP 5.346E-1   
r35 ATP + AMP  ADP + ADP 7.215E-3   
r36 ADP + ADP  ATP + AMP 2.2222E-3   
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Table 7.3 Run-time analysis of auto-regulatory gene network over different simulation time 
Time (s) Crossover (s) 
Dizzy (s) 
Difference 
100 0.077 0.042 -83.3% 
1000 0.670 0.481 -39.3% 
10,000 6.670 7.434 10.2% 
100,000 67.514 82.844 18.5% 
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Table 7.4 Run-time analysis of different systems 
Systems  
(# of reactions) Crossover (s) Dizzy (s) Difference 
Michaelis-Menten (3) 0.019 0.021 9.1% 
auto-regulatory gene 
network (8) 
6.670 7.434 10.2% 
glycolysis (36) 32.37 N/A N/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 System design of the crossover algorithm
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Figure 7.2 Comparison of simulation results for auto
 
 
 
-regulatory gene network 
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Figure 7.3 Testing of multiple-compartment system
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Figure 7.4 Simulation results of glycolysis system.
AMP; (C) NAD+, NADH; (D) Phosphoenol pyruvate; (E) 1, 3
 (A) ATP, ADP, AMP; (B) Sum of ATP, ADP and 
-Bisphosglycerate; (F) Pyruvate
179 
 
 
  
Figure 7.5 Testing events in glycolysis system. Results without events are shown in gray.
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8 OVERALL SUMMARY 
 In this study, we have performed crystallographic study and structural modeling to investigate the 
structural basis of P5 recognition of executioner caspases. The S5 subsite of caspase-3 was identified by 
our group and further studied in caspase-6 and -7 [34, 37]. Caspase-3 and -6 recognize P5 in 
pentapeptides as shown by enzyme activity data and interactions observed in the crystal structure of 
caspase-3/LDESD and in a model for caspase-6. In caspase-3 the P5 main-chain was anchored by interac-
tions with Ser209 in loop-3 and the P5 Leu side-chain interacted with Phe250 and Phe252 in loop-4 con-
sistent with 50% increased hydrolysis of LDEVD relative to DEVD [37]. Binding of P5 residue into 
caspase-3 active site leads to conformational changes in the loop-4 via an induced fit mechanism [34, 37]. 
Caspase-6 formed similar interactions and showed a preference for polar P5 in QDEVD likely due to in-
teractions with polar Lys265 and hydrophobic Phe263 in loop-4. Caspase-7 exhibited no preference for 
P5 residue in agreement with the absence of P5 interactions in the caspase-7/LDESD crystal structure. 
Our structural and kinetic analysis of the preference of executioner caspases for the P5 position of sub-
strates will help identify the specific protein substrates and apoptotic pathways activated by each caspase. 
These findings are valuable in understanding the presence of redundant executioner caspases. Important-
ly, differences were identified in P5 recognition of caspase-3 and -7, which otherwise recognize very sim-
ilar substrates, and these differences were correlated with the residue present in the newly defined loop-3 
anchoring position and the caspase conformation with pentapeptides rather than tetrapeptides. Such dif-
ferences in substrate recognition can be exploited in the rational design of selective inhibitors, which has 
proved a challenge, especially for caspase-3 and -7. Selective pharmacological inhibitors of specific 
caspases are desirable to reduce cell death for treatment of diseases characterized by increased apoptosis, 
such as stroke, heart disease and neurodegenerative diseases. 
 The first crystal structure of D-arginine dehydrogenase was determined at 1.06 Å resolution and 
its substrate specificity has been thoroughly investigated by crystallography and kinetic study [45, 88].  
DADH catalyzes the conversion of D-arginine into 2-ketoarginine and ammonia. However, it is character-
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ized by broad substrate specificity, being able to oxidize basic and hydrophobic D-amino acids of various 
sizes, but not reacting with acidic D-amino acids [45, 84]. A ping-pong bi-bi kinetic mechanism has been 
established by steady-state kinetic studies with D-arginine or D-histidine as substrate [88]. Comparison of 
the structures of DADH in complexes with iminoarginine and iminohistidine indicated very distinct bind-
ing modes between the two ligands, which is in agreement with detailed kinetic analysis on substrate 
specificity reported previously [45, 84]. Structural analysis indicates that the negatively charged side 
chain of Glu87 may be responsible for the high selectivity of DADH for positively charged substrates like 
D-arginine and D-lysine. Other active site residues, such as Tyr53, Tyr249, Met240 and Val242, form 
hydrophobic walls for specificity of the long aliphatic and unbranched substrate. Further comparison of 
structures of the ligand-free DADH and its complexes with imino acids has revealed that the protein ac-
tive site undergoes major conformational upon binding of the ligand. Residues 50-56 were designated as 
an active site lid controlling the substrate accessibility to the active site, similar to those reported in other 
flavin-dependent enzymes [74]. It possesses a ligand-free conformation in the free enzyme but shows a 
product-bound conformation upon binding of the ligand. Comparison of DADH with other functional re-
lated enzymes like DAAO and L-amino acids oxidase has revealed some key components and structural 
arrangement that are responsible for their specificity toward different enantiomers and different amino 
acids [45]. Overall, the high-resolution structures for DADH will provide useful information for future 
studies of similar flavin-dependent enzymes [218]. 
 Besides the crystallographic study, we have performed computational study on a novel crossover 
system for simulating biochemical networks. We have extended the functions of this deterministic-
stochastic crossover method, making it a more competitive system for the simulation of biochemical net-
works while retaining accuracy and efficiency. The crossover method employs Bernoulli trial to introduce 
randomness into the simulation. Testing of this method on several systems like auto-regulatory gene net-
work indicated that it not only retains the efficiency of deterministic methods, but also reflects the fluc-
tuations generally only captured by stochastic methods [104]. When compared with other hybrid methods, 
the major advantage of our crossover method over these hybrid algorithms is it does not require partition-
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ing of the modeled system. It is not actually a combination of deterministic and stochastic methods, but a 
deterministic method with the randomness introduced by Bernoulli trial. We have also introduced XML 
representation into this crossover system. The standard format of model representation makes it very con-
venient for researchers to read, write, and modify the system. Further, it would be easier to transfer the 
system among different software platforms. Another notable feature of this crossover system is its capa-
bility of simulating more complex Michaelis-Menten type reactions, instead of being restricted to simple 
elementary reactions. Overall, development of this crossover system would be very useful for researches 
and applications based on systems biology. 
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APPENDICES 
Appendix A: List of crystal structures 
Protein  Ligand PDB code Resolution (Å) 
Caspases-3 Ac-LDESD-Cho 3EDQ 1.61  
Caspases-3 Ac-YVAD-Cho 3GJS 1.90 
DADH  3NYC 1.06 
DADH Imino-arginine 3NYE 1.30 
DADH imino-histidine 3NYF 1.30 
DADH Ketoleucine N5 adduct 3SM8 1.07 
DADH imino-lysine 4H1A 1.09 
DADH imino-methionine 4H1B 1.05 
DADH imino-phenylalanine 4H1C 1.05 
DADH imino-proline 4H1F 1.03 
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Appendix C: Mutagenesis study of DADH 
 Crystallographic study and kinetic studies have showed that DADH prefers positively charged D-
amino acids and our analysis suggested that DADH Glu87 may play an important role in its substrate 
specificity. In order to test this hypothesis, we have performed mutagenesis study followed by crystallo-
graphic study on this enzyme. The idea of this study is to mutate the negatively charged Glu87 into posi-
tively charged arginine or hydrophobic phe, in an attempt to see decreased activity towards positively 
charged D-amino acids but increased activity towards negatively charged or hydrophobic D-amino acids. 
In addition, we also made a mutation of Tyr53 into phe. Tyr53 is located on the "active site lid" of 
DADH. It undergoes a major conformational change and forms a polar interaction with the ligand with 
substrate binding. This residue may be important for the active site conformational change during the sub-
strate binding and product releasing. A mutation of Y53F will eliminate the polar interaction between 
Tyr53 and the ligand. We would like to investigate how this will affect the activity of DADH. 
 The standard site-directed mutagenesis protocol did not work well for introducing mutations 
E87R, E87F, and Y53F into the wild type DADH cDNA, respectively, due to the high GC content near 
these regions. Asymmetric PCR was then applied to construct the mutations. Taking mutation E87R as an 
example, the sequence between 5' NcoI site and DADH residue 87 were amplified with primers 5’-
GGAGGAATTAACCATGGGTCATCATC (NcoI cleavage site underlined) and 5'-
GACCACCATACGCGGACGC (E87R mutation site underlined). The sequence between DADH residue 
87 and 3' HindIII site were amplified with primers 5'- GCGTCCGCGTATGGTGGTC (E87R mutation 
site underlined) and 5'- GGTAAGCTTCA GGGGGACAGGCG (HindIII cleavage site underlined). The 
corresponding primers for E87F are 5'-GACCACCATGAACGGACGC and 5'-
GCGTCCGTTCATGGTGGTC, and the primers for Y53F are 5'-GTGCCGAAGGCCACCGTGTAG and 
5'- CTACACGGTGGCCTTCGGCAC. The two pieces of PCR products were then purified by gel extrac-
195 
tion kit and used as megaprimers for each other in the second PCR to generate the full length DADH se-
quence. Primers containing 5' NcoI site and 3' HindIII site were used to amplify the whole DADH se-
quence with desired mutation in the third PCR. The final PCR transcript was excised by NcoI and HindIII 
endonucleases and is subcloned into the expression vector pBAD-His-6 used in previous DADH studies 
[83]. The resulting plasmid was used to transform E. coli Top10, and transformants were selected on LB 
plates with ampicillin. The sequences of the mutations were confirmed by nucleotide sequencings with 
pBAD forward primer. The expression of these mutants followed the same as described in previous stud-
ies [45, 83]. 
